GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic Acidemia (MMA): This is an inherited metabolic disorder caused by a deficiency of methylmalonic acid (MMA) mutase enzyme. Patients with MMA present with symptoms such as metabolic acidosis, decreased methylmalonyl-CoA mutase activity, and can present with symptoms of metabolic crisis leading to death in infancy or childhood.

+2. Propionic Acidemia: This is another inherited metabolic disorder caused by a deficiency of propionyl-CoA carboxylase enzyme. Patients with propionic acidemia can present with symptoms such as metabolic acidosis, decreased methylmalonyl-CoA mutase activity, and can present with symptoms of metabolic crisis leading to death in infancy or childhood. However, they typically do not present with death in infancy as a primary symptom.

+3. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the branched-chain ketoacid dehydrogenase complex. Patients with MSUD can present with symptoms such as metabolic acidosis, but they do not typically present with decreased methylmalonyl-CoA mutase activity or death in infancy or childhood as primary symptoms. Instead, they typically present with a characteristic sweet urine odor, irritability, and developmental delay.

+4. Organic Acidemia: This is a broad category of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Patients with organic acidemia can present with symptoms such as metabolic acidosis, but the specific symptoms and underlying causes can vary widely. Some forms of organic acidemia may present with decreased methylmalonyl-CoA mutase activity and death in infancy or childhood, while others may not.

+5. Reye Syndrome: This is a rare but serious condition that can cause metabolic acidosis, liver damage, and brain swelling. It is typically associated with the use of aspirin in children with viral infections. Patients with Reye syndrome do not typically present with decreased methylmalonyl-CoA mutase activity or death in infancy or childhood as primary symptoms. Instead, they typically present with symptoms such as vomiting, lethargy, and confusion."
['Succinic semialdehyde dehydrogenase deficiency']," +1. Metabolic Disorder (Mucopolysaccharidoses): Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are common symptoms. Pneumonia and Death in infancy are variable symptoms.
+2. Muscular Dystrophy: Motor delay and Generalized hypotonia are common symptoms. Pneumonia and Death in infancy are not typical symptoms.
+3. Organic Acidemia: Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are common symptoms. Pneumonia is a variable symptom, and Death in infancy can occur in severe cases.
+4. Sepsis: Pneumonia is a common symptom. Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are not typical symptoms.
+5. Down Syndrome: Motor delay and Generalized hypotonia are common symptoms. Pneumonia and Death in infancy are not typical symptoms, but some individuals with Down Syndrome may experience increased susceptibility to respiratory infections.
+6. Hypothyroidism: Motor delay and Generalized hypotonia are common symptoms. Pneumonia is not a typical symptom, but hypothyroidism can increase the risk of respiratory infections. Elevated urinary carboxylic acid is not a symptom of hypothyroidism.
+7. Cerebral Palsy: Motor delay and Generalized hypotonia are common symptoms. Pneumonia is not a typical symptom, but individuals with Cerebral Palsy may be more susceptible to respiratory infections. Elevated urinary carboxylic acid is not a symptom of Cerebral Palsy.
+8. Scoliosis: Motor delay and Generalized hypotonia are not typical symptoms. Pneumonia is not a typical symptom, but scoliosis can increase the risk of respiratory infections. Elevated urinary carboxylic acid is not a symptom of scoliosis.
+9. Cystic Fibrosis: Motor delay and Generalized hypotonia are not typical symptoms. Pneumonia is a common symptom, and Elevated urinary carboxylic acid can be a marker for this condition. Death in infancy is a risk for severe cases."
['Phenylketonuria']," +1. Metabolic Disorders (Neonatal Onset): This category includes various metabolic disorders that can present with symptoms such as abnormality of prenatal development or birth, neonatal death, and death in infancy. Among these disorders, two specific conditions are worth considering:

   +1.1. Inherited Metabolic Disorders (IMDs): IMDs are a group of genetic disorders that affect the body's ability to process certain nutrients or metabolites. Hypertyrosinemia and Hyperphenylalaninemia are two examples of IMDs.

      + Symptoms in common: Abnormality of prenatal development or birth, neonatal death, and death in infancy.

      + Symptoms not in common: Hypertyrosinemia specifically presents with an excess of tyrosine in the blood, which can lead to liver damage and other complications. Hyperphenylalaninemia, on the other hand, is characterized by an excessive accumulation of phenylalanine in the blood due to a deficiency of the enzyme phenylalanine hydroxylase.

   +1.2. Inborn Errors of Metabolism (IEMs): IEMs are a subclass of IMDs that result from genetic mutations affecting specific enzymes or metabolic pathways. Both Hypertyrosinemia and Hyperphenylalaninemia are examples of IEMs.

      + Symptoms in common: Abnormality of prenatal development or birth, neonatal death, and death in infancy.

      + Symptoms not in common: Hypertyrosinemia specifically presents with an excess of tyrosine in the blood, while Hyperphenylalaninemia is characterized by an excessive accumulation of phenylalanine in the blood.

+2. Congenital Disorders: This category includes various genetic conditions that can present with symptoms such as abnormality of prenatal development or birth and neonatal death. Some examples include:

   +2.1. Down Syndrome: A chromosomal disorder caused by the presence of all or part of a third copy of chromosome 21. It can lead to developmental delays, intellectual disability, and characteristic physical features.

      + Symptoms in common: Abnormality of prenatal development or birth and neonatal death.

      + Symptoms not in common: Hypertyrosinemia and Hyperphenylalaninemia are not associated with Down Syndrome.

   +2.2. Cystic Fibrosis: A genetic disorder that affects the respiratory, digestive, and reproductive systems. It is characterized by the production of thick, sticky mucus that can obstruct airways and interfere with nutrient absorption.

      + Symptoms in common: Abnormality of prenatal development or birth and neonatal death (in severe cases).

      + Symptoms not in common: Hypertyrosinemia and Hyperphenylalaninemia are not associated with Cystic Fibrosis.

+3. Infectious Diseases: This category includes various infections that can present with symptoms such as neonatal death. Some examples include:

   +3.1. Neonatal Sepsis: An infection that occurs in newborns, typically caused by bacteria that enter the bloodstream during birth or shortly thereafter. It can lead to a range of symptoms, including fever"
['PMM2-CDG']," +1. Congenital diaphragmatic hernia: A birth defect where the diaphragm, the muscle that separates the chest and abdomen, does not form properly. Symptoms include difficulty breathing and feeding, and the patient may have a bulge in the chest area. + Common symptoms: Difficulty breathing, Failure to thrive. + Uncommon symptoms: Motor delay, Cerebellar atrophy, Cerebellar agenesis, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Death in infancy.

+2. Motor delay: A condition where the child's development of motor skills, such as crawling, walking, or using their hands, is delayed. + Common symptoms: Motor delay. + Uncommon symptoms: Congenital diaphragmatic hernia, Cerebellar atrophy, Failure to thrive, Cerebellar agenesis, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Death in infancy.

+3. Cerebellar atrophy: A condition where the cerebellum, a part of the brain that controls coordination and balance, shrinks in size. + Common symptoms: Cerebellar atrophy. + Uncommon symptoms: Congenital diaphragmatic hernia, Motor delay, Failure to thrive, Cerebellar agenesis, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Death in infancy.

+4. Failure to thrive: A condition where a child does not gain weight or grow at a normal rate. + Common symptoms: Failure to thrive, Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Cerebellar agenesis, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Death in infancy.

+5. Hiatus hernia: A condition where the stomach pushes up into the chest through an enlarged opening in the diaphragm. + Common symptoms: Hiatus hernia. + Uncommon symptoms: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Failure to thrive, Cerebellar agenesis, Lipodystrophy, Abnormal muscle physiology, Death in infancy.

+6. Lipodystrophy: A condition where there is a lack of fat tissue in certain parts of the body. + Common symptoms: None. + Uncommon symptoms: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Failure to thrive, Cerebellar agenesis, Hiatus hernia, Abnormal muscle physiology, Death in infancy.

+7. Abnormal muscle physiology: A condition where the muscles do not function properly. + Common symptoms: None. + Uncommon symptoms: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Failure to thrive, Cerebellar agenesis, Hiatus hernia, Lipodystrophy, Death in infancy.

+8. Cerebellar agenesis: A condition where the cerebellum does not develop properly in the womb. + Common symptoms: Cerebellar agenesis. + Uncommon symptoms: Congenital diaphragmatic hernia, Motor delay, Failure to thrive, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Death in infancy.

+9. Death"
['Maple syrup urine disease']," +1. Neurogenic Hypotonia: This condition is characterized by decreased muscle tone and weakness, which is often associated with neurological disorders. The patient presents with Generalized hypotonia.
+2. Congenital Nephropathies: A group of kidney disorders present at birth, which can cause Hydronephrosis and Elevated urinary carboxylic acid.
+3. Inborn Errors of Metabolism: A group of genetic disorders that affect the body's ability to process certain nutrients, such as Hypervalinemia, Hyperleucinemia, and Hyperisoleucinemia. The patient may also present with Intellectual disability, Delayed speech and language development, and Feeding difficulties.
+4. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It can cause Intellectual disability, Delayed speech and language development, Motor delay, and Hypotonia.
+5. Spinal Dysraphism: A group of birth defects affecting the formation of the spine and spinal cord, which can cause Kyphoscoliosis and Opisthotonus.
+6. Menkes Disease: A rare X-linked genetic disorder that affects the absorption of copper, leading to neurological symptoms such as Athetosis, Intellectual disability, and Motor delay.
+7. TORCH Infections: A group of infections caused by Toxoplasmosis, Other infections (such as syphilis), Rubella, Cytomegalovirus, and Herpes simplex virus. These infections can cause Intellectual disability, Delayed speech and language development, and Motor delay.
+8. Sepsis: A life-threatening condition caused by the body's response to an infection, which can lead to Fever, Neonatal death, and Death in childhood.
+9. Metabolic Disorders: A broad category of disorders that affect the body's metabolism, which can cause various symptoms such as Intellectual disability, Delayed speech and language development, Motor delay, and Feeding difficulties.
+10. Infectious Encephalopathy: An inflammation of the brain caused by an infection, which can lead to Intellectual disability, Delayed speech and language development, and Motor delay.
+11. Lysosomal Storage Disorders: A group of genetic disorders that affect the body's ability to break down certain substances, leading to various symptoms such as Intellectual disability, Delayed speech and language development, and Motor delay.
+12. Mitochondrial Disorders: A group of genetic disorders that affect the mitochondria, the energy-producing structures in cells, leading to various symptoms such as Intellectual disability, Delayed speech and language development, and Motor delay.
+13. Craniosynostosis: A birth defect that causes the premature fusion of one or more skull bones, which can lead to abnormal head shape and neurological symptoms such as Intellectual disability and Motor delay.
+14. Hydrocephalus: A condition characterized by an abnormal accumulation of cerebrospinal fluid in the brain, which can lead to Intellectual disability, Delayed speech and language development, and Motor delay.
+15. Rett Syndrome: A genetic disorder that affects girls, causing Intellectual disability, Delayed speech and language development, Motor delay, and Stereotypic movements.
+16. Corn"
['Phenylketonuria']," +1. Cystic Fibrosis: A genetic disorder that causes persistent lung infections and difficulty in digesting food due to thick and sticky mucus. Common symptoms: Skin rash (late in the disease), Recurrent viral infections, Neonatal death, Death in childhood. Uncommon symptoms: Abnormality of prenatal development or birth, Obesity, Diarrhea, Hypertyrosinemia, Hernia, Gastrointestinal inflammation, Hyperphenylalaninemia, Erythematous plaque, Erythematous macule, Erythematous papule.

+2. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. Common symptoms: Developmental delays, Abnormality of prenatal development or birth. Uncommon symptoms: Skin rash, Obesity, Death in infancy, Diarrhea, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Hernia, Erythematous plaque, Erythematous macule, Erythematous papule.

+3. Sickle Cell Anemia: A genetic disorder that affects the production of hemoglobin, leading to abnormal and crescent-shaped red blood cells. Common symptoms: Anemia, Recurrent infections. Uncommon symptoms: Skin rash, Abnormality of prenatal development or birth, Obesity, Death in infancy, Diarrhea, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Hernia, Erythematous plaque, Erythematous macule, Erythematous papule.

+4. Celiac Disease: An autoimmune disorder that damages the small intestine and interferes with the absorption of nutrients from food. Common symptoms: Diarrhea, Abdominal pain. Uncommon symptoms: Skin rash, Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Hernia, Erythematous plaque, Erythematous macule, Erythematous papule.

+5. Hemangioma: A benign tumor of the blood vessels, usually occurring in the skin. Common symptoms: Erythematous plaque, Erythematous macule, Erythematous papule. Uncommon symptoms: Skin rash, Abnormality of prenatal development or birth, Obesity, Death in infancy, Diarrhea, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Hernia.

+6. Hirschsprung's Disease: A congenital disorder of the enteric nervous system that results in the absence of ganglion cells in the distal part of the colon. Common symptoms: Constipation, Delayed passage of meconium. Uncommon symptoms: Skin rash, Abnormality of prenatal development or birth, Obesity, Death in infancy, Diarrhea, Hypertyrosinemia, Neonatal death"
['Biotinidase deficiency']," +1. Maple Syrup Urine Disease: This is an inherited metabolic disorder that affects the ability to break down certain amino acids, leading to an accumulation of toxic substances in the body. Symptoms include a distinctive sweet urine odor, vomiting, seizures, and developmental delays. The patient does not have the symptoms of obsolete eczematoid dermatitis, alopecia, or death in infancy.

+2. Lactic Acidosis: This is a metabolic disorder characterized by an excessive buildup of lactic acid in the blood. Symptoms include weakness, fatigue, shortness of breath, and abdominal pain. The patient has the symptoms of increased circulating lactate concentration and increased CSF lactate. The patient does not have the symptoms of obsolete eczematoid dermatitis, skin rash, or alopecia.

+3. Seborrheic Dermatitis: This is a common inflammatory skin condition that causes red, scaly patches, usually on the face, scalp, or other areas rich in sebaceous glands. Symptoms include itching, flaking, and dandruff. The patient has the symptom of skin rash but does not have the symptoms of obsolete eczematoid dermatitis, alopecia, death in infancy, or increased circulating lactate concentration.

+4. Alopecia Areata: This is an autoimmune disorder that causes hair loss, usually in circular patches. Symptoms include sudden hair loss, often starting with the head or beard area. The patient has the symptom of alopecia but does not have the symptoms of obsolete eczematoid dermatitis, skin rash, death in infancy, or increased circulating lactate concentration or increased CSF lactate.

+5. Menkes Disease: This is a rare genetic disorder that affects the absorption and utilization of copper, leading to impaired development and function of the nervous system and other organs. Symptoms include progressive neurological deterioration, growth retardation, and characteristic hair changes. The patient does not have the symptoms of obsolete eczematoid dermatitis, skin rash, death in infancy, or increased circulating lactate concentration but does have the symptom of alopecia (hair loss) in common. However, the hair loss in Menkes disease is typically different in appearance from that seen in alopecia areata."
['PMM2-CDG']," +1. Rod-cone dystrophy: A group of rare, genetic disorders that involve a progressive degeneration of the rod and cone photoreceptors in the retina. Common symptoms include night blindness, difficulty adapting to light changes, and gradual loss of central vision. The patient does not have intellectual disability, cerebellar atrophy, death in infancy, thromboembolism, abnormal facial shape, abnormal calvaria morphology, lipodystrophy, cerebellar agenesis, acute hepatitis, or chronic hepatitis.

+2. Intellectual disability: A condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This condition is present from birth or early childhood. The patient does not have rod-cone dystrophy, cerebellar atrophy, death in infancy, thromboembolism, abnormal facial shape, abnormal calvaria morphology, lipodystrophy, cerebellar agenesis, acute hepatitis, or chronic hepatitis.

+3. Cerebellar atrophy: A condition characterized by the degeneration of the cerebellum, which is the part of the brain responsible for coordination and balance. Symptoms include poor coordination, tremors, and difficulty with fine motor skills. The patient does not have rod-cone dystrophy, intellectual disability, death in infancy, thromboembolism, abnormal facial shape, abnormal calvaria morphology, lipodystrophy, cerebellar agenesis, acute hepatitis, or chronic hepatitis.

+4. Death in infancy: A condition that results in death before the age of one. This can be caused by various genetic, infectious, or environmental factors. The patient does not have rod-cone dystrophy, intellectual disability, cerebellar atrophy, thromboembolism, abnormal facial shape, abnormal calvaria morphology, lipodystrophy, cerebellar agenesis, acute hepatitis, or chronic hepatitis.

+5. Thromboembolism: A condition characterized by the formation of a blood clot that travels through the bloodstream and blocks a blood vessel. Symptoms include pain, swelling, and warmth in the affected area, as well as shortness of breath if the clot travels to the lungs. The patient does not have rod-cone dystrophy, intellectual disability, cerebellar atrophy, death in infancy, abnormal facial shape, abnormal calvaria morphology, lipodystrophy, cerebellar agenesis, acute hepatitis, or chronic hepatitis.

+6. Abnormal facial shape: A condition characterized by an unusual or asymmetrical facial appearance. This can be caused by various genetic or developmental conditions. The patient does not have rod-cone dystrophy, intellectual disability, cerebellar atrophy, death in infancy, thromboembolism, cerebellar agenesis, lipodystrophy, acute hepatitis, or chronic hepatitis.

+7. Abnormal calvaria morphology: A condition characterized by an abnormal shape or development of the skull. This can be caused by various genetic or developmental conditions. The patient does not have rod-cone dystrophy, intellectual disability, cerebellar atrophy, death in infancy, thromboembolism, facial shape abnormality, lipodystrophy, cerebellar agenesis, acute hepat"
['Glutaryl-CoA dehydrogenase deficiency']," +1. Trisomy 21 (Down syndrome): Macrocephaly, Lethargy, Generalized hypotonia, Dyspnea, Sleep abnormality, Neonatal death. +2. Pompe Disease: Macrocephaly, Lethargy, Generalized hypotonia, Dyspnea, Dystonia, Neonatal death, Decreased plasma free carnitine. +3. Cystic Fibrosis: Cystic hygroma (not common in CF), Lethargy, Generalized hypotonia, Dyspnea, Fever, Vomiting, Diarrhea, Drowsiness. +4. Mucopolysaccharidosis: Macrocephaly, Lethargy, Generalized hypotonia, Dyspnea, Dyspnea, Drowsiness, Sleep abnormality, Glutaric aciduria (not a typical symptom). +5. Neonatal Meningoencephalitis: Macrocephaly, Lethargy, Fever, Drowsiness, Dyspnea, Drowsiness, Sleep abnormality. +6. Neonatal Sepsis: Macrocephaly (rare), Lethargy, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality. +7. Neonatal Inherited Metabolic Disorders (various): Macrocephaly, Lethargy, Generalized hypotonia, Dyspnea, Dystonia, Neonatal death, Glutaric aciduria, Decreased plasma free carnitine. +8. Neonatal Inborn Errors of Metabolism (various): Macrocephaly, Lethargy, Generalized hypotonia, Dyspnea, Dystonia, Neonatal death, Glutaric aciduria, Dyskinesia."
['Isovaleric acidemia']," +1. Inborn Errors of Metabolism (IEM): This group of genetic disorders affects various metabolic processes. The patient exhibits symptoms such as Abnormality of prenatal development or birth, Neonatal death, and Abnormal circulating glycine concentration. They do not have symptoms like Lethargy or Drowsiness in common with IEM.

+2. Menkes Disease: A rare X-linked recessive disorder causing copper deficiency. The patient shows symptoms like Abnormality of prenatal development or birth, Neonatal death, and Abnormal circulating carnitine concentration. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+3. Maple Syrup Urine Disease (MSUD): An inherited metabolic disorder affecting the breakdown of certain amino acids. The patient presents with Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating glycine concentration, and Hyperammonemia. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+4. Zellweger Syndrome: A rare genetic disorder affecting the synthesis of certain proteins in the endoplasmic reticulum. The patient displays symptoms like Abnormality of prenatal development or birth, Neonatal death, and Abnormal circulating glycine concentration. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+5. Krabbe Disease: An inherited disorder affecting the myelin sheath in the central and peripheral nervous system. The patient presents with Abnormality of prenatal development or birth, Neonatal death, and Abnormal circulating carnitine concentration. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+6. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase. The patient displays symptoms like Abnormality of prenatal development or birth, Neonatal death, and Hyperammonemia. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+7. Organic Acidemias: A group of metabolic disorders affecting the breakdown of certain organic acids. The patient presents with Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating glycine concentration, and Abnormal circulating carnitine concentration. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+8. Citrullinemia: An inherited metabolic disorder affecting the urea cycle. The patient displays symptoms like Abnormality of prenatal development or birth, Neonatal death, and Hyperammonemia. They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+9. Galactosemia: An inherited metabolic disorder affecting the metabolism of galactose. The patient presents with Abnormality of prenatal development or birth, Neonatal death, and Lactose intolerance (not explicitly mentioned in the symptoms but can be inferred from Feeding difficulties). They do not have Lethargy, Drowsiness, or Sleep abnormality in common.

+10. Mitochondrial Disorders: A group of genetic disorders affecting the mitochondria. The patient displays symptoms like Abnormality of prenatal development or birth, Neonatal"
['PMM2-CDG']," +1. Down syndrome: Microcephaly, Intellectual disability, Motor delay, Cerebral hypotonia, Growth delay, Facial dysmorphism, Brachydactyly, Tongue protrusion, Congenital heart disease. (Strabismus, Nystagmus, Ataxia, Hyporeflexia, Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Cerebellar agenesis, Death in infancy: Not typically associated with Down syndrome)

+2. Rett syndrome: Microcephaly, Intellectual disability, Motor delay, Hypotonia, Breathing abnormalities, Scoliosis, Hand stereotypies, Loss of speech, Seizures. (Strabismus, Nystagmus, Ataxia, Growth delay, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis, Death in infancy: Not typically associated with Rett syndrome)

+3. Krabbe disease: Microcephaly, Intellectual disability, Motor delay, Hyporeflexia, Ataxia, Seizures, Deafness, Vision loss, Progressive neurological deterioration. (Strabismus, Nystagmus, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis, Growth delay, Death in infancy: Not typically associated with Krabbe disease)

+4. Joubert syndrome: Microcephaly, Intellectual disability, Motor delay, Ataxia, Hyporeflexia, Strabismus, Nystagmus, Cerebellar vermis hypoplasia, Breathing abnormalities. (Strabismus, Nystagmus, Ataxia, Hyporeflexia, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis, Growth delay, Death in infancy: Strabismus, Nystagmus, Ataxia, Hyporeflexia, Cerebellar vermis hypoplasia are common symptoms)

+5. Pelizaeus-Merzbacher disease: Microcephaly, Intellectual disability, Motor delay, Hyporeflexia, Ataxia, Nystagmus, Optic atrophy, Seizures. (Strabismus, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis, Growth delay, Death in infancy: Not typically associated with Pelizaeus-Merzbacher disease)

+6. Zellweger syndrome: Microcephaly, Intellectual disability, Motor delay, Hypotonia, Seizures, Hepatomegaly, Hypogonadism, Hypopigmentation. (Strabismus, Nystagmus, Ataxia, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis, Growth delay, Death in infancy: Not typically associated with Zellweger syndrome)

+7. Canavan disease: Microcephaly, Intellectual disability, Motor delay, Hypotonia, Progressive neurological deterioration, Seizures. (Strabismus, Nystagmus, Ataxia, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis, Growth delay, Death in infancy: Not typically associated with Canavan disease)

+8. Tay-Sachs disease: Microceph"
"['Methylmalonic acidemia with homocystinuria, type cblC']"," +1. Nystagmus: Involuntary and repetitive eye movements, which the patient exhibits. +2. Abnormality of prenatal development or birth: The patient's symptoms suggest a possible developmental issue. +3. Motor delay: The patient's motor development is delayed, which could indicate various neurological conditions. +4. Generalized hypotonia: Reduced muscle tone and weakness throughout the body. +5. Neonatal death or Death in infancy: Some of the listed symptoms, such as developmental issues and motor delay, could potentially lead to neonatal or infant death. +6. Ventricular septal defect: A congenital heart defect characterized by a hole in the wall separating the left and right ventricles. The patient does not have symptoms such as shortness of breath or heart murmur commonly associated with this condition. +7. Hyperammonemia: An accumulation of ammonia in the blood, which can lead to neurological symptoms such as developmental delay and muscle weakness. +8. Hyperhomocystinemia: An accumulation of homocysteine in the blood, which can lead to neurological symptoms such as developmental delay, muscle weakness, and mental retardation. +9. Hyperalaninemia: An accumulation of alanine in the blood, which can lead to neurological symptoms such as developmental delay and muscle weakness. +10. Methylmalonic aciduria: An inherited metabolic disorder characterized by the accumulation of methylmalonic acid in the body, which can lead to neurological symptoms such as developmental delay, muscle weakness, and mental retardation. +11. Elevated urinary carboxylic acid: An excess of carboxylic acid in the urine can indicate various metabolic disorders, such as methylmalonic aciduria or propionic acidemia. The patient does not have symptoms such as metabolic acidosis or ketoacidosis commonly associated with these conditions."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Reye's Syndrome: This is a rare but serious condition that affects the brain and liver, typically occurring in children and adolescents. Common symptoms include vomiting, lethargy, and brain swelling. Hypoglycemia, vomiting, and liver dysfunction are common in Reye's Syndrome. +2. Hepatitis A: This is a viral infection that causes inflammation of the liver. Symptoms include jaundice, abdominal pain, and fever. Hepatitis A can cause elevated circulating hepatic transaminase concentrations and diarrhea, but it is not associated with hypoglycemia or abnormal circulating carnitine concentrations. +3. Maple Syrup Urine Disease: This is an inherited metabolic disorder that affects the ability to break down certain amino acids. Symptoms include vomiting, lethargy, and developmental delay. Maple Syrup Urine Disease can cause elevated circulating hepatic transaminase concentrations and abnormal circulating carnitine concentrations, but it is not associated with hypoglycemia or diarrhea. +4. Zollinger-Ellison Syndrome: This is a condition characterized by the overproduction of stomach acid, leading to peptic ulcers and diarrhea. Symptoms include abdominal pain, diarrhea, and weight loss. Zollinger-Ellison Syndrome is not associated with hypoglycemia or elevated circulating hepatic transaminase concentrations. +5. Galactosemia: This is a genetic disorder that affects the body's ability to metabolize galactose, a sugar found in milk and milk products. Symptoms include vomiting, diarrhea, and jaundice. Galactosemia can cause hypoglycemia and elevated circulating hepatic transaminase concentrations, but it is not associated with abnormal circulating carnitine concentrations."
['Succinic semialdehyde dehydrogenase deficiency']," +1. Metabolic Acidosis: This condition is characterized by an excess accumulation of acid in the body fluids, resulting in a decrease in pH. The patient presents with symptoms such as Respiratory acidosis and Elevated urinary carboxylic acid.

+2. Renal Tubular Acidosis: This is a metabolic disorder that impairs the kidneys' ability to maintain the normal acid-base balance in the body. The patient exhibits symptoms of Hyponatremia and Elevated urinary carboxylic acid.

+3. Diabetic Ketoacidosis: A metabolic complication of diabetes mellitus, characterized by hyperglycemia, hyperketonemia, and metabolic acidosis. The patient does not have symptoms of Death in infancy or Neonatal death.

+4. Ethylene Glycol Poisoning: Ethylene glycol is a sweet-tasting, colorless, odorless liquid that can cause metabolic acidosis, kidney damage, and central nervous system depression. The patient presents with symptoms of Coma and Elevated urinary carboxylic acid.

+5. Hyperkalemia-induced Respiratory Acidosis: Hyperkalemia, or an excess of potassium in the blood, can lead to respiratory acidosis due to the inhibition of diaphragmatic contraction. The patient exhibits symptoms of Hyperkalemia and Respiratory acidosis.

+6. Severe Hypokalemia: Hypokalemia, or a deficiency of potassium in the blood, can lead to various symptoms, including muscle weakness, paralysis, and cardiac arrhythmias. The patient does not have symptoms of Coma, Death in infancy, Neonatal death, Hyponatremia, or Elevated urinary carboxylic acid.

+7. Hypernatremia: This condition is characterized by an excess of sodium in the blood, leading to an increase in osmolality and water loss from the body. The patient does not have symptoms of Coma, Death in infancy, Neonatal death, Hyperkalemia, Hyponatremia, or Elevated urinary carboxylic acid.

+8. Carbon Monoxide Poisoning: Carbon monoxide is a colorless, odorless gas that can cause methemoglobinemia, leading to respiratory acidosis and other symptoms. The patient presents with symptoms of Coma and Respiratory acidosis.

+9. Methanol Poisoning: Methanol is a toxic alcohol that can cause metabolic acidosis, blindness, and other symptoms. The patient does not have symptoms of Death in infancy, Neonatal death, Hyperkalemia, Hyponatremia, or Elevated urinary carboxylic acid.

+10. Lactic Acidosis: Lactic acidosis is a metabolic disorder characterized by an excess of lactic acid in the blood, leading to metabolic acidosis and other symptoms. The patient does not have symptoms of Coma, Death in infancy, Neonatal death, Hyperkalemia, Hyponatremia, or Elevated urinary carboxylic acid."
['Classic homocystinuria']," +1. Marfan Syndrome: Ptosis, Ectopia lentis, Long limbs (including hands and feet), Joint hypermobility, Chest deformities, Scoliosis, Disproportionate body, Dilated aortic root, Mitral valve prolapse, Dislocated lens, Prone to dislocations, Not Intellectual disability, Not Hyperhomocystinemia, Not Hypermethioninemia, Not Death in childhood or adolescence, Fatigue.

+2. Down Syndrome: Intellectual disability, Motor delay, Short stature, Flat face, Brachycephaly, Epicanthic folds, Brushfield spots, Small ears, Short neck, Hypotonia, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Not Hyperhomocystinemia, Not Hypermethioninemia, Not Death in childhood or adolescence, Fatigue.

+3. Ehlers-Danlos Syndrome: Joint hypermobility, Skin elasticity, Widened scars, Easy bruising, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Not Intellectual disability, Not Motor delay, Not Hyperhomocystinemia, Not Hypermethioninemia, Not Death in childhood or adolescence, Fatigue.

+4. Homocystinuria: Hyperhomocystinemia, Developmental delay, Mental retardation, Seizures, Muscle weakness, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Not Intellectual disability (mild), Not Motor delay, Not Fatigue, Death in childhood or adolescence if untreated.

+5. Methionine Alpha-Methyltransferase Deficiency: Hypermethioninemia, Developmental delay, Seizures, Muscle weakness, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Not Intellectual disability (mild), Not Motor delay, Not Fatigue, Death in childhood or adolescence if untreated.

+6. Prader-Willi Syndrome: Intellectual disability, Short stature, Hypotonia, Hyperphagia, Obesity, Small hands and feet, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Not Hyperhomocystinemia, Not Hypermethioninemia, Not Death in childhood or adolescence, Fatigue.

+7. Marfanoid Progeroid Syndrome: Marfanoid body habitus, Aging phenotype, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Not Intellectual disability, Not Motor delay, Not Hyperhomocystinemia, Not Hypermethioninemia, Not Death in childhood or adolescence, Fatigue.

+8. Morquio A Syndrome: Short stature, Corneal clouding, Skeletal dysplasia, Not Ptosis, Not Ectopia lentis, Not Large hands, Not Long foot, Intellectual disability, Motor delay, Not Hyperhomocystinemia, Not Hypermethioninemia, Not Death in childhood or adolescence, Fatigue.

+9. Morquio B Syndrome: Short stature"
[]," +1. Down syndrome: Wide mouth, Epicanthus, Sparse hair, Developmental delays, Heart defects (not mentioned in symptoms) +2. Cretinism: Wide mouth, Sparse hair, Hypothyroidism (not mentioned in symptoms), Mental retardation, Goiter (not mentioned in symptoms) +3. Phenylketonuria (PKU): Seizure, Developmental delays, Feeding difficulties, Abnormal metabolism of phenylalanine (not mentioned in symptoms) +4. Sickle cell anemia: Abnormal hemoglobin, Anemia, Painful swelling of hands and feet (not mentioned in symptoms) +5. Diabetes mellitus: Hyperinsulinemia, Hypoglycemia, Polyuria, Polydipsia, Weight loss (not mentioned in symptoms) +6. Celiac disease: Feeding difficulties, Abdominal pain, Diarrhea (not mentioned in symptoms), Malnutrition (not mentioned in symptoms) +7. Epilepsy: Seizure (not mentioned if it's a single seizure or a recurrent condition) +8. Ricketts: Sparse hair, Rickets (not mentioned in symptoms), Bowing of legs, Painful bones (not mentioned in symptoms) +9. Cystic fibrosis: Feeding difficulties, Persistent cough, Frequent lung infections (not mentioned in symptoms) +10. Marfan syndrome: Tall stature, Long, thin limbs, Chest deformity, Dislocated joints (not mentioned in symptoms) +11. Hemochromatosis: Abdominal pain, Joint pain, Fatigue, Diarrhea (not mentioned in symptoms), Cirrhosis (not mentioned in symptoms) +12. Thalassemia: Abnormal hemoglobin, Anemia, Jaundice (not mentioned in symptoms), Splenomegaly (not mentioned in symptoms)"
['Propionic acidemia']," +1. Metabolic Disorders: This group of disorders includes various conditions that affect the body's ability to convert food into energy. The patient presents with the following symptoms: Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Anemia, Hepatomegaly, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration. The patient does not have Hyperammonemia, Hyperglycinemia, or Hypoglycinemia.

+2. Inborn Errors of Metabolism: These are genetic disorders that affect specific metabolic pathways. The patient exhibits the following symptoms: Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Anemia, Hepatomegaly, Neonatal death, Death in childhood. The patient does not have Hyperammonemia, Hyperglycinemia, or Hypoglycinemia. Some possible inborn errors of metabolism that could be considered include Pompe disease, Mucopolysaccharidoses, and Gaucher disease.

+3. Neurological Disorders: A variety of conditions that affect the nervous system can cause developmental delays, intellectual disability, and seizures. The patient shows the following symptoms: Intellectual disability, Seizure, Motor delay. The patient does not have Abnormality of prenatal development or birth, Anemia, Hepatomegaly, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Hyperammonemia, Hyperglycinemia, or Hypoglycinemia. Some possible neurological disorders that could be considered include Cerebral Palsy, Epilepsy, and Down syndrome.

+4. Genetic Disorders: Genetic conditions can cause a wide range of symptoms, including developmental delays, intellectual disability, and seizures. The patient presents with the following symptoms: Intellectual disability, Seizure, Motor delay. The patient does not have Abnormality of prenatal development or birth, Anemia, Hepatomegaly, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Hyperammonemia, Hyperglycinemia, or Hypoglycinemia. Some possible genetic disorders that could be considered include Fragile X syndrome, Fetal Alcohol Spectrum Disorders, and Turner syndrome.

+5. Liver Disorders: Conditions that affect the liver can cause developmental delays, intellectual disability, and hepatomegaly. The patient shows the following symptoms: Intellectual disability, Seizure, Motor delay, Hepatomegaly. The patient does not have Abnormality of prenatal development or birth, Anemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Hyperammonemia, Hyperglycinemia, or Hypoglycinemia. Some possible liver disorders that could be considered include Hemochromatosis, Wilson disease, and Alpha-1 antitrypsin deficiency."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic Acidemia (MMA): This is a metabolic disorder caused by a deficiency of methylmalonic acid (MMA) mutase enzyme. The patient presents with symptoms such as Generalized hypotonia, Metabolic acidosis, Methylmalonic aciduria, and Abnormal nervous system physiology. +2. Menkes Disease: A genetic disorder caused by mutations in the ATP7A gene, leading to copper deficiency. The patient does not have Thrombocytopenia and Leukopenia but presents with Neonatal death, Decreased methylmalonyl-CoA mutase activity, and Feeding difficulties. +3. Severe Combined Immunodeficiency (SCID): A group of disorders that impair the immune system, leading to recurrent infections. The patient does not have Hypotonia, Metabolic acidosis, Apnea, or Methylmalonic aciduria but presents with Thrombocytopenia and Leukopenia. +4. Zellweger Syndrome: A rare genetic disorder that affects the synthesis of certain proteins involved in the formation of myelin sheaths around nerve fibers. The patient presents with Hypotonia, Neonatal death, and Abnormal nervous system physiology but does not have Thrombocytopenia, Leukopenia, Metabolic acidosis, Apnea, or Methylmalonic aciduria. +5. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase. The patient does not have Thrombocytopenia, Leukopenia, Metabolic acidosis, Apnea, or Methylmalonic aciduria but presents with Generalized hypotonia and Feeding difficulties."
['Systemic primary carnitine deficiency']," +1. Reye's Syndrome: Coma, Vomiting, Elevated circulating alkaline phosphatase concentration, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration. This disease is characterized by acute encephalopathy and fatty infiltration of the liver, often occurring in children after viral infection or following aspirin use.

+2. Hepatocellular Carcinoma: Hypoglycemia, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration. This is a type of liver cancer that can cause a variety of symptoms, including jaundice, abdominal pain, and weight loss. Hypoglycemia is not a common symptom.

+3. Wilson's Disease: Hepatocellular Carcinoma (some symptoms in common), Coma (rare), Sudden death (rare), Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration. Wilson's disease is a genetic disorder that causes copper to accumulate in the liver, brain, and other organs. It can lead to liver damage, neurological symptoms, and psychiatric problems.

+4. Maple Syrup Urine Disease: Coma, Vomiting, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. This is an inherited metabolic disorder that affects the ability to break down certain amino acids, leading to their accumulation in the body. Symptoms can include vomiting, lethargy, and developmental delay. Hypoglycemia, Sudden death, Elevated circulating alkaline phosphatase concentration, and Increased circulating lactate dehydrogenase concentration are not typical symptoms.

+5. Galactosemia: Hypoglycemia, Vomiting, Decreased plasma free carnitine, Abnormal circulating alanine concentration. This is a genetic disorder that affects the ability to metabolize galactose, a sugar found in milk and other dairy products. Symptoms can include vomiting, diarrhea, and developmental delay. Coma, Sudden death, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, and Increased circulating lactate dehydrogenase concentration are not typical symptoms.

+6. Fulminant Hepatic Failure: Coma, Sudden death, Hypoglycemia, Elevated circulating alkaline phosphatase concentration, Increased circulating lactate dehydrogenase concentration. This is a severe and rapid form of liver failure that can be caused by various conditions, including viral hepatitis, drug toxicity, and metabolic disorders. Symptoms can include confusion, jaundice, and bleeding. Vomiting, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, and Abnormal circulating alanine concentration are not typical symptoms.

+7. Sepsis:"
['3-methylcrotonyl-CoA carboxylase deficiency']," +1. Metabolic Disorder (Carnitine Deficiency): Lethargy, Decreased plasma free carnitine +2. Neurological Disorder (Cerebral Palsy): Clumsiness, Poor coordination +3. Mitochondrial Disorder: Lethargy, Drowsiness, Sleep abnormality +4. Inherited Metabolic Disease (Phenylketonuria): Feeding difficulties (if not treated) +5. Neurological Disorder (Hypotonia): Lethargy, Poor coordination, Clumsiness +6. Inborn Error of Metabolism (Maple Syrup Urine Disease): Lethargy, Poor feeding, Decreased plasma free carnitine +7. Neurological Disorder (Ataxia): Poor coordination, Drowsiness, Decreased plasma free carnitine +8. Genetic Disorder (Down Syndrome): Lethargy, Decreased plasma free carnitine, Developmental delays (including feeding difficulties and poor coordination) +9. Genetic Disorder (Pompe Disease): Lethargy, Muscle weakness, Feeding difficulties (in infancy) +10. Genetic Disorder (Huntington's Disease): Drowsiness, Poor coordination (later in life) +11. Genetic Disorder (Spinal Muscular Atrophy): Poor coordination, Weakness, Decreased plasma free carnitine (type 3) +12. Genetic Disorder (Mucopolysaccharidosis): Lethargy, Developmental delays, Feeding difficulties (in infancy) +13. Genetic Disorder (Gaucher Disease): Lethargy, Poor coordination, Decreased plasma free carnitine (type 3) +14. Genetic Disorder (Tay-Sachs Disease): Lethargy, Decreased plasma free carnitine, Progressive neurological deterioration (in childhood) +15. Genetic Disorder (Canavan Disease): Lethargy, Decreased plasma free carnitine, Progressive neurological deterioration (in infancy)"
[]," +1. Dysarthria: Motor speech disorder causing difficulty in articulating words due to muscle weakness or poor coordination. (Common symptoms: Speech difficulties, +Hypothyroidism: Hormonal disorder causing low thyroid function, +Encephalopathy: Brain dysfunction, +Spasticity: Increased muscle tone and reflexes)

+2. Spastic Diplegia: A form of cerebral palsy characterized by stiffness and spasms in the legs. (Common symptoms: +Delayed speech and language development, +Spasticity)

+3. Ethylmalonic Aciduria: A metabolic disorder caused by a deficiency in the enzyme ethylmalonic encephalopathy, leading to the accumulation of ethylmalonic acid in the body. (Common symptoms: +Recurrent viral infections, +Abnormal circulating glycine concentration, +Death in adolescence or early adulthood)

+4. Cytochrome C Oxidase-negative muscle fibers: A condition characterized by the absence of cytochrome C oxidase in muscle fibers, leading to impaired energy production. (Common symptoms: +Muscle weakness, +Delayed speech and language development, +Hypothyroidism)

+5. Hypothyroidism: A hormonal disorder causing low thyroid function, leading to various symptoms such as delayed growth, fatigue, and cognitive impairment. (Common symptoms: +Delayed speech and language development, +Constipation, +Weight gain, +Cold intolerance, +Dry skin, +Depression, +Forgetfulness, +Heart problems, +Joint pain, +Muscle weakness)

+6. Encephalopathy: A general term for any disorder affecting the brain, leading to impaired mental function, consciousness, or behavior. (Common symptoms: +Delayed speech and language development, +Seizures, +Lethargy, +Confusion, +Abnormal reflexes)

+7. Hyperreflexia: An abnormal increase in muscle reflexes, often a sign of neurological disorders. (Common symptoms: +Spasticity, +Muscle weakness, +Tendon reflexes are increased)

+8. Spastic Tetraplegia: A form of cerebral palsy affecting all four limbs, characterized by stiffness and spasms. (Common symptoms: +Delayed speech and language development, +Spasticity, +Difficulty with fine motor skills)

+9. Hyperglycinemia: A metabolic disorder caused by a deficiency in the enzyme N-acetyltransferase, leading to the accumulation of glycine in the body. (Common symptoms: +Abnormal circulating glycine concentration, +Seizures, +Hypotonia, +Lethargy, +Poor feeding, +Vomiting, +Death in infancy or early childhood)

+10. Rett Syndrome: A neurodevelopmental disorder characterized by regression of development, seizures, and stereotypic movements. (Common symptoms: +Delayed speech and language development, +Hypotonia, +Stereotypic movements, +Breathing abnormalities, +Seizures)"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorders (Includes inborn errors of metabolism): Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+2. Carnitine Deficiency: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+3. Organic Acidemias: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration (some types).
+4. Lysosomal Storage Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+5. Mitochondrial Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+6. Congenital Heart Diseases: Abnormality of prenatal development or birth, Neonatal death (in some cases) (not directly related to the given symptoms).
+7. Inborn Errors of Immunity: Death in infancy (in some cases), Neonatal death (in some cases) (not directly related to the given symptoms).
+8. Sepsis: Neonatal death (in some cases) (not directly related to the given symptoms).
+9. Respiratory Distress Syndrome: Neonatal death (in some cases) (not directly related to the given symptoms).
+10. Congenital Infections: Neonatal death (in some cases) (not directly related to the given symptoms).

Please note that the given symptoms are not exclusive to any single disease, and a proper diagnosis would require further testing and evaluation by a healthcare professional."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Mornar syndrome: Macrocephaly, Cystic hygroma, Generalized hypotonia, Dyspnea, Neonatal death, Decreased plasma free carnitine. This condition is characterized by macrocephaly, cystic hygromas, hypotonia, and respiratory distress. Patients may also experience neonatal death and decreased plasma free carnitine. However, they do not typically present with fever, vomiting, diarrhea, dyspnoea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, or dystonia.

+2. Down syndrome: Macrocephaly, Generalized hypotonia, Dyspnea, Sleep abnormality. Down syndrome is characterized by intellectual and developmental disabilities, as well as physical features such as macrocephaly and hypotonia. Some individuals with Down syndrome may experience respiratory issues and sleep disturbances. However, they do not typically present with cystic hygromas, fever, vomiting, diarrhea, dystonia, lethargy, or metabolic acidosis.

+3. Pompe disease: Generalized hypotonia, Dyspnea, Elevated circulating glutaric acid concentration, Elevated circulating glutaric acid concentration. Pompe disease is a lysosomal storage disorder characterized by progressive muscle weakness and respiratory distress. Patients may also experience elevated circulating glutaric acid concentration. However, they do not typically present with macrocephaly, cystic hygromas, fever, vomiting, diarrhea, dystonia, lethargy, or death in infancy or childhood.

+4. Krabbe disease: Lethargy, Dyspnea, Sleep abnormality, Neonatal death. Krabbe disease is a demyelinating disorder characterized by progressive neurological deterioration. Patients may experience lethargy, respiratory distress, and sleep disturbances. Some may also experience neonatal death. However, they do not typically present with macrocephaly, cystic hygromas, fever, vomiting, diarrhea, dystonia, or metabolic acidosis.

+5. Maple Syrup Urine Disease: Vomiting, Diarrhea, Elevated circulating glutaric acid concentration, Elevated circulating glutaric acid concentration. Maple Syrup Urine Disease is a metabolic disorder characterized by the inability to metabolize certain amino acids, leading to the accumulation of ketoacids in the body. Patients may experience vomiting, diarrhea, and elevated circulating glutaric acid concentration. However, they do not typically present with macrocephaly, cystic hygromas, lethargy, dystonia, or death in infancy or childhood.

+6. Dystonia: Dystonia, Generalized hypotonia. Dystonia is a neurological disorder characterized by involuntary muscle contractions leading to repetitive twisting movements or abnormal postures. Patients may also experience generalized hypotonia. However, they do not typically present with macrocephaly, cystic hygromas, fever, vomiting, diarrhea, lethargy, or metabolic acidosis.

+7. Metachromatic leukodystrophy: Dyspnea, Neonatal death"
['Phenylketonuria']," +1. Hemangioma Nidalis: A group of benign vascular tumors that can occur in various organs, including the liver. This condition is not directly related to the given symptoms, but some cases may present with neonatal death or death in infancy if the liver is affected.

+2. Cystic Fibrosis: A genetic disorder that affects the respiratory, digestive, and reproductive systems. Common symptoms include persistent coughing, lung infections, difficulty breathing, and malnutrition. While not directly related to the given symptoms, some individuals with Cystic Fibrosis may experience neonatal death or death in childhood due to respiratory complications.

+3. Tay-Sachs Disease: A rare, inherited metabolic disorder caused by a deficiency of the enzyme hexosaminidase A. Symptoms include progressive loss of motor skills, vision, and intellectual abilities, usually starting in infancy or early childhood. This condition is not directly related to the given symptoms of abnormal prenatal development or birth, but it can result in neonatal death or death in infancy.

+4. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. Common symptoms include developmental delays, intellectual disability, and characteristic physical features. While not directly related to the given symptoms of Hypertyrosinemia and Hyperphenylalaninemia, individuals with Down Syndrome may have an increased risk of developing these conditions due to their genetic makeup.

+5. Sickle Cell Anemia: A genetic disorder that affects the production of hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. Symptoms include anemia, pain crises, and organ damage. While not directly related to the given symptoms of Hypertyrosinemia and Hyperphenylalaninemia, individuals with Sickle Cell Anemia may have an increased risk of developing these conditions due to their genetic makeup.

+6. Inherited Metabolic Disorders: A group of disorders caused by genetic mutations that affect the body's ability to process certain nutrients or metabolites. Symptoms can vary widely depending on the specific disorder, but may include developmental delays, intellectual disability, seizures, and organ damage. Both Hypertyrosinemia and Hyperphenylalaninemia are examples of inherited metabolic disorders.

+7. Neonatal Lupus: A rare autoimmune disorder that can affect newborns whose mothers have systemic lupus erythematosus (SLE). Symptoms include rash, liver problems, and heart problems. While not directly related to the given symptoms of Hypertyrosinemia and Hyperphenylalaninemia, neonatal lupus can result in neonatal death or death in infancy due to heart or liver complications.

+8. Inborn Errors of Metabolism: A group of genetic disorders that affect the body's ability to metabolize certain nutrients or metabolites. Symptoms can vary widely depending on the specific disorder, but may include developmental delays, intellectual disability, seizures, and organ damage. Both Hypertyrosinemia and Hyperphenylalaninemia are examples of inborn errors of metabolism.

+9. Mitochondrial Disorders: A group of genetic disorders that affect the mitochondria, the energy-producing structures in cells. Symptoms can vary widely depending on the specific"
['L-2-hydroxyglutaric aciduria']," +1. Cerebral Palsy: Delayed speech and language development, Intellectual disability, Hyperreflexia, Difficulty walking, Abnormal cerebral white matter morphology.
+2. Rett Syndrome: Delayed speech and language development, Intellectual disability, Difficulty walking, Difficulty climbing stairs, Abnormal cerebral white matter morphology.
+3. Spinal Muscular Atrophy: Intellectual disability, Difficulty walking, Difficulty climbing stairs, Death in childhood.
+4. Metachromatic Leukodystrophy: Delayed speech and language development, Intellectual disability, Abnormal cerebral white matter morphology, Death in childhood.
+5. Duchenne Muscular Dystrophy: Intellectual disability, Difficulty walking, Difficulty running, Death in childhood.
+6. Krabbe Disease: Delayed speech and language development, Intellectual disability, Abnormal cerebral white matter morphology, Death in infancy.
+7. Huntington's Disease: Intellectual disability, Difficulty walking, Difficulty running (onset in adulthood).
+8. Friedreich's Ataxia: Intellectual disability, Difficulty walking, Difficulty running, Abnormal cerebral white matter morphology.
+9. Pompe Disease: Intellectual disability, Difficulty walking, Muscle weakness (onset in infancy).
+10. Down Syndrome: Delayed speech and language development, Intellectual disability.

Note: This list is not exhaustive and other conditions may also present with similar symptoms. A proper diagnosis requires a thorough medical evaluation by a healthcare professional."
['Maple syrup urine disease']," +1. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-1,4-glucosidase, leading to glycogen accumulation in various tissues. Symptoms: Apathy, Generalized hypotonia, Neonatal death, and Death in early aduldomhood.
+2. Krabbe Disease: A demyelinating disorder caused by a deficiency of galactocerebrosidase, leading to the accumulation of galactosylsphingosine (psychosine) in the central nervous system. Symptoms: Spasticity, Neonatal death, and Death in early adulthood.
+3. Mucopolysaccharidosis Type I: A lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, leading to the accumulation of dermatan and heparan sulfate in various tissues. Symptoms: Apathy, Spasticity, Generalized hypotonia, and Hypoglycemia.
+4. Prader-Willi Syndrome: A genetic disorder caused by a deletion or mutation of genes on chromosome 15, leading to hypothalamic dysfunction. Symptoms: Apathy, Obesity, and Hypoglycemia.
+5. Maple Syrup Urine Disease: An inherited metabolic disorder caused by a deficiency of branched-chain ketoacid dehydrogenase complex, leading to the accumulation of branched-chain amino acids in the blood and urine. Symptoms: Hypoglycemia, Hypervalinemia, Hyperleucinemia, and Hyperisoleucinemia.
+6. Zellweger Syndrome: A peroxisomal disorder caused by a deficiency of multiple peroxisomal proteins, leading to the accumulation of very long-chain fatty acids and other metabolites in various tissues. Symptoms: Neonatal death and Death in infancy.
+7. Gaucher Disease: A lysosomal storage disorder caused by a deficiency of glucocerebrosidase, leading to the accumulation of glucocerebroside in various tissues. Symptoms: Apathy, Spasticity, and Generalized hypotonia (not typically associated with this disease).
+8. Canavan Disease: A metabolic disorder caused by a deficiency of aspartoacylase, leading to the accumulation of N-acetylaspartic acid in the brain. Symptoms: Apathy, Spasticity, and Neonatal death (not typically associated with this disease).
+9. Tay-Sachs Disease: A lysosomal storage disorder caused by a deficiency of hexosaminidase A, leading to the accumulation of GM2 ganglioside in the brain. Symptoms: Apathy, Spasticity, and Neonatal death (not typically associated with this disease).
+10. Niemann-Pick Disease Type A: A lysosomal storage disorder caused by a deficiency of sphingomyelinase, leading to the accumulation of sphingomyelin and cholesterol in various tissues. Symptoms: Apathy, Spasticity, and Hypoglycemia (not typically associated with this disease)."
['Classic galactosemia']," +1. Metachromatic Leukodystrophy: Delayed speech and language development, Abnormality of galactoside metabolism, Death in adolescence. +2. Pompe Disease: Delayed speech and language development, Obesity, Hyperalaninemia, Aminoaciduria. +3. Galactosemia: Delayed speech and language development, Abnormality of galactoside metabolism, Hypergalactosemia. +4. Tyrosinemia: Abnormal circulating tyrosine concentration, Death in infancy. +5. Hemolytic Anemia: Increased total bilirubin, Death in infancy. +6. Maple Syrup Urine Disease: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration. +7. Wilson's Disease: No symptoms in common with the given list. +8. Cystic Fibrosis: No symptoms in common with the given list. +9. Down Syndrome: Delayed speech and language development, but no other symptoms in common. +10. Celiac Disease: No symptoms in common with the given list."
['3-hydroxy-3-methylglutaric aciduria']," +1. Metabolic Acidosis: A metabolic disorder characterized by a buildup of acid in the body. The patient presents with metabolic acidosis and elevated urinary carboxylic acid.
+2. Dicarboxylic Aciduria: A group of metabolic disorders characterized by an excessive excretion of dicarboxylic acids in the urine. The patient exhibits dicarboxylic aciduria and metabolic acidosis.
+3. 3-Methylglutaric Aciduria: A metabolic disorder caused by a deficiency of the enzyme 3-methylglutaconate CoA-transferase. The patient shows symptoms of 3-methylglutaric aciduria, metabolic acidosis, and elevated urinary carboxylic acid.
+4. Reye's Syndrome: A rare, life-threatening condition that affects the brain and liver, often following a viral infection. The patient does not present with Reye's Syndrome as it does not typically cause hyperammonemia or abnormal circulating glycine concentration.
+5. Maple Syrup Urine Disease: An inherited metabolic disorder caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase complex. The patient does not have Maple Syrup Urine Disease as it primarily affects the excretion of leucine, isoleucine, and valine, and does not typically cause metabolic acidosis or hyperammonemia.
+6. Urea Cycle Disorders: A group of metabolic disorders that affect the urea cycle, leading to the accumulation of ammonia in the blood. The patient presents with hyperammonemia and metabolic acidosis, making Urea Cycle Disorders a potential diagnosis.
+7. Organic Acidemias: A group of metabolic disorders characterized by the accumulation of organic acids in the body due to a deficiency of specific enzymes. The patient exhibits symptoms of organic acidemias, including dicarboxylic aciduria, metabolic acidosis, and hyperammonemia.
+8. Propionic Acidemia: A metabolic disorder caused by a deficiency of propionyl-CoA carboxylase. The patient shows symptoms of propionic acidemia, including metabolic acidosis, hyperammonemia, and vomiting.
+9. Glutaric Acidemia Type I: A metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. The patient exhibits symptoms of Glutaric Acidemia Type I, including metabolic acidosis, hyperammonemia, and vomiting.
+10. Isovaleric Acidemia: A metabolic disorder caused by a deficiency of isovaleryl-CoA dehydrogenase. The patient does not have Isovaleric Acidemia as it primarily affects the excretion of isovaleric acid and does not typically cause metabolic acidosis or hyperammonemia."
['Classic homocystinuria']," +1. Hemolytic Anemia: This condition is characterized by the destruction of red blood cells, leading to anemia and jaundice. The patient presents with anemia and jaundice. +2. Metabolic Disorder (Phenylketonuria): This genetic disorder impairs the ability to metabolize phenylalanine, leading to an accumulation of this amino acid in the blood. The patient does not have symptoms of phenylketonuria, as there is no mention of a specific odor to the urine or breath. +3. Neurometabolic Disorder (Krabbe Disease): This condition is characterized by the destruction of the myelin sheath in the nervous system, leading to neurologic deterioration and death in childhood. The patient presents with progressive neurologic deterioration and death in childhood. +4. Inherited Disorder (Sickle Cell Anemia): This condition is characterized by the production of abnormal hemoglobin, leading to anemia, jaundice, and recurrent infections. The patient presents with anemia, jaundice, and recurrent viral infections. +5. Neurometabolic Disorder (Methylmalonic Acidemia): This condition is characterized by an impairment in the metabolism of methylmalonic acid, leading to metabolic acidosis, neurologic symptoms, and developmental delay. The patient does not have symptoms of metabolic acidosis or developmental delay. +6. Neurometabolic Disorder (Canavan Disease): This condition is characterized by the breakdown of N-acetylaspartic acid, leading to neurologic deterioration and death in childhood. The patient presents with progressive neurologic deterioration and death in childhood. +7. Inherited Disorder (Fanconi Anemia): This condition is characterized by bone marrow failure, anemia, and developmental abnormalities. The patient does not have symptoms of developmental abnormalities. +8. Metabolic Disorder (Maple Syrup Urine Disease): This condition is characterized by an impairment in the metabolism of branched-chain amino acids, leading to an accumulation of these amino acids in the urine and neurologic symptoms. The patient does not have symptoms of an abnormal urine odor or neurologic symptoms. +9. Inherited Disorder (Tay-Sachs Disease): This condition is characterized by the breakdown of a lipid called GM2 ganglioside, leading to neurologic deterioration and death in childhood. The patient presents with progressive neurologic deterioration and death in childhood. +10. Metabolic Disorder (Gaucher Disease): This condition is characterized by the accumulation of a lipid called glucocerebroside in various tissues, leading to anemia, hepatosplenomegaly, and bone involvement. The patient does not have symptoms of hepatosplenomegaly or bone involvement."
['Phenylketonuria']," +1. Cystic Fibrosis: A genetic disorder that causes persistent lung infections and difficulty in breathing due to thick and sticky mucus. +Symptoms: Upper airway obstruction, Death in childhood, Death in adolescence, Death in early adulthood

+2. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. +Symptoms: Abnormality of prenatal development or birth, Death in infancy, Death in childhood (rare), Hypertyrosinemia (mild), Neonatal death (rare)

+3. Phenylketonuria (PKU): A genetic disorder that affects the metabolism of the amino acid phenylalanine. +Symptoms: Hyperphenylalaninemia, Neonatal death (if untreated), Death in infancy (if untreated), Death in childhood (if untreated), Death in early adulthood (if untreated)

+4. Tay-Sachs Disease: A genetic disorder that causes progressive damage to the nervous system. +Symptoms: Neonatal death, Death in childhood, Death in early adulthood

+5. Marfan Syndrome: A genetic disorder that affects the connective tissue, causing problems with the heart, eyes, and skeleton. +Symptoms: Abnormality of prenatal development or birth (rare), Upper airway obstruction (rare), Death in adolescence (rare), Death in early adulthood (rare)

+6. Sickle Cell Anemia: A genetic disorder that affects the production of hemoglobin in the red blood cells. +Symptoms: Neonatal death (rare), Death in childhood, Death in early adulthood

+7. Thalassemia: A group of genetic disorders that affect the production of hemoglobin. +Symptoms: Neonatal death (rare), Death in childhood, Death in early adulthood

+8. Congenital Diaphragmatic Hernia: A birth defect that causes the diaphragm to have a hole, allowing the abdominal organs to move into the chest cavity. +Symptoms: Abnormality of prenatal development or birth, Neonatal death (if untreated), Death in infancy (if untreated)

+9. Spinal Muscular Atrophy: A genetic disorder that causes progressive muscle weakness and wasting. +Symptoms: Death in childhood, Death in early adulthood

+10. Duchenne Muscular Dystrophy: A genetic disorder that causes progressive muscle weakness and wasting, primarily affecting boys. +Symptoms: Death in childhood, Death in early adulthood

+11. Hemolytic Disease of the Newborn: A condition caused by Rh incompatibility between the mother and the fetus. +Symptoms: Neonatal death (if untreated), Death in infancy (if untreated)

+12. Congenital Heart Disease: A group of birth defects that affect the structure and function of the heart. +Symptoms: Neonatal death (if severe), Death in infancy (if severe), Death in childhood (if severe), Death in early adulthood (if severe)

+13. Neonatal Lupus: A condition caused by a mother's autoantibodies that can affect the baby's heart or skin. +Symptoms:"
['Biotinidase deficiency']," +1. Metabolic Disorders (e.g., Mitochondrial Diseases): Apathy, Fatigue, Elevated urinary carboxylic acid.
+2. Epilepsy: Seizure.
+3. Cerebral Palsy: Spasticity, Death in infancy (usually not applicable), Alopecia (rare).
+4. Methylmalonic Acidemia: Apathy, Fatigue, Elevated urinary carboxylic acid.
+5. Canavan Disease: Apathy, Death in infancy, Alopecia.
+6. Muscular Dystrophies: Fatigue, Alopecia (rare), Spasticity (some types).
+7. Pulmonary Diseases (e.g., Chronic Obstructive Pulmonary Disease): Dyspnea.
+8. Depression: Apathy, Fatigue.
+9. Renal Diseases: Elevated urinary carboxylic acid.

Please note that the symptoms listed for each disease are not exhaustive and that a definitive diagnosis requires a thorough medical evaluation."
['Phenylketonuria']," +1. Obesity: Excessive body weight for age, often accompanied by an unhealthy lifestyle and poor nutrition. Symptoms: Excess weight, not related to the given symptoms.

+2. Fever: An elevated body temperature, usually above 37.5°C (99.5°F), caused by an infection or other medical condition. Symptoms: Fever, some cases of obesity may be associated with low-grade inflammation.

+3. Gastrointestinal inflammation: Inflammation of the gastrointestinal tract, which can cause symptoms such as abdominal pain, diarrhea, and vomiting. Symptoms: Gastrointestinal inflammation, vomiting.

+4. Hypertyrosinemia: A condition characterized by an excessive amount of tyrosine in the blood, which can lead to liver damage and neurological problems. Symptoms: Not related to the given symptoms.

+5. Hyperphenylalaninemia: A genetic disorder that affects the metabolism of the amino acid phenylalanine, leading to its accumulation in the body and causing neurological damage. Symptoms: Not related to the given symptoms.

+6. Neonatal death: Death of a newborn baby, often within the first 28 days of life. Symptoms: Neonatal death, not related to the given symptoms.

+7. Death in infancy: Death of a child before the age of 1. Symptoms: Death in infancy, not related to the given symptoms.

+8. Death in childhood: Death of a child between the ages of 1 and 14. Symptoms: Death in childhood, not related to the given symptoms.

+9. Death in adolescence: Death of an adolescent, typically between the ages of 13 and 18. Symptoms: Death in adolescence, not related to the given symptoms.

+10. Vomiting: The forceful expulsion of the contents of the stomach through the mouth. Symptoms: Vomiting, gastrointestinal inflammation.

+11. Fever and vomiting: A combination of a fever and vomiting, often caused by gastroenteritis or food poisoning. Symptoms: Fever, vomiting.

+12. Infectious disease: An illness caused by a microorganism, such as a bacterium, virus, or parasite. Symptoms: Fever, vomiting, gastrointestinal inflammation (may be a cause of some of the given symptoms).

+13. Foodborne illness: An illness caused by consuming contaminated food or water. Symptoms: Vomiting, gastrointestinal inflammation (may be a cause of some of the given symptoms).

+14. Inflammatory bowel disease: A chronic inflammatory condition of the gastrointestinal tract, such as Crohn's disease or ulcerative colitis. Symptoms: Gastrointestinal inflammation, vomiting, abdominal pain.

+15. Sepsis: A life-threatening condition caused by the body's response to an infection, which can lead to organ failure and death. Symptoms: Fever, vomiting, gastrointestinal inflammation (may be a cause of some of the given symptoms).

+16. Gastroenteritis: An inflammation of the gastrointestinal"
['Biotinidase deficiency']," +1. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the enzyme responsible for breaking down certain amino acids, leading to their accumulation in the body. Symptoms include: Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid, and Metabolic acidosis. The patient does not have Skin rash, Death in infancy, Alopecia, Erythematous plaque, Erythematous macule, Erythematous papule.

+2. Phenylketonuria (PKU): Another inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body. Symptoms include: Aminoaciduria, Elevated urinary carboxylic acid, and Metabolic acidosis. The patient does not have Skin rash, Death in infancy, Alopecia, Erythematous plaque, Erythematous macule, Erythematous papule.

+3. Ataxia-Telangiectasia: This is a genetic disorder characterized by cerebellar ataxia, telangiectasias, and immune deficiency. Symptoms include: Nystagmus, Ataxia, and Telangiectasias. The patient does not have Skin rash, Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Erythematous plaque, Erythematous macule, Erythematous papule, Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

+4. Tuberous Sclerosis Complex: This is a genetic disorder characterized by the growth of non-cancerous (benign) tumors in various organs, including the brain, skin, heart, kidneys, and eyes. Symptoms include: Epilepsy, Skin rashes (ash-leaf spots), and Facial angiofibromas. The patient does not have Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid.

+5. Neonatal Onset Multisystem Inflammatory Disease (NOMID): This is a rare autoinflammatory disorder characterized by recurrent fever, rash, arthritis, and other inflammatory symptoms. Symptoms include: Fever, Rash, Arthritis, and Serositis. The patient does not have Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid.

+6. Wilson's Disease: This is an inherited metabolic disorder caused by a deficiency of ceruloplasmin, leading to the accumulation of copper in various organs, including the liver and brain."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Inborn Errors of Metabolism: Maple Syrup Urine Disease (MSUD): This is a group of disorders caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase complex. Patients with MSUD have difficulty metabolizing the essential amino acids leucine, isoleucine, and valine. Common symptoms include a distinctive sweet urine odor, decreased methylmalonyl-CoA mutase activity, and feeding difficulties. Neonatal death and dehydration can also occur if the condition is not treated.

+2. Inborn Errors of Metabolism: Propionic Acidemia: This is a metabolic disorder caused by a deficiency of propionyl-CoA carboxylase. Patients with propionic acidemia have difficulty metabolizing certain amino acids and odd-chain fatty acids. Common symptoms include metabolic acidosis, dehydration, and feeding difficulties. Neonatal death can occur if the condition is not treated. Decreased methylmalonyl-CoA mutase activity is also a symptom of this condition.

+3. Inborn Errors of Metabolism: Urea Cycle Disorders: This group of disorders includes conditions such as ornithine transcarbamylase deficiency and argininosuccinic acidemia. Patients with urea cycle disorders have difficulty processing ammonia, leading to a buildup of this toxic substance in the blood. Common symptoms include vomiting, lethargy, and developmental delay. Dehydration and feeding difficulties can also occur. Neonatal death can occur if the condition is not treated. Decreased methylmalonyl-CoA mutase activity is not a symptom of urea cycle disorders.

+4. Sepsis: This is a life-threatening condition caused by the body's response to an infection. Common symptoms include fever, chills, and decreased urine output. Dehydration, feeding difficulties, and neonatal death can also occur in severe cases. Decreased methylmalonyl-CoA mutase activity is not a symptom of sepsis.

+5. Gastrointestinal Disorders: Malabsorption Syndrome: This condition is characterized by an inability to absorb nutrients from food due to various gastrointestinal disorders, such as celiac disease or pancreatic insufficiency. Common symptoms include diarrhea, weight loss, and feeding difficulties. Dehydration and neonatal death can occur if the condition is not treated. Decreased methylmalonyl-CoA mutase activity is not a symptom of malabsorption syndrome.

+6. Renal Disorders: Congenital Nephrotic Syndrome: This is a group of disorders characterized by the loss of large amounts of protein in the urine. Common symptoms include edema, decreased urine output, and feeding difficulties. Dehydration and neonatal death can occur if the condition is not treated. Decreased methylmalonyl-CoA mutase activity is not a symptom of congenital nephrotic syndrome.

+7. Endocrine Disorders: Congenital Adrenal Hyperplasia: This is a group of disorders caused by a deficiency of enzymes involved in the production of cortisol and aldosterone. Common symptoms include salt cravings, dehydration, and feeding difficulties. Neonatal death can occur if the condition is not treated. Dec"
['Biotinidase deficiency']," +1. Metabolic Acidosis with Propionic Acidemia: This is a metabolic disorder caused by a deficiency of propionyl-CoA carboxylase. Patients present with metabolic acidosis, increased circulating lactate and propionic acid, decreased pyruvate carboxylase activity, aminoaciduria, and metabolic decompensation leading to lethargy, hypotonia, and coma. +2. Maple Syrup Urine Disease: This is a metabolic disorder caused by a deficiency of the branched-chain ketoacid dehydrogenase complex. Patients present with lethargy, hypotonia, metabolic acidosis, increased circulating lactate and branched-chain amino acids, and a characteristic maple syrup odor of urine. +3. Reye's Syndrome: This is a metabolic disorder characterized by hepatic dysfunction and encephalopathy. Patients present with lethargy, hypotonia, metabolic acidosis, and elevated urinary carboxylic acids. +4. Menkes Disease: This is a genetic disorder caused by a deficiency of copper transport. Patients present with lethargy, hypotonia, growth retardation, and neurological symptoms such as seizures and developmental delay. +5. Maple Syrup Urine Disease with Stomatitis: This is a variant of Maple Syrup Urine Disease with the additional symptom of stomatitis. +6. Urea Cycle Disorders: This is a group of metabolic disorders characterized by a deficiency in the urea cycle enzymes. Patients present with lethargy, hypotonia, metabolic acidosis, and aminoaciduria. +7. Sepsis: This is a systemic inflammatory response to an infection. Patients present with fever, lethargy, hypotonia, and metabolic acidosis. +8. Sepsis with Stomatitis: This is a variant of sepsis with the additional symptom of stomatitis. +9. Sepsis with Stridor: This is a variant of sepsis with the additional symptom of stridor. +10. Gangrene with Metabolic Acidosis: This is a condition where gangrene is associated with metabolic acidosis, which can be caused by various underlying conditions such as sepsis, shock, or metabolic disorders."
['Phenylketonuria']," +1. Hemangioma NVD: A common benign vascular birth defect, not typically associated with prenatal abnormalities or death. +Symptoms in common: Abnormality of prenatal development or birth.
+2. Cystic Fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems, causing persistent lung infections and difficulty digesting food. +Symptoms in common: Death in childhood.
+3. Tay-Sachs Disease: A rare, inherited metabolic disorder causing progressive degeneration of the central nervous system, leading to blindness, deafness, and eventual death. +Symptoms in common: Neonatal death, Death in infancy.
+4. Sickle Cell Anemia: A genetic disorder causing the production of abnormal hemoglobin, leading to red blood cells that are crescent-shaped and prone to clumping, resulting in anemia and various complications. +Symptoms in common: Death in childhood.
+5. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21, leading to developmental delays, physical growth delays, and characteristic facial features. +Symptoms in common: Abnormality of prenatal development or birth.
+6. Phenylketonuria (PKU): A metabolic disorder caused by the inability to metabolize phenylalanine, leading to its accumulation in the body and causing intellectual disability, seizures, and other health problems. +Symptoms in common: Hyperphenylalaninemia.
+7. Maple Syrup Urine Disease: A metabolic disorder caused by the inability to break down certain amino acids, leading to their accumulation in the body and causing neurological symptoms, including poor feeding, vomiting, and developmental delays. +Symptoms in common: Hyperammonemia, Hypertyrosinemia.
+8. Zellweger Syndrome: A rare, genetic disorder affecting the synthesis of certain proteins in the endoplasmic reticulum, leading to multiple organ dysfunctions and developmental delays. +Symptoms in common: Neonatal death.
+9. Krabbe Disease: A metabolic disorder caused by the inability to produce a myelin protein, leading to demyelination of nerve fibers and causing neurological symptoms, including developmental delays, muscle weakness, and vision and hearing loss. +Symptoms in common: Neonatal death, Death in infancy.
+10. Canavan Disease: A metabolic disorder caused by the inability to break down the amino acid N-acetylaspartic acid, leading to its accumulation in the brain and causing neurological symptoms, including developmental delays, muscle weakness, and vision and hearing loss. +Symptoms in common: Neonatal death, Death in infancy."
['3-hydroxy-3-methylglutaric aciduria']," +1. Dicarboxylic aciduria (Maple Syrup Urine Disease): This is a metabolic disorder caused by a deficiency of the branched-chain ketoacid dehydrogenase complex. Patients present with symptoms such as poor feeding, vomiting, lethargy, and developmental delay. They may also have a characteristic ""maple syrup"" odor of their urine due to the accumulation of branched-chain amino acids. + Symptoms in common: Elevated urinary carboxylic acid, Death in infancy. + Symptoms not in common: 3-Methylglutaric aciduria.

+2. Propionic acidemia: This is another metabolic disorder caused by a deficiency of propionyl-CoA carboxylase. Patients present with symptoms such as metabolic acidosis, vomiting, lethargy, and developmental delay. They may also have a characteristic acetone-like odor of their breath and urine due to the accumulation of propionic acid. + Symptoms in common: Elevated urinary carboxylic acid, Death in infancy. + Symptoms not in common: Dicarboxylic aciduria, 3-Methylglutaric aciduria.

+3. 3-Methylglutaconic aciduria: This is a metabolic disorder caused by a deficiency of the enzyme 3-methylglutaconyl-CoA hydratase. Patients present with symptoms such as developmental delay, hypotonia, and ataxia. They may also have a characteristic odorless urine and a normal or slightly increased anion gap. + Symptoms in common: Elevated urinary carboxylic acid. + Symptoms not in common: Dicarboxylic aciduria, Death in infancy.

+4. Ethylmalonic aciduria: This is a metabolic disorder caused by a deficiency of the enzyme ethylmalonyl-CoA thiolase. Patients present with symptoms such as metabolic acidosis, vomiting, lethargy, and developmental delay. They may also have a characteristic ""fishy"" odor of their urine due to the accumulation of ethylmalonic acid. + Symptoms in common: Elevated urinary carboxylic acid, Dicarboxylic aciduria. + Symptoms not in common: 3-Methylglutaric aciduria, Death in infancy.

+5. Glutaric aciduria type 1: This is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Patients present with symptoms such as vomiting, lethargy, and developmental delay. They may also have a characteristic ""rancid fruit"" odor of their urine and a normal or slightly increased anion gap. + Symptoms in common: Elevated urinary carboxylic acid. + Symptoms not in common: Dicarboxylic aciduria, 3-Methylglutaric aciduria, Death in infancy."
['Wilson disease']," +1. Wilson's Disease: A genetic disorder causing copper accumulation in the liver, brain, and other organs. Common symptoms: Carious teeth, Elevated circulating hepatic transaminase concentration, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration. Uncommon symptoms: Obesity, Death in childhood, Decreased circulating copper concentration, Decreased serum iron.

+2. Hemochromatosis: A genetic disorder causing excessive absorption of iron from the diet. Common symptoms: Decreased circulating iron, Decreased serum iron. Uncommon symptoms: Carious teeth, Obesity, Elevated circulating hepatic transaminase concentration, Death in childhood, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased circulating copper concentration.

+3. Non-Alcoholic Fatty Liver Disease (NAFLD): A condition characterized by the accumulation of fat in the liver not caused by alcohol consumption. Common symptoms: Obesity, Elevated circulating hepatic transaminase concentration. Uncommon symptoms: Carious teeth, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Decreased circulating copper concentration, Decreased serum iron.

+4. Hepatitis: An inflammation of the liver, which can be caused by various viruses or other factors. Common symptoms: Elevated circulating hepatic transaminase concentration. Uncommon symptoms: Carious teeth, Obesity, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Decreased circulating copper concentration, Decreased serum iron.

+5. Cirrhosis: A chronic liver disease characterized by the replacement of normal liver tissue with scar tissue. Common symptoms: Elevated circulating hepatic transaminase concentration, Decreased circulating copper concentration. Uncommon symptoms: Carious teeth, Obesity, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased serum iron."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorders (Includes inborn errors of metabolism): Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+2. Carnitine Deficiency: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+3. Organic Acidemias: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration (some types).
+4. Lysosomal Storage Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+5. Mitochondrial Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+6. Congenital Heart Diseases: Abnormality of prenatal development or birth, Neonatal death (in some cases) (not directly related to the given symptoms).
+7. Inborn Errors of Immunity: Death in infancy (in some cases), Neonatal death (in some cases) (not directly related to the given symptoms)."
['Phenylketonuria']," +1. Metabolic Disorder - Hurler Syndrome: Symptoms include Death in infancy, Heightened sensitivity to infections (recurrent viral inctions), and Progressive mental and physical deterioration. However, Hypertyrosinemia and Hyperphenylalaninemia are not associated with this condition.

+2. Metabolic Disorder - Maple Syrup Urine Disease: Symptoms include Recurrent viral infections, Developmental delay, and Hyperphenylalaninemia. This condition is not associated with Death in infancy or Death in childhood.

+3. Metabolic Disorder - Tyrosinemia Type 1: Symptoms include Hypertyrosinemia, Hepatomegaly, and Frequent infections. This condition is not associated with Death in infancy or Death in childhood.

+4. Immunodeficiency Disorder - Severe Combined Immunodeficiency (SCID): Symptoms include Recurrent viral infections, Frequent bacterial infections, and Failure to thrive. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+5. Metabolic Disorder - Krabbe Disease: Symptoms include Developmental delay, Progressive neurological deterioration, and Death in childhood. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+6. Metabolic Disorder - Pompe Disease: Symptoms include Muscle weakness, Enlarged heart, and Death in infancy or childhood. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+7. Metabolic Disorder - Galactosemia: Symptoms include Jaundice, Vomiting, and Failure to thrive. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+8. Metabolic Disorder - Cystic Fibrosis: Symptoms include Persistent cough, Frequent lung infections, and Failure to thrive. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+9. Metabolic Disorder - Gaucher Disease: Symptoms include Enlarged liver and spleen, Bone pain, and Anemia. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+10. Metabolic Disorder - Fabry Disease: Symptoms include Painful crises, Kidney damage, and Cardiac involvement. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+11. Metabolic Disorder - Mucopolysaccharidosis Type I: Symptoms include Progressive mental and physical deterioration, Heightened sensitivity to infections, and Joint stiffness. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+12. Metabolic Disorder - Mucopolysaccharidosis Type II: Symptoms include Progressive mental and physical deterioration, Heightened sensitivity to infections, and Heart problems. This condition is not associated with Hypertyrosinemia or Hyperphenylalaninemia.

+13. Metabolic Disorder - Mucopolysaccharidos"
['3-methylcrotonyl-CoA carboxylase deficiency']," +1. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids (leucine, isoleucine, and valine). Patients with MSUD have an increased urinary excretion of these amino acids and their metabolites, including aminoaciduria and abnormal circulating glycine concentration. They may also have an abnormal carnitine concentration due to the buildup of these amino acids in the body. +

+2. Carnitine Palmitoyltransferase Deficiency: This is a metabolic disorder that affects the transport of fatty acids into the mitochondria for oxidation. Patients with this condition have an abnormal circulating carnitine concentration due to the impaired transport of carnitine. They may also have an elevated urinary carboxylic acid due to the accumulation of fatty acids in the blood. However, they do not typically have an abnormal circulating glycine concentration. +

+3. Propionic Acidemia: This is a metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Patients with this condition have an increased urinary excretion of propionic acid and its metabolites, including carboxylic acids. They may also have an aminoaciduria due to the buildup of certain amino acids in the blood. However, they do not typically have an abnormal circulating glycine concentration or carnitine concentration. +

+4. Organic Acidemia: This is a broad category of metabolic disorders characterized by an accumulation of organic acids in the body. Patients with organic acidemia may have an aminoaciduria, abnormal circulating glycine concentration, and elevated urinary carboxylic acids. However, the specific symptoms and underlying causes can vary widely depending on the specific type of organic acidemia. +

+5. Urea Cycle Disorders: This is a group of metabolic disorders that affect the production or utilization of urea, a waste product produced when the body breaks down proteins. Patients with urea cycle disorders may have an aminoaciduria due to the buildup of ammonia and other amino acids in the blood. They may also have an abnormal circulating glycine concentration due to the impaired conversion of glycine to serine. However, they typically do not have an abnormal circulating carnitine concentration or elevated urinary carboxylic acids. +"
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. Mucopolysaccharidosis Type I: Generalized hypotonia, Hepatomegaly, Tachypnea, Neonatal death, Feeding difficulties. This is a group of lysosomal storage disorders caused by a deficiency of the enzyme iduronidase. Patients accumulate glycosaminoglycans in various tissues and organs, leading to progressive multisystemic involvement.

+2. Pompe Disease: Generalized hypotonia, Feeding difficulties. This is a lysosomal storage disorder caused by a deficiency of the enzyme acid alpha-glucosidase. Patients accumulate glycogen in various tissues and organs, leading to muscle weakness and heart involvement. Hepatomegaly and Tachypnea are not common symptoms in Pompe disease.

+3. Zellweger Syndrome: Generalized hypotonia, Neonatal death. This is a peroxisomal disorder caused by a deficiency of multiple peroxisomal enzymes. Patients present with severe neurological dysfunction, including hypotonia, and often die in infancy. Hepatomegaly and Tachypnea are not common symptoms in Zellweger syndrome.

+4. Metabolic Acidosis: 3-Methylglutaconic aciduria. This is a metabolic disorder caused by a deficiency of the enzyme methylglutaconyl-CoA hydratase. Patients accumulate 3-methylglutaconic acid in the urine, leading to metabolic acidosis. Generalized hypotonia, Hepatomegaly, Tachypnea, Neonatal death, and Feeding difficulties are not common symptoms in Metabolic Acidosis."
['Citrullinemia type I']," +1. Down syndrome: Delayed speech and language development, Abnormality of prenatal development or birth, Motor delay + Several other common symptoms not listed: Short stature, Flat facial features, Small ears, Short neck, Tongue sticking out of mouth, Small hands and feet, Brushfield spots on iris + Does not have: Hyperhidrosis, Hypoglycemia, Respiratory alkalosis, Hyperammonemia, Hypothermia, Drowsiness, Sleep abnormality, Tachypnea, Oroticaciduria, Neonatal death, Death in childhood, Elevated plasma citrulline, Pustule, Acute hepatitis, Chronic hepatitis

+2. Cerebral palsy: Motor delay, Drowsiness, Developmental delay + Several other common symptoms not listed: Muscle stiffness or tightness, Abnormal reflexes, Floppy limbs, Trouble with coordination and balance, Speech problems + Does not have: Hyperhidrosis, Abnormality of prenatal development or birth, Obesity, Hypoglycemia, Respiratory alkalosis, Hyperammonemia, Hypothermia, Sleep abnormality, Tachypnea, Oroticaciduria, Neonatal death, Death in childhood, Elevated plasma citrulline, Pustule, Acute hepatitis, Chronic hepatitis

+3. Hypothyroidism: Motor delay, Drowsiness, Developmental delay, Hypoglycemia + Several other common symptoms not listed: Weight gain, Cold intolerance, Dry skin, Constipation, Brittle hair, Hoarse voice, Pale, Fatigue + Does not have: Hyperhidrosis, Abnormality of prenatal development or birth, Obesity, Respiratory alkalosis, Hyperammonemia, Hypothermia, Sleep abnormality, Tachypnea, Oroticaciduria, Neonatal death, Death in childhood, Elevated plasma citrulline, Pustule, Acute hepatitis, Chronic hepatitis

+4. Phenylketonuria (PKU): Delayed speech and language development, Motor delay, Elevated plasma citrulline + Several other common symptoms not listed: Pale skin, Rash, Seizures, Intellectual disability, Episodic vomiting, Irritability, Musty odor to the breath, urine, or body odor + Does not have: Hyperhidrosis, Abnormality of prenatal development or birth, Obesity, Hypoglycemia, Respiratory alkalosis, Hyperammonemia, Hypothermia, Sleep abnormality, Tachypnea, Oroticaciduria, Neonatal death, Death in childhood, Pustule, Acute hepatitis, Chronic hepatitis

+5. Sickle cell disease: Motor delay, Anemia (can cause lethargy), Jaundice (can cause yellowing of skin and eyes), Frequent infections + Several other common symptoms not listed: Painful swelling of hands and feet, Painful crises, Delayed growth, Fatigue, Vision problems, Hearing problems, Swollen belly + Does not have: Hyperhidrosis, Abnormality of prenatal development or birth, Obesity, Hypoglycemia, Respir"
['Glutaryl-CoA dehydrogenase deficiency']," +1. Metabolic Disorder: Glutaric Acidemia Type I (Glutaric Aciduria)
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: Yes
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: Yes
   - Athetosis: Yes

 +2. Neurological Disorder: Krabbe Disease
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: Yes
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Neonatal death: Yes
   - Athetosis: Yes

 +3. Metabolic Disorder: Pompe Disease
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: No
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: Yes
   - Athetosis: No

 +4. Neurological Disorder: Rett Syndrome
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: Yes
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: No
   - Athetosis: Yes

 +5. Metabolic Disorder: Maple Syrup Urine Disease
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: No
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: Yes
   - Athetosis: No

 +6. Neurological Disorder: Canavan Disease
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: Yes
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: Yes
   - Athetosis: No

 +7. Metabolic Disorder: Zellweger Syndrome
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: Yes
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: Yes
   - Athetosis: No

 +8. Neurological Disorder: Mitochondrial Disorder
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: Yes
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: No
   - Athetosis: Yes

 +9. Metabolic Disorder: Mucopolysaccharidosis Type I
   - Macrocephaly: Yes
   - Abnormality of visual evoked potentials: No
   - Irritability: Yes
   - Seizure: Yes
   - Generalized hypotonia: Yes
   - Death in infancy: Yes
   - Athetosis: No

 +10. Neurological Disorder: Lissenceph"
['Tyrosinemia type 1']," +1. Phenylketonuria (PKU): Delayed speech and language development, Elevated urinary phenylalanine concentration, Hypertyrosinemia. +2. Maple Syrup Urine Disease (MSUD): Delayed speech and language development, Elevated urinary delta-aminolevulinic acid, Elevated urinary branched-chain amino acids. +3. Tyrosinemia Type 1: Delayed speech and language development, Elevated urinary delta-aminolevulinic acid, Hypertyrosinemia, Death in childhood. +4. 4-Hydroxyphenylpyruvic aciduria: 4-Hydroxyphenylpyruvic aciduria, Delayed speech and language development. +5. Menkes Disease: Delayed speech and language development (not typically a symptom, but can occur), Neurological symptoms, Hair changes, not associated with the other symptoms listed. +6. Fanconi Syndrome: Delayed speech and language development (rare), Renal tubular dysfunction, not associated with the other symptoms listed. +7. Glutaric Acidemia Type 1: Delayed speech and language development (not typically a symptom, but can occur), Elevated urinary glutaric acid, not associated with the other symptoms listed. +8. Propionic Acidemia: Delayed speech and language development (not typically a symptom, but can occur), Metabolic acidosis, not associated with the other symptoms listed."
['Phenylketonuria']," +1. Mucopolysaccharidoses (MPS): Abnormality of prenatal development or birth, various developmental delays, coarse facial features, hepatosplenomegaly, and death in childhood. + Symptoms: Abnormality of prenatal development or birth, Death in childhood.

+2. Cystic Fibrosis: Obesity is not a common symptom, but it can occur in some cases. + Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Neonatal death, Elevated urinary carboxylic acid.

+3. Inherited Metabolic Disorders (IMDs): Abnormality of prenatal development or birth, developmental delay, and various symptoms depending on the specific IMD. + Symptoms: Abnormality of prenatal development or birth.

+4. Phenylketonuria (PKU): Hyperphenylalaninemia, Elevated urinary carboxylic acid. + Symptoms: Hyperphenylalaninemia.

+5. Maple Syrup Urine Disease (MSUD): Hyperammonemia, Elevated urinary carboxylic acids. + Symptoms: Abnormality of prenatal development or birth, Neonatal death, Elevated urinary carboxylic acid.

+6. Tyrosinemia: Hypertyrosinemia, Elevated urinary carboxylic acid. + Symptoms: Hypertyrosinemia.

+7. Organic Acidemias: Elevated urinary carboxylic acids. + Symptoms: Abnormality of prenatal development or birth, Neonatal death, Death in childhood.

+8. Zellweger Spectrum Disorders: Abnormality of prenatal development or birth, developmental delay, and various symptoms depending on the specific disorder. + Symptoms: Abnormality of prenatal development or birth.

+9. Lysosomal Storage Disorders: Abnormality of prenatal development or birth, developmental delay, and various symptoms depending on the specific disorder. + Symptoms: Abnormality of prenatal development or birth.

+10. Galactosemia: Neonatal death, Elevated urinary carboxylic acid. + Symptoms: Neonatal death.

+11. Sickle Cell Disease: Not directly related to the given symptoms. + Symptoms: None.

+12. Down Syndrome: Abnormality of prenatal development or birth, developmental delay, and various physical features. + Symptoms: Abnormality of prenatal development or birth.

+13. Fetal Alcohol Spectrum Disorders: Developmental delay, growth problems, and various physical and behavioral symptoms. + Symptoms: Abnormality of prenatal development or birth.

+14. Congenital Hypothyroidism: Developmental delay, growth problems, and various symptoms related to thyroid function. + Symptoms: None.

+15. Cretinism: Developmental delay, growth problems, and various symptoms related to thyroid function. + Symptoms: None.

+16. Gaucher Disease: Developmental delay, hepatosplenomegaly, and various symptoms depending on the specific type. + Symptoms: Abnormality of prenatal development or birth."
['Phenylketonuria']," +1. Phenylketonuria (PKU): Intellectual disability, Hyperphenylalaninemia, Elevated urinary carboxylic acid. The patient does not have symptoms of Hyperactivity, Seizure, Obesity, Hyperactivity, Hypertyrosinemia, Severe short stature, Death in childhood, Death in adolescence, Death in early adulthood.

+2. Creutzfeldt-Jakob Disease: No known preventive measures, Progressive dementia, Myoclonus, Visual disturbances. The patient does not have symptoms of Hyperactivity, Intellectual disability, Seizure, Obesity, Hypertyrosinemia, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid.

+3. Mucopolysaccharidosis: Intellectual disability, Short stature, Coarse facial features, Joint stiffness. The patient does not have symptoms of Hyperactivity, Seizure, Obesity, Hypertyrosinemia, Hyperactivity, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid, or a seizure disorder.

+4. Prader-Willi Syndrome: Intellectual disability, Short stature, Obesity, Hypotonia. The patient does not have symptoms of Hyperactivity, Seizure, Hypertyrosinemia, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid.

+5. Wilson's Disease: Intellectual disability, Tremors, Kayser-Fleischer rings. The patient does not have symptoms of Hyperactivity, Seizure, Obesity, Hypertyrosinemia, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid, or a seizure disorder.

+6. Huntington's Disease: Intellectual disability, Chorea, Psychiatric symptoms. The patient does not have symptoms of Hyperactivity, Seizure, Obesity, Hypertyrosinemia, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid.

+7. Cystic Fibrosis: Obesity is not a symptom, Chronic lung infections, Foul-smelling stools. The patient does not have symptoms of Hyperactivity, Intellectual disability, Seizure, Hypertyrosinemia, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid.

+8. Down Syndrome: Intellectual disability, Short stature, Flat face, Brushfield spots. The patient does not have symptoms of Hyperactivity, Seizure, Obesity, Hypertyrosinemia, Severe short stature, Death"
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Menkes disease: Seizures, Neonatal death, Generalized hypotonia, Metabolic acidosis, Methylmalonic acidemia, Methylmalonic aciduria, + Symptoms: Thrombocytopenia, Leukopenia, Vomiting are not common in Menkes disease.

+2. Maple Syrup Urine Disease: Seizures, Generalized hypotonia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, + Symptoms: Thrombocytopenia, Leukopenia, Vomiting are not common in Maple Syrup Urine Disease.

+3. Pompe disease: Seizures, Generalized hypotonia, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Neonatal death, Vomiting are not common in Pompe disease.

+4. Krabbe disease: Seizures, Generalized hypotonia, Neonatal death, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Vomiting are not common in Krabbe disease.

+5. Canavan disease: Seizures, Generalized hypotonia, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Neonatal death, Vomiting are not common in Canavan disease.

+6. Citrullinemia: Seizures, Generalized hypotonia, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Vomiting are not common in Citrullinemia.

+7. Biotinidase deficiency: Seizures, Generalized hypotonia, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Vomiting are not common in Biotinidase deficiency.

+8. Zellweger syndrome: Seizures, Generalized hypotonia, Neonatal death, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Vomiting are not common in Zellweger syndrome.

+9. Smith-Lemli-Opitz syndrome: Seizures, Generalized hypotonia, + Symptoms: Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria, Vomiting are not common in Smith-Lemli-Opitz syndrome.

+10. Propionic acidemia: Seizures, Generalized hypotonia"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorders (Includes inborn errors of metabolism): Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+2. Carnitine Deficiency: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+3. Organic Acidemias: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration (some types).
+4. Lysosomal Storage Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+5. Mitochondrial Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+6. Congenital Heart Diseases: Abnormality of prenatal development or birth, Neonatal death (in some cases) (not directly related to the given symptoms).
+7. Inborn Errors of Immunity: Death in infancy (in some cases), Neonatal death (in some cases) (not directly related to the given symptoms)."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Maple Syrup Urine Disease: Metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids, leading to an accumulation of these compounds in the body. Symptoms include: Metabolic acidosis, Hyperammonemia, and Methylmalonic aciduria. Vomiting and Death in infancy are common in severe cases.
+2. Urea Cycle Disorder: A group of metabolic disorders that affect the body's ability to process ammonia. Symptoms include: Metabolic acidosis, Hyperammonemia, and Vomiting. Death in infancy is a common complication, but not all cases present with this symptom. Methylmalonic aciduria is not a typical symptom of urea cycle disorders.
+3. Reye's Syndrome: A rare but serious condition that affects the liver and brain, often following a viral infection. Symptoms include: Vomiting, Metabolic acidosis, and encephalopathy (brain dysfunction). Hyperammonemia and Methylmalonic aciduria are not typically associated with Reye's Syndrome.
+4. Galactosemia: A metabolic disorder caused by a deficiency of the enzyme needed to metabolize galactose, a sugar found in milk and milk products. Symptoms include: Vomiting, Metabolic acidosis, and Hyperammonemia. Methylmalonic aciduria is not a typical symptom of galactosemia. Death in infancy can occur if the condition is not diagnosed and treated promptly.
+5. Propionic Acidemia: A metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids and fatty acids, leading to an accumulation of these compounds in the body. Symptoms include: Metabolic acidosis, Hyperammonemia, and Vomiting. Methylmalonic aciduria is a common symptom of propionic acidemia. Death in infancy can occur if the condition is not diagnosed and treated promptly."
['Ornithine transcarbamylase deficiency']," +1. Reye's Syndrome: Seizures, Cerebral edema, Oroticaciduria, Neonatal death. This metabolic disorder is characterized by the sudden onset of encephalopathy, often following a viral infection. It is marked by vomiting, lethargy, and metabolic acidosis, leading to coma and potential death. +

+2. Meningoencephalitis: Seizures, Cerebral edema. This condition is characterized by inflammation of the meninges and brain tissue, often caused by a viral or bacterial infection. Symptoms include fever, headache, stiff neck, and altered mental status. +

+3. Maple Syrup Urine Disease: Seizures, Hyperammonemia. This metabolic disorder is caused by a deficiency in the enzyme needed to break down certain amino acids. It results in the buildup of these amino acids in the blood, leading to neurological symptoms such as seizures and developmental delays. +

+4. Mitochondrial Disorders: Seizures, Neonatal death. Mitochondrial disorders are a group of genetic conditions that affect the mitochondria, the energy-producing structures in cells. Symptoms can vary widely, but may include developmental delays, muscle weakness, and seizures. Some forms of these disorders can be fatal in infancy. +

+5. Urea Cycle Disorders: Seizures, Hyperammonemia. Urea cycle disorders are a group of metabolic disorders that affect the body's ability to process ammonia. This can lead to the buildup of ammonia in the blood, which can cause neurological symptoms such as seizures and developmental delays. +

+6. Creutzfeldt-Jakob Disease: Seizures, Death in infancy (rare). Creutzfeldt-Jakob Disease is a rare, degenerative brain disorder caused by prions. It is characterized by progressive neurological symptoms, including seizures, memory loss, and cognitive decline. It is typically a disease of older adults and is very rare in infancy. +

+7. Meningiomas: Seizures. Meningiomas are benign tumors that grow on the meninges, the protective covering of the brain and spinal cord. They can cause seizures, as well as other symptoms such as headaches and cognitive changes. +

+8. Brain Abscess: Seizures, Cerebral edema. A brain abscess is a collection of pus in the brain, typically caused by a bacterial infection. Symptoms include fever, headache, and altered mental status, as well as seizures and cerebral edema in severe cases. +

+9. Brain Tumors: Seizures, Neonatal death (rare). Brain tumors can cause seizures, as well as other symptoms such as headaches, cognitive changes, and developmental delays. Some types of brain tumors, such as medulloblastoma and glioblastoma, can be fatal in infancy. +

+10. Epilepsy: Seizures. Epilepsy is a chronic neurological condition characterized by recurrent seizures. The cause of epilepsy is not always known, but it can be caused by various conditions, including brain injury, infection, and genetic factors. +

+11. Meningitis: Seizures, Cerebral edema. M"
['Biotinidase deficiency']," +1. Metabolic Disorder (Mitochondrial Disease): Seizures, Generalized hypotonia, Growth delay, Death in infancy, + Alopecia, + Fasciculations, + Elevated urinary carboxylic acid
+2. Neuromuscular Disorder (Spinal Muscular Atrophy): Seizures, Generalized hypotonia, Growth delay, - Alopecia, + Fasciculations, - Elevated urinary carboxylic acid
+3. Inborn Error of Metabolism (Organic Acidemia): Seizures, Generalized hypotonia, Growth delay, - Alopecia, + Fasciculations, + Elevated urinary carboxylic acid
+4. Lysosomal Storage Disease: Seizures, Generalized hypotonia, Growth delay, - Alopecia, + Fasciculations, + Elevated urinary carboxylic acid
+5. Epilepsy: Seizures, - Generalized hypotonia, - Growth delay, - Death in infancy, - Alopecia, + Fasciculations, - Elevated urinary carboxylic acid
+6. Hypothyroidism: Seizures, Generalized hypotonia, Growth delay, - Alopecia, + Fasciculations, - Elevated urinary carboxylic acid
+7. Muscular Dystrophy: Seizures, Generalized hypotonia, Growth delay, - Alopecia, + Fasciculations, - Elevated urinary carboxylic acid
+8. Malignant Neonatal Seizures: Seizures, Generalized hypotonia, Growth delay, Death in infancy, - Alopecia, + Fasciculations, + Elevated urinary carboxylic acid
+9. Menkes Disease: Seizures, Generalized hypotonia, Growth delay, Death in infancy, Alopecia, + Fasciculations, + Elevated urinary carboxylic acid (but this disease is characterized by copper deficiency, not an excess of carboxylic acid)

Please note that this list is not exhaustive and further diagnostic tests are required to confirm a definitive diagnosis. The patient's medical history, family history, and physical examination should also be taken into consideration."
['Phenylketonuria']," +1. Diabetes Mellitus: Obesity, Hypercholesterolemia, and Hypertension may be common symptoms. However, Diabetes Mellitus does not typically cause Hyperphenylalaninemia or Hypertyrosinemia, and it does not lead to death in early adulthood in most cases.

+2. Atherosclerosis: Obesity, Hypercholesterolemia, and Hypertension are all common symptoms of Atherosclerosis. This condition involves the buildup of plaque in the arteries, which can lead to various health complications, but it does not cause Hyperphenylalaninemia or Hypertyrosinemia.

+3. Hemochromatosis: Although not directly related to the given symptoms, Hemochromatosis can cause obesity due to the body's inability to properly absorb iron from food. However, it does not typically cause Hypercholesterolemia, Hyperphenylalaninemia, or Hypertyrosinemia. Additionally, Hemochromatosis does not usually lead to death in early adulthood.

+4. Wilson's Disease: This condition is characterized by the accumulation of copper in the liver, which can lead to various symptoms, including liver damage, neurological problems, and psychiatric symptoms. It can cause neither Hypercholesterolemia nor Hyperphenylalaninemia. However, it may lead to death in early adulthood if left untreated.

+5. Gaucher's Disease: This is a lysosomal storage disorder that can cause various symptoms, including hepatosplenomegaly, bone pain, and bruising. It does not typically cause Hypercholesterolemia, Hyperphenylalaninemia, or Hypertyrosinemia. Gaucher's Disease does not usually lead to death in early adulthood, but it can significantly shorten life expectancy if left untreated.

+6. Cushing's Syndrome: This condition is characterized by the overproduction of cortisol, which can lead to various symptoms, including obesity, Hypertension, and Hypercholesterolemia. However, it does not cause Hyperphenylalaninemia or Hypertyrosinemia. Cushing's Syndrome does not typically lead to death in early adulthood.

+7. Hypothyroidism: This condition can cause obesity, fatigue, and cold intolerance. It does not typically cause Hypercholesterolemia, Hyperphenylalaninemia, or Hypertyrosinemia. Hypothyroidism does not usually lead to death in early adulthood.

+8. Polycystic Ovary Syndrome (PCOS): This condition can cause obesity, Hyperinsulinemia, and Hyperandrogenism. It does not typically cause Hypercholesterolemia, Hyperphenylalaninemia, or Hypertyrosinemia. PCOS does not usually lead to death in early adulthood.

+9. Non-Alcoholic Fatty Liver Disease (NAFLD): This condition is characterized by the accumulation of fat in the liver, which can lead to various symptoms, including obesity and Hypercholesterolemia. It does"
['Phenylketonuria']," +1. Hypertyrosinemia: This is a genetic metabolic disorder that affects the body's ability to process the amino acid phenylalanine. Patients with this condition may have symptoms such as liver damage, neurological problems, and a musty odor in the urine. The patient does not have symptoms of Hypospadias, Death in infancy, Premature birth, Neonatal death, Severe short stature, or Hernia.

+2. Hyperphenylalaninemia: This is another inherited metabolic disorder that affects the metabolism of phenylalanine. Patients with this condition may experience mental and physical developmental delays, seizures, and a musty odor in the urine. The patient does not have symptoms of Hypospadias, Death in infancy, Premature birth, Neonatal death, or Hernia.

+3. Hernia: A hernia is a condition where an organ or tissue protrudes through a weakened area in the abdominal wall. Patients with this condition may experience a bulge or swelling in the affected area, pain, and discomfort. The patient does not have symptoms of Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, or Severe short stature.

+4. Severe short stature: This condition is characterized by significantly shorter than average height. Patients may also have other health issues such as respiratory problems, cardiovascular issues, and developmental delays. The patient does not have symptoms of Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, or Hernia.

+5. Neonatal death: This refers to the death of a newborn baby, usually within the first 28 days of life. The cause of neonatal death can vary, but common causes include infections, birth defects, and respiratory distress. The patient is not a newborn and does not have this condition.

+6. Premature birth: This is when a baby is born before 37 weeks of gestation. Premature babies may have health issues such as respiratory distress, jaundice, and developmental delays. The patient does not have this condition.

+7. Hypospadias: This is a congenital condition where the opening of the urethra is not at the tip of the penis. Patients with this condition may have difficulty urinating and may require surgery. The patient does not have symptoms of Hypertyrosinemia, Neonatal death, Premature birth, Hernia, Severe short stature, or Hyperphenylalaninemia.

+8. Death in infancy: This refers to the death of an infant before the age of one. The cause of death can vary, but common causes include infections, birth defects, and accidents. The patient is not an infant and does not have this condition."
['Smith-Lemli-Opitz syndrome']," +1. Down syndrome: Microcephaly, Low-set ears, Flattened facial features, Brachydactyly (not Syndactyly), Intellectual disability, Motor delay, Delayed speech and language development.
+2. Smith-Lemli-Opitz syndrome: Microcephaly, Low-set ears, Wide nasal bridge, Intellectual disability, Motor delay, Delayed speech and language development, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration.
+3. Cornelia de Lange syndrome: Microcephaly, Low-set ears, Wide nasal bridge, Intellectual disability, Motor delay, Delayed speech and language development, Severe short stature.
+4. Fetal Alcohol Spectrum Disorders: Intellectual disability, Delayed speech and language development, Motor delay, Difficulty walking, Difficulty running.
+5. Prader-Willi syndrome: Intellectual disability, Delayed speech and language development, Motor delay, Severe short stature, Elevated circulating 7-dehydrocholesterol concentration.
+6. Cri-du-chat syndrome: Microcephaly, Intellectual disability, Delayed speech and language development, Distinctive cry.
+7. Marfan syndrome: Difficulty climbing stairs, Severe hearing impairment (not mentioned in the symptoms).
+8. Skeletal dysplasias: Severe short stature, Difficulty walking, Difficulty climbing stairs, Difficulty running.
+9. Usher syndrome: Severe hearing impairment, Intellectual disability (not mentioned in the symptoms: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Syndactyly, Motor delay, Delayed speech and language development, Difficulty walking, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Neonatal death, Death in childhood)."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Menkes Disease: Ataxia, Progressive neurologic deterioration, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration. This is a genetic disorder that affects the absorption and utilization of copper. Patients typically present with neurological symptoms, including ataxia and developmental delay. They may also have characteristic hair changes and failure to thrive.

+2. Reye's Syndrome: Fever, Vomiting, Lethargy, Decreased consciousness, Hepatomegaly, Hypoglycemia. This is a serious condition that can affect the liver and brain. It is often triggered by viral infections and is characterized by fever, vomiting, and decreased consciousness. Patients may also have liver enlargement and low blood sugar levels.

+3. Meningitis: Fever, Neck stiffness, Altered mental status, Nausea, Vomiting. This is an inflammation of the meninges, the membranes that cover the brain and spinal cord. It can be caused by bacterial or viral infections and is characterized by fever, neck stiffness, and altered mental status. Patients may also have nausea and vomiting.

+4. Tuberculosis: Fever, Weight loss, Night sweats, Cough, Chest pain. This is a bacterial infection that primarily affects the lungs but can also affect other parts of the body. It is characterized by fever, weight loss, night sweats, and a persistent cough. Patients may also have chest pain and cough up blood.

+5. Diabetic Ketoacidosis: Fever, Polydipsia, Polyuria, Dehydration, Ketosis, Elevated blood sugar. This is a complication of diabetes that occurs when the body cannot produce enough insulin to meet its needs. It is characterized by fever, increased thirst and urination, dehydration, and ketosis. Patients may also have an elevated blood sugar level.

+6. Wilson's Disease: Ataxia, Speech difficulties, Tremors, Kayser-Fleischer rings, Decreased plasma ceruloplasmin. This is a genetic disorder that affects copper metabolism. It is characterized by neurological symptoms, including ataxia, speech difficulties, and tremors. Patients may also have Kayser-Fleischer rings, which are yellowish-brown rings around the cornea of the eye.

+7. Maple Syrup Urine Disease: Ataxia, Developmental delay, Opisthotonus, Elevated circulating glutaric acid concentration, Elevated ammonia level. This is an inherited metabolic disorder that affects the breakdown of certain amino acids. It is characterized by neurological symptoms, including ataxia and developmental delay. Patients may also have opisthotonus, which is a rigid posture with the back arched and the head thrown back. They may also have an elevated circulating glutaric acid concentration and an elevated ammonia level.

+8. Botulism: Weakness, Paralysis, Double vision, Dysphagia, Dry mouth. This is a rare but serious bacterial infection that affects the nervous system. It is caused by a toxin produced by the bacterium Clostridium botulinum. It is characterized by weakness and paralysis, including of the muscles controlling the eyes, face, and throat. Patients may also have double vision and difficulty swallowing.

+9. Gu"
['Phenylketonuria']," +1. Down Syndrome: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, +Hip dysplasia, +Death in infancy, +Hypertyrosinemia, +Neonatal death.
+2. Muscular Dystrophy: Motor delay, Generalized hypotonia, +Abnormality of prenatal development or birth (some types), +Hip dysplasia (some types), +Death in infancy (some types), -Hyperphenylalaninemia.
+3. Cerebral Palsy: Motor delay, Generalized hypotonia, +Abnormality of prenatal development or birth, +Hip dysplasia, -Death in infancy, -Hypertyrosinemia, -Hyperphenylalaninemia.
+4. Mucopolysaccharidoses: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, +Hip dysplasia, +Death in infancy (some types), +Hypertyrosinemia (some types), +Hyperphenylalaninemia (some types).
+5. Spinal Muscular Atrophy: Motor delay, Generalized hypotonia, -Abnormality of prenatal development or birth, -Hip dysplasia, -Death in infancy (most types), -Hypertyrosinemia, -Hyperphenylalaninemia.
+6. Sickle Cell Disease: Motor delay (not common), Generalized hypotonia (not common), Abnormality of prenatal development or birth (not common), +Hip dysplasia (not common), +Death in infancy (severe cases), +Hypertyrosinemia (not related), +Neonatal death (severe cases), -Hyperphenylalaninemia (not related).
+7. Congenital Dislocation of the Hip: Hip dysplasia, +Abnormality of prenatal development or birth (in some cases), +Motor delay (in some cases), +Generalized hypotonia (in some cases), -Death in infancy (unless dislocation causes other complications), -Hypertyrosinemia, -Hyperphenylalaninemia.
+8. Metabolic Disorders: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, +Death in infancy (some types), +Hypertyrosinemia (some types), +Hyperphenylalaninemia (some types), -Hip dysplasia (unless associated with a specific metabolic disorder)."
['Phenylketonuria']," +1. Down syndrome: Retrognathia, Abnormality of prenatal development or birth, Generalized hypotonia, Seizure (possible), Death in infancy (possible), Apnea (possible), Opisthotonus (rare), Hypertyrosinemia (no), Neonatal death (possible), Death in childhood (possible).

+2. Krabbe disease: Retrognathia (rare), Abnormality of prenatal development or birth, Seizure (possible), Generalized hypotonia, Death in infancy (common), Apnea (common), Opisthotonus (common), Hypertyrosinemia (no), Neonatal death (common), Death in childhood (common).

+3. Phenylketonuria: Retrognathia (rare), Abnormality of prenatal development or birth (rare), Seizure (possible), Generalized hypotonia (rare), Death in infancy (rare), Apnea (rare), Opisthotonus (rare), Hypertyrosinemia (yes, elevated levels of phenylalanine), Neonatal death (rare), Death in childhood (rare).

+4. TORCH infections: Retrognathia (rare), Abnormality of prenatal development or birth, Seizure (possible), Generalized hypotonia (rare), Death in infancy (possible), Apnea (rare), Opisthotonus (rare), Hypertyrosinemia (no), Neonatal death (possible), Death in childhood (possible).

+5. Metabolic storage diseases: Retrognathia, Abnormality of prenatal development or birth, Seizure (possible), Generalized hypotonia, Death in infancy (common), Apnea (common), Opisthotonus (common), Hypertyrosinemia (rare), Neonatal death (common), Death in childhood (common).

+6. Neonatal sepsis: Retrognathia (rare), Abnormality of prenatal development or birth (rare), Seizure (possible), Generalized hypotonia (rare), Death in infancy (common), Apnea (common), Opisthotonus (rare), Hypertyrosinemia (no), Neonatal death (common), Death in childhood (rare).

+7. Hydrocephalus: Retrognathia (rare), Abnormality of prenatal development or birth (rare), Seizure (possible), Generalized hypotonia (rare), Death in infancy (rare), Apnea (rare), Opisthotonus (rare), Hypertyrosinemia (no), Neonatal death (rare), Death in childhood (rare).

+8. Congenital myasthenia gravis: Retrognathia (rare), Abnormality of prenatal development or birth (rare), Seizure (rare), Generalized hypotonia (yes), Death in infancy (rare), Apnea (rare), Opisthotonus (rare), Hypertyrosinemia (no), Neonatal death (rare), Death in childhood (rare).

+9. Mitochondrial disorders: Retrognathia (rare), Abnormality of prenatal development or birth (rare), Seizure (possible), Generalized hypotonia (yes), Death in infancy (common), Apnea (common), Opisthotonus"
['Tyrosinemia type 1']," +1. Intellectual disability (Autistic behavior, Motor delay, Seizure, Elevated circulating alkaline phosphatase concentration, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration): This condition is characterized by significant limitations in intellectual functioning and adaptive behavior. Autistic behavior and motor delay are common symptoms. Seizures, elevated alkaline phosphatase, alpha-fetoprotein, aspartate family amino acids, and alanine levels may indicate specific subtypes of intellectual disability, such as Down syndrome or inborn errors of metabolism.

+2. Phenylketonuria (Intellectual disability, Self-mutilation, Hyperactivity, Hyperphenylalaninemia, Elevated circulating alkaline phosphatase concentration): This genetic disorder affects the metabolism of the amino acid phenylalanine, leading to its accumulation in the body. Symptoms include intellectual disability, self-mutilation, and hyperactivity. Elevated alkaline phosphatase may indicate liver involvement.

+3. Neonatal hemochromatosis (Neonatal death, Decreased serum iron): This condition is characterized by liver damage in newborns, leading to jaundice, feeding difficulties, and poor weight gain. Decreased serum iron levels are a common finding.

+4. Mucopolysaccharidosis (Intellectual disability, Motor delay, Elevated circulating alkaline phosphatase concentration, Elevated circulating alpha-fetoprotein concentration): This group of disorders is caused by the deficiency of enzymes needed to break down complex sugars called mucopolysaccharides. Symptoms include intellectual disability, motor delay, and elevated alkaline phosphatase and alpha-fetoprotein levels.

+5. Wilson's disease (Liver disease, Elevated circulating copper, Decreased serum ceruloplasmin): This inherited disorder causes copper to accumulate in the liver and other organs, leading to liver damage, neurological symptoms, and psychiatric problems. It is characterized by elevated copper levels and decreased ceruloplasmin. Self-mutilation, intellectual disability, and seizures are not typical symptoms.

+6. Maple Syrup Urine Disease (Hyperactivity, Hyperammonemia, Elevated circulating alkaline phosphatase concentration, Hyperglycinemia): This metabolic disorder affects the breakdown of certain amino acids, leading to their accumulation in the body. Symptoms include hyperactivity, hyperammonemia, and elevated alkaline phosphatase levels. Self-mutilation, intellectual disability, and seizures are not typical symptoms.

+7. Cystic fibrosis (Obesity, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration): This genetic disorder affects the production and transport of mucus in the body, leading to respiratory and digestive problems. Obesity and elevated alkaline phosphatase levels are not typical symptoms, but some people with cystic fibrosis may have abnormal aspartate family amino acid levels.

+8. Galactosemia (Neonatal death, Elevated circulating alkaline phosphatase concentration, Elevated circulating galactose):"
['Classic galactosemia']," +1. Galactosemia: This is a genetic metabolic disorder caused by the deficiency of the enzyme galactose-1-phosphate uridyltransferase. Patients cannot metabolize galactose, leading to an accumulation of galactose-1-phosphate in the body. Symptoms include vomiting, jaundice, and failure to thrive. Galactosemics cannot tolerate milk or milk products. In severe cases, it can lead to intellectual disability and developmental delay. Neonatal death can occur if left untreated.

+2. Hemolytic Disease of the Newborn: This condition occurs when a Rh-negative mother produces antibodies against Rh-positive fetal red blood cells, leading to hemolysis (destruction of red blood cells) in the fetus or newborn. Symptoms include jaundice, anemia, and hemoglobinuria. Vomiting and death in infancy can occur due to anemia and kernicterus (brain damage caused by bilirubin toxicity).

+3. Cystic Fibrosis: This is a genetic disorder affecting the exocrine glands, leading to thick, sticky mucus production. Symptoms include persistent cough, frequent lung infections, and difficulty gaining weight. While jaundice and neonatal death are not common symptoms, increased total bilirubin can occur due to liver involvement in some cases.

+4. Inborn Errors of Metabolism: This term refers to a group of genetic disorders that affect the body's ability to metabolize certain substances. Symptoms can vary widely depending on the specific disorder. Some inborn errors of metabolism can cause vomiting, jaundice, and developmental delay. However, not all inborn errors of metabolism cause these symptoms, and some may not present with symptoms until later in life.

+5. Sepsis: This is a life-threatening condition caused by the body's response to an infection. Symptoms include fever, chills, rapid heart rate, and difficulty breathing. Vomiting and jaundice can occur due to organ dysfunction. Neonatal sepsis can be caused by bacterial infections acquired during childbirth.

+6. Hepatitis: This is an inflammation of the liver, which can be caused by viral or non-viral infections. Symptoms include jaundice, abdominal pain, and fever. Vomiting can occur due to liver dysfunction. Neonatal hepatitis can be caused by viral infections, toxins, or metabolic disorders.

+7. Congenital Hypothyroidism: This is a condition caused by the absence or underfunctioning of the thyroid gland. Symptoms include developmental delay, constipation, and hypothermia. Jaundice is not a common symptom, but increased total bilirubin can occur due to liver dysfunction. Vomiting is not a common symptom, but it can occur due to gastrointestinal dysfunction. Neonatal death is rare if diagnosed and treated early."
['Phenylketonuria']," +1. Phenylketonuria (PKU): A genetic disorder caused by the lack of an enzyme needed to break down phenylalanine, leading to an accumulation of this amino acid in the body. Patients with PKU may experience mental and developmental problems if left untreated. +Symptoms in common: Abnormality of prenatal development or birth, Neonatal death, Hyperphenylalaninemia +Symptoms not in common: Death in infancy, Abnormal circulating tyrosine concentration

+2. Maple Syrup Urine Disease (MSUD): Another metabolic disorder caused by a deficiency of the enzymes needed to break down certain amino acids, leading to their accumulation in the body. Patients with MSUD may experience symptoms such as poor feeding, vomiting, and developmental delays. +Symptoms in common: Abnormality of prenatal development or birth, Neonatal death, Hyperphenylalaninemia +Symptoms not in common: Death in infancy, Abnormal circulating tyrosine concentration

+3. Galactosemia: A metabolic disorder caused by a deficiency of the enzyme needed to break down galactose, a sugar found in milk and milk products. Patients with galactosemia may experience symptoms such as jaundice, vomiting, and diarrhea. +Symptoms in common: Abnormality of prenatal development or birth +Symptoms not in common: Death in infancy, Neonatal death, Hyperphenylalaninemia (Galactosemia does not cause hyperphenylalaninemia), Abnormal circulating tyrosine concentration (Galactosemia does not cause an abnormal circulating tyrosine concentration)

+4. Congenital Hypothyroidism: A condition caused by a deficiency of thyroid hormones at birth. Patients with congenital hypothyroidism may experience symptoms such as poor growth, developmental delays, and constipation. +Symptoms in common: Abnormality of prenatal development or birth +Symptoms not in common: Death in infancy, Neonatal death, Hyperphenylalaninemia, Abnormal circulating tyrosine concentration (Congenital hypothyroidism does not cause hyperphenylalaninemia or an abnormal circulating tyrosine concentration)"
['Biotinidase deficiency']," +1. Carnitine Deficiency: This metabolic disorder impairs the body's ability to transport fatty acids into the mitochondria for energy production. Patients may present with symptoms such as muscle weakness, hypoglycemia, and cardiac problems. Obesity is not a common symptom, but abnormal circulating carnitine concentration is a hallmark of this condition.

+2. Mitochondrial Disorders: These genetic conditions affect the mitochondria, the energy-producing organelles in cells. Symptoms can vary widely but may include developmental delays, muscle weakness, seizures, and cardiac problems. Obesity is not typically associated with mitochondrial disorders, but some forms may present with growth failure or abnormal metabolism.

+3. Cystic Fibrosis: This genetic disorder affects the respiratory, digestive, and reproductive systems. Symptoms include persistent cough, lung infections, difficulty gaining weight, and malnutrition. Obesity is not a common symptom, but some individuals with cystic fibrosis may experience weight gain due to malabsorption or overeating to compensate for poor nutrient absorption.

+4. Hemochromatosis: This genetic disorder causes the body to absorb too much iron from the diet, leading to iron overload. Symptoms may include joint pain, abdominal pain, fatigue, and liver damage. Obesity is a common symptom due to the body's inability to effectively use the excess iron for energy production.

+5. Prader-Willi Syndrome: This genetic disorder is characterized by developmental delays, short stature, and insatiable appetite leading to obesity. Other symptoms include hypotonia, small hands and feet, and cognitive impairment. Death in childhood or adolescence is not a common symptom, but some individuals with Prader-Willi Syndrome may have reduced life expectancy due to complications related to obesity.

+6. Wilson's Disease: This rare genetic disorder causes copper to accumulate in the liver, brain, and other organs. Symptoms may include jaundice, tremors, speech problems, and liver damage. Obesity is not a common symptom, but some individuals with Wilson's Disease may experience weight gain due to loss of muscle mass or other metabolic disturbances.

+7. Gaucher's Disease: This lysosomal storage disorder causes the accumulation of a lipid called glucocerebroside in the body's tissues. Symptoms may include enlarged liver and spleen, bone pain, and bruising. Obesity is not a common symptom, but some individuals with Gaucher's Disease may experience weight gain due to complications related to the disease or its treatment.

+8. Niemann-Pick Disease: This lysosomal storage disorder causes the accumulation of cholesterol and other lipids in the body's tissues. Symptoms may include hepatosplenomegaly, lung involvement, and neurological problems. Obesity is not a common symptom, but some individuals with Niemann-Pick Disease may experience weight gain due to complications related to the disease or its treatment.

+9. Hurler Syndrome: This lysosomal storage disorder causes the accumulation of a sugar called heparan sulfate in the body's tissues. Symptoms may include coarse facial features, hearing loss, and heart problems. Obesity"
['Phenylketonuria']," +1. Down Syndrome: Abnormality of prenatal development or birth, Intellectual disability.
+2. Cystic Fibrosis: Intellectual disability (rare), Hyperphenylalaninemia (no), Neonatal death (yes in severe cases), Death in infancy (yes in severe cases), Hypertyrosinemia (no).
+3. Tay-Sachs Disease: Intellectual disability, Neonatal death, Death in infancy (yes in late-onset form), Hypertyrosinemia (no), Hyperphenylalaninemia (no).
+4. Phenylketonuria (PKU): Intellectual disability, Hyperphenylalaninemia (yes), Neonatal death (rare), Death in infancy (rare), Hypertyrosinemia (no).
+5. Hurler Syndrome: Abnormality of prenatal development or birth, Intellectual disability, Death in adolescence (yes), Hypertyrosinemia (no), Hyperphenylalaninemia (no), Neonatal death (rare), Death in infancy (rare).
+6. Krabbe Disease: Abnormality of prenatal development or birth (rare), Intellectual disability, Neonatal death (yes), Death in infancy (yes), Hypertyrosinemia (no), Hyperphenylalaninemia (no).
+7. Marfan Syndrome: Intellectual disability (rare), Abnormality of prenatal development or birth (rare), Neonatal death (no), Death in infancy (no), Hypertyrosinemia (no), Hyperphenylalaninemia (no).
+8. Sickle Cell Anemia: Intellectual disability (rare), Abnormality of prenatal development or birth (rare), Neonatal death (rare), Death in infancy (rare), Hypertyrosinemia (no), Hyperphenylalaninemia (no).
+9. Thalassemia: Intellectual disability (rare), Abnormality of prenatal development or birth (rare), Neonatal death (rare), Death in infancy (rare), Hypertyrosinemia (no), Hyperphenylalaninemia (no).
+10. Hemophilia: Intellectual disability (rare), Abnormality of prenatal development or birth (rare), Neonatal death (no), Death in infancy (no), Hypertyrosinemia (no), Hyperphenylalaninemia (no)."
['Smith-Lemli-Opitz syndrome']," +1. Down syndrome: Cryptorchidism, Hypospadias, Intellectual disability, Motor delay, Hypotonia, Facial dysmorphism (low-set ears, flat face, upslanting palpebral fissures, epicanthic folds), Brachydactyly, Congenital heart disease, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Feeding difficulties, Hypoxemia, Hearing impairment.
+2. Cornelia de Lange syndrome: Intellectual disability, Motor delay, Hypotonia, Dystonia, Facial dysmorphism (low-set ears, synophrys, long eyelashes, small jaw), Microcephaly, Severe constipation, Feeding difficulties, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Recurrent viral infections.
+3. Smith-Lemli-Opitz syndrome: Intellectual disability, Motor delay, Hypotonia, Dystonia, Facial dysmorphism (low-set ears, short nose, micrognathia, cleft palate), Microcephaly, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Vomiting, Constipation, Feeding difficulties, Hypoxemia, Severe hearing impairment.
+4. Trisomy 13 (Patau syndrome): Intellectual disability, Motor delay, Hypotonia, Dystonia, Facial dysmorphism (low-set ears, microcephaly, coloboma, cleft lip/palate), Polydactyly, Severe developmental delay, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Vomiting, Constipation, Feeding difficulties, Hypoxemia, Severe hearing impairment, Congenital heart disease.
+5. Trisomy 18 (Edwards syndrome): Intellectual disability, Motor delay, Hypotonia, Dystonia, Facial dysmorphism (low-set ears, microcephaly, micrognathia, short neck), Severe developmental delay, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Vomiting, Constipation, Feeding difficulties, Hypoxemia, Severe hearing impairment, Congenital heart disease, Respiratory distress.
+6. Neonatal Adrenoleukodystrophy: Intellectual disability, Motor delay, Hypotonia, Dystonia, Vomiting, Constipation, Feeding difficulties, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Severe hearing impairment.
+7. Mucopolysaccharidosis: Intellectual disability, Motor delay, Hypotonia, Dystonia, Facial dysmorphism (coarse facial features, macroglossia, short stature), Joint stiffness, Hepatosplenomegaly, Hearing impairment, Feeding difficulties.
+8. Cystic fibrosis: Motor delay, Hypotonia, Recurrent viral infections, Severe hearing impairment, Feeding difficulties, Hyp"
['Canavan disease']," +1. Metabolic Disorder (e.g., Pompe Disease): Strabismus, Hyporeflexia, Generalized hypotonia, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration. This condition is characterized by a deficiency of lysosomal enzyme, leading to glycogen accumulation in various tissues. The patient does not have Obesity, Fever, or Death in infancy as symptoms.

+2. Leigh Syndrome: Strabismus, Hyporeflexia, Generalized hypotonia, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration. Leigh Syndrome is a mitochondrial disorder that affects the central nervous system. The patient does not have Obesity, Fever, or Death in infancy as symptoms.

+3. Prader-Willi Syndrome: Hyporeflexia, Generalized hypotonia, Obesity. Prader-Willi Syndrome is a genetic disorder characterized by hypotonia, hyperphagia, and obesity. The patient does not have Strabismus, Cerebral atrophy, Fever, or Abnormal circulating aspartate family amino acid concentration as symptoms.

+4. Mitochondrial Encephalomyopathy: Strabismus, Hyporeflexia, Generalized hypotonia, Cerebral atrophy. Mitochondrial Encephalomyopathy is a group of disorders caused by mutations in mitochondrial DNA. The patient does not have Obesity, Fever, or Abnormal circulating aspartate family amino acid concentration as symptoms.

+5. Krabbe Disease: Strabismus, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration. Krabbe Disease is a demyelinating disorder caused by a deficiency of galactocerebrosidase. The patient does not have Hyporeflexia, Generalized hypotonia, Obesity, Fever, or Death in infancy as symptoms.

+6. Canavan Disease: Hyporeflexia, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration. Canavan Disease is a metabolic disorder caused by a deficiency of N-acetylaspartate-acyltransferase. The patient does not have Strabismus, Generalized hypotonia, Obesity, Fever, or Death in infancy as symptoms.

+7. Mucopolysaccharidosis Type III: Strabismus, Hyporeflexia, Generalized hypotonia, Cerebral atrophy. Mucopolysaccharidosis Type III is a group of lysosomal storage disorders. The patient does not have Obesity, Fever, or Death in infancy as symptoms.

+8. Wilson Disease: Hyporeflexia, Generalized hypotonia, Abnormal circulating aspartate family amino acid concentration. Wilson Disease is a disorder of copper metabolism. The patient does not have Strabismus, Cerebral atrophy, Obesity, Fever, or Death in infancy as symptoms.

+9. Sjögren-Larsson Syndrome: Hyporeflexia, Generalized hypotonia, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration. Sjögren-Larsson Syndrome is a per"
['Phenylketonuria']," +1. Obesity: Excessive body weight for age, often accompanied by an unhealthy lifestyle and poor nutrition. Symptoms: Obesity, +Fever: Body temperature above normal range.
+2. Coarctation of aorta: A narrowing of the aorta, usually located between the origin of the left subclavian artery and the diaphragm. Symptoms: Coarctation of aorta, +Fever.
+3. Pneumonia: An infection that causes inflammation in the lungs, often resulting in cough, chest pain, and difficulty breathing. Symptoms: Pneumonia, +Fever.
+4. Hypertyrosinemia: A metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic substances in the body. Symptoms: Hypertyrosinemia, +Fever.
+5. Hyperphenylalaninemia: A genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body. Symptoms: Hyperphenylalaninia, +Neonatal death, +Death in infancy.
+6. Neonatal death: The death of a newborn baby before the age of 28 days. Symptoms: Neonatal death, +Death in infancy.
+7. Death in childhood: The death of an individual between the ages of infancy and adolescence. Symptoms: Death in childhood, +Death in infancy, +Death in adolescence.
+8. Death in adolescence: The death of an individual between the ages of adolescence and early adulthood. Symptoms: Death in adolescence, +Death in childhood.
+9. Death in early adulthood: The death of an individual between the ages of early adulthood and middle age. Symptoms: Death in early adulthood, +Death in adolescence.

Note: The symptoms listed for each disease are the most common and not exhaustive. Other symptoms may be present depending on the specific case."
['Classic homocystinuria']," +1. Cystic Fibrosis: A genetic disorder that affects the respiratory, digestive, and reproductive systems. It is characterized by thick, sticky mucus that obstructs the lungs and pancreas, leading to chronic lung infections and difficulty digesting food. +Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.

+2. Maple Syrup Urine Disease: An inherited metabolic disorder caused by a deficiency of the enzymes needed to break down certain amino acids. It results in the buildup of these amino acids in the body, leading to a sweet-smelling urine and a variety of neurological symptoms. +Symptoms: Aminoaciduria, Neonatal death, Death in childhood.

+3. Phenylketonuria (PKU): An inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It results in the buildup of phenylalanine in the body, leading to intellectual disability, seizures, and other neurological symptoms. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Death in childhood.

+4. Homocystinuria: An inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It results in the buildup of homocysteine in the body, leading to intellectual disability, neurological symptoms, and skeletal abnormalities. +Symptoms: Abnormality of prenatal development or birth, Hyperhomocystinemia, Neonatal death, Death in childhood.

+5. Krabbe Disease: An inherited metabolic disorder caused by a deficiency of the enzyme galactocerebrosidase. It results in the accumulation of a fatty substance called galactosylsphingosine in the nervous system, leading to demyelination and neurological symptoms. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Death in childhood.

+6. Tay-Sachs Disease: An inherited metabolic disorder caused by a deficiency of the enzyme hexosaminidase A. It results in the accumulation of a fatty substance called GM2 ganglioside in the nervous system, leading to progressive neurological deterioration and eventual death. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Death in childhood.

+7. Zellweger Syndrome: A rare genetic disorder caused by mutations in genes involved in the synthesis of peroxisomes, which are organelles that play a role in breaking down certain fats and other substances. It results in a variety of neurological symptoms, including seizures, developmental delays, and vision and hearing problems. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Death in childhood.

+8. Mucopolysaccharidosis: A group of lysosomal storage disorders caused by a deficiency of enzymes needed to break down complex sugars called glycosaminoglycans. It results in the accumulation of these sugars in various tissues and organs, leading to a range of symptoms including developmental delays, skeletal abnormalities, and organ dysfunction. +Symptoms: Abnormality of prenatal development or birth,"
[]," +1. Wilson's Disease: A genetic disorder causing copper accumulation in the liver and brain. Patients may exhibit hepatic dysfunction, neurological symptoms such as ataxia and tremors, and may have low uric acid levels in the urine. +2. Maple Syrup Urine Disease: An inherited metabolic disorder affecting the breakdown of certain amino acids. Patients may present with symptoms such as poor feeding, vomiting, and developmental delay. Urine may have a sweet smell, and uraciluria is a common finding. +3. Sjögren's Syndrome: An autoimmune disorder affecting the exocrine glands, leading to dryness of the eyes and mouth. Ataxia and generalized hypotonia are not typical symptoms, but some patients may have neurological involvement. +4. Muscular Dystrophies: A group of genetic disorders causing progressive muscle weakness and wasting. Hypotonia is a common symptom, but ataxia and death in childhood are not typical for all types. +5. Fanconi Syndrome: A group of rare genetic disorders characterized by the loss of tubular function in the kidneys. Patients may present with symptoms such as proteinuria, glycosuria, and aminoaciduria, including uraciluria. Ataxia and death in childhood are not typical symptoms. +6. Menkes Disease: A rare X-linked genetic disorder causing copper deficiency and impaired copper transport. Patients may exhibit neurological symptoms such as ataxia, developmental delay, and hypotonia. Uraciluria is not a typical symptom. +7. Ornithine Transcarbamylase Deficiency: An inherited metabolic disorder affecting the urea cycle. Patients may present with symptoms such as poor feeding, vomiting, and developmental delay. Uraciluria is a common finding, but ataxia and death in childhood are not typical for all cases. +8. Pyruvate Dehydrogenase Complex Deficiency: A metabolic disorder affecting the breakdown of pyruvate in the mitochondria. Patients may present with symptoms such as hypotonia, developmental delay, and metabolic acidosis. Ataxia and death in childhood are not typical symptoms. +9. Abetalipoproteinemia: An inherited disorder of fat absorption, leading to deficiencies in fat-soluble vitamins and essential fatty acids. Patients may present with symptoms such as ataxia, peripheral neuropathy, and hypotonia. Uraciluria is not a typical symptom."
['Phenylketonuria']," +1. Wilson's Disease: A genetic disorder causing copper buildup in the liver and brain. Common symptoms: none of the mentioned. +2. Hemochromatosis: A genetic condition where the body absorbs too much iron from the diet. Common symptoms: none of the mentioned. +3. Cystic Fibrosis: A genetic disease that affects the respiratory, digestive, and reproductive systems. Common symptoms: none of the mentioned. +4. Huntington's Disease: A progressive brain disorder causing uncontrolled movements, emotional problems, and cognitive decline. Common symptoms: none of the mentioned. +5. Gaucher's Disease: A lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase. Common symptoms: none of the mentioned. +6. Fabry Disease: A lysosomal storage disorder caused by a deficiency of the enzyme alpha-galactosidase A. Common symptoms: none of the mentioned. +7. Niemann-Pick Disease: A group of lysosomal storage disorders caused by a deficiency of sphingomyelinase or hexosaminidase A and S. Common symptoms: none of the mentioned. +8. Krabbe Disease: A demyelinating disorder caused by a deficiency of galactocerebrosidase. Common symptoms: none of the mentioned. +9. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase. Common symptoms: none of the mentioned.

+10. Maple Syrup Urine Disease: An inherited metabolic disorder caused by a deficiency of the enzymes needed to break down certain amino acids. Common symptoms: Hyperphenylalaninemia.

+11. Tyrosinemia Type 1: An inherited metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Common symptoms: Hypertyrosinemia.

+12. Phenylketonuria (PKU): An inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Common symptoms: Hyperphenylalaninemia.

The patient's symptoms of Hypertyrosinemia and Hyperphenylalaninemia suggest the possibility of an inherited metabolic disorder. The absence of other common symptoms such as developmental delays, seizures, or neurological symptoms helps to narrow down the possibilities to Maple Syrup Urine Disease, Tyrosinemia Type 1, or Phenylketonuria (PKU). Further diagnostic tests would be needed to confirm the diagnosis."
[]," +1. Cystic Fibrosis: A genetic disorder that causes persistent lung infections and difficulty in breathing. While it can lead to neonatal death and respiratory insufficiency, it does not typically cause death in infancy or abnormal circulating pyrimidine concentrations. +

+2. Maple Syrup Urine Disease: An inherited metabolic disorder that affects the breakdown of certain amino acids. It can cause uraciluria and neurological symptoms, but it does not usually cause death in infancy or respiratory insufficiency. +

+3. Inborn Errors of Metabolism: A group of genetic disorders that affect the body's ability to process certain nutrients. They can cause a variety of symptoms, including neonatal death, respiratory insufficiency, and abnormal circulating pyrimidine concentrations. However, not all inborn errors of metabolism cause uraciluria. +

+4. Sepsis: A life-threatening condition caused by the body's response to an infection. It can lead to respiratory insufficiency, neonatal death, and abnormal circulating pyrimidine concentrations due to organ failure. However, it does not typically cause uraciluria. +

+5. Congenital Diaphragmatic Hernia: A birth defect that causes the diaphragm to be abnormally formed or weakened, leading to respiratory insufficiency and neonatal death. It does not typically cause death in infancy, abnormal circulating pyrimidine concentrations, or uraciluria. +

+6. Sickle Cell Anemia: A genetic disorder that affects the production of hemoglobin, leading to abnormal red blood cells and various complications. It can cause neonatal death and respiratory insufficiency, but it does not typically cause abnormal circulating pyrimidine concentrations or uraciluria. +

+7. Methemoglobinemia: A condition in which the amount of methemoglobin in the blood is abnormally high, leading to impaired oxygen delivery to the body's tissues. It can cause respiratory insufficiency and neonatal death, but it does not typically cause abnormal circulating pyrimidine concentrations or uraciluria. +

+8. Neonatal Sepsis and Meningitis: An infection that affects newborns, typically caused by bacteria that enter the bloodstream or the meninges (the membranes surrounding the brain and spinal cord). It can lead to neonatal death, respiratory insufficiency, and abnormal circulating pyrimidine concentrations due to organ failure. However, it does not typically cause uraciluria. +

+9. Neonatal Jaundice: A condition characterized by the yellowing of the skin and eyes due to an accumulation of bilirubin in the blood. While it can lead to neonatal death and respiratory insufficiency in severe cases, it does not typically cause abnormal circulating pyrimidine concentrations or uraciluria. +

+10. Neonatal Infections: Infections that affect newborns, including bacterial, viral, and fungal infections. They can lead to neonatal death, respiratory insufficiency, and abnormal circulating pyrimidine concentrations due to organ failure. However, they do not typically cause uraciluria. +
"
['Tyrosinemia type 1']," +1. Sickle Cell Anemia: A genetic disorder causing the production of abnormal hemoglobin, leading to RBCs with a crescent shape, resulting in hemolysis, anemia, and splenomegaly. Common symptoms: Anemia, Pallor. Not common: Death in infancy, Ascites, Thrombocytosis, Hypoalbuminemia, Hypoproteinemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration.

+2. Cirrhosis: A chronic liver disease characterized by the replacement of normal liver tissue with scar tissue, leading to impaired liver function. Common symptoms: Jaundice (pallor), Ascites, Hypoalbuminemia, Hypoproteinemia. Not common: Death in infancy, Thrombocytosis, Anemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration.

+3. Hemangioma: A benign tumor of blood vessels, usually occurring in the liver. Common symptoms: None, often asymptomatic. Not common: Pallor, Death in infancy, Ascites, Thrombocytosis, Anemia, Hypoalbuminemia, Hypoproteinemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration.

+4. Wilson's Disease: A rare genetic disorder causing copper accumulation in the liver, leading to liver damage and neurological symptoms. Common symptoms: Jaundice (pallor), Hepatosplenomegaly, Elevated circulating alkaline phosphatase concentration, Hypoproteinemia. Not common: Death in infancy, Ascites, Thrombocytosis, Anemia, Hypoalbuminemia, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration.

+5. Hemochromatosis: A genetic disorder causing excessive iron absorption, leading to iron accumulation in various organs, including the liver. Common symptoms: Fatigue, Jaundice (pallor), Abdominal pain. Not common: Death in infancy, Ascites, Thrombocytosis, Anemia, Hypoalbuminemia, Hypoproteinemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration.

+6. Congenital Adrenal Hyperplasia: A genetic disorder causing the deficiency of enzymes involved in cortisol and aldosterone synthesis, leading to various symptoms, including salt wasting and hyperpigmentation. Common symptoms: None. Not common: Pallor, Death in infancy, Ascites, Thrombocytosis, Anemia, Hypoalbuminem"
['Canavan disease']," +1. Metabolic Disorder - Maple Syrup Urine Disease: Seizures, Motor delay, Abnormal circulating aspartate family amino acid concentration (specifically, elevated levels of branched-chain amino acids).
+2. Neurological Disorder - Epilepsy: Seizures.
+3. Metabolic Disorder - Urea Cycle Disorder: Seizures, Abnormal circulating aspartate family amino acid concentration (specifically, hyperammonemia).
+4. Neurological Disorder - Cerebral Palsy: Motor delay.
+5. Metabolic Disorder - Organic Acidemia: Seizures, Abnormal circulating aspartate family amino acid concentration (specifically, elevated levels of organic acids).
+6. Neurological Disorder - Mitochondrial Disorder: Motor delay, Seizures (can also present with other neurological symptoms).
+7. Metabolic Disorder - Leigh Syndrome: Seizures, Motor delay, Abnormal circulating aspartate family amino acid concentration (specifically, decreased levels of NAD and ATP).
+8. Neurological Disorder - Krabbe Disease: Motor delay, Seizures (can also present with other neurological symptoms, such as vision and hearing loss).
+9. Metabolic Disorder - Canavan Disease: Motor delay, Seizures, Abnormal circulating aspartate family amino acid concentration (specifically, decreased levels of N-acetylaspartate).

Please note that this list is not exhaustive and further diagnostic tests are required to confirm a definitive diagnosis. The patient's symptoms and medical history should be evaluated in the context of other clinical findings and diagnostic tests."
['Isovaleric acidemia']," +1. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids, leading to a build-up of toxic substances in the body. Common symptoms include: Fever, Vomiting, Abdominal pain, Neonatal death, Death in infancy, Death in childhood, and Abnormal circulating glycine concentration. The patient does not have symptoms of Recurrent viral infections, Gastrointestinal inflammation, Abnormal circulating carnitine concentration, Death in adolescence, or Body odor.

+2. Carnitine Palmitoyltransferase Deficiency: This is another inherited metabolic disorder that affects the body's ability to transport fatty acids into the mitochondria for energy production. Symptoms include: Vomiting, Abdominal pain, and Recurrent viral infections. The patient does not have symptoms of Death in infancy, Neonatal death, Death in childhood, Gastrointestinal inflammation, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, Death in adolescence, or Body odor.

+3. Cystic Fibrosis: This is a genetic disorder that affects the respiratory, digestive, and reproductive systems. Common symptoms include: Recurrent viral infections, Abdominal pain, and Body odor. The patient does not have symptoms of Death in infancy, Neonatal death, Death in childhood, Gastrointestinal inflammation, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, or Death in adolescence.

+4. Inflammatory Bowel Disease (IBD): This is a chronic inflammatory condition of the intestines, causing symptoms such as: Abdominal pain, Diarrhea, and Vomiting. The patient does not have symptoms of Death in infancy, Neonatal death, Death in childhood, Gastrointestinal inflammation (as this is a part of the definition), Recurrent viral infections, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, or Death in adolescence.

+5. Typhoid Fever: This is a bacterial infection caused by Salmonella typhii or Salmonella paratyphi. Common symptoms include: Fever, Abdominal pain, and Diarrhea. The patient does not have symptoms of Death in infancy, Neonatal death, Death in childhood, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, or Death in adolescence.

+6. Celiac Disease: This is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. Common symptoms include: Abdominal pain, Vomiting, and Diarrhea. The patient does not have symptoms of Death in infancy, Neonatal death, Death in childhood, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, or Death in adolescence.

+7. Intestinal Lymphoma: This is a type of cancer that affects the lymphatic tissue in the intestines. Symptoms include: Abdominal pain, Vomiting, and Diarrhea. The patient does"
['Phenylketonuria']," +1. Wilson's Disease: Intellectual disability, Liver disease (may cause elevated urinary carboxylic acids), Death in adolescence or early adulthood : Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia
+2. Huntington's Disease: Intellectual disability, Death in early adulthood : Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Hypertension, Death in adolescence, Elevated urinary carboxylic acid
+3. Hemochromatosis: Obesity, Elevated urinary carboxylic acid : Hypertension, Intellectual disability, Hypertyrosinemia, Hyperphenylalaninia, Death in adolescence, Death in early adulthood
+4. Phenylketonuria: Intellectual disability, Hyperphenylalaninemia : Hypertension, Obesity, Hypertyrosinemia, Hypertension, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid
+5. Tyrosinemia: Intellectory disability, Hypertyrosinemia : Hypertension, Obesity, Hypertension, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid
+6. Cystic Fibrosis: Not applicable (not a metabolic disorder) : Hypertension, Intellectual disability, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid
+7. Diabetes Mellitus: Not applicable (not a metabolic disorder causing these symptoms) : Hypertension, Intellectual disability, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid
+8. Renal Disease: Elevated urinary carboxylic acid : Hypertension, Intellectual disability, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood
+9. Thyroid Disease: Not applicable : Hypertension, Intellectual disability, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid (unless associated with renal dysfunction)
+10. Sepsis: Not applicable : Hypertension, Intellectual disability, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid (unless secondary to renal dysfunction)"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Inborn Errors of Metabolism (such as Pompe Disease, Maple Syrup Urine Disease, or Krabbe Disease): Abnormality of prenatal development or birth, Neonatal death, Hyperalaninemia, Abnormal circulating carnitine concentration. +2. Cystic Fibrosis: Abnormality of prenatal development or birth, Small for gestational age, Severe hearing impairment. +3. Mucopolysaccharidoses: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration. +4. Zellweger Spectrum Disorder: Abnormality of prenatal development or birth, Small for gestational age, Neonatal death, Severe hearing impairment. +5. Lysosomal Storage Diseases: Abnormality of prenatal development or birth, Neonatal death, Hyperalaninemia, Abnormal circulating carnitine concentration. +6. Organic Acidemias: Abnormality of prenatal development or birth, Neonatal death, Hyperalaninemia, Abnormal circulating carnitine concentration. +7. Peroxisomal Disorders: Abnormality of prenatal development or birth, Small for gestational age, Neonatal death, Severe hearing impairment, Abnormal circulating carnitine concentration. +8. Usher Syndrome: Abnormality of prenatal development or birth, Severe hearing impairment, Neonatal death (in some types), Death in childhood."
['Ornithine transcarbamylase deficiency']," +1. Urea Cycle Disorders (Citrullinemia, Argininemia, Ornithinemia): Lethargy, Drowsiness, Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration.
+2. Reye's Syndrome: Lethargy, Drowsiness, Sleep abnormality, Vomiting, Hepatomegaly (absence of Death in infancy).
+3. Hepatic Encephalopathy: Lethargy, Drowsiness, Sleep abnormality, Confusion, Disorientation (absence of Oroticaciduria, Abnormal circulating ornithine concentration).
+4. Sepsis: Lethargy, Drowsiness, Fever, Chills, Rapid heart rate (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration).
+5. Hypothyroidism: Lethargy, Drowsiness, Cold intolerance, Constipation, Dry skin (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration).
+6. Diabetic Ketoacidosis: Lethargy, Drowsiness, Polydipsia, Polyuria, Ketosis (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration).
+7. Meningoencephalitis: Lethargy, Drowsiness, Fever, Headache, Neck stiffness (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration).
+8. Wilson's Disease: Lethargy, Drowsiness, Kayser-Fleischer rings, Tremors, Speech difficulties (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration).
+9. Creutzfeldt-Jakob Disease: Lethargy, Drowsiness, Myoclonus, Progressive dementia, Visual disturbances (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration).
+10. Metabolic Encephalopathy: Lethargy, Drowsiness, Confusion, Disorientation, Ataxia (absence of Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration)."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Metachromatic Leukodystrophy: This is a lysosomal storage disorder caused by a deficiency of arylsulfatase A. Patients present with progressive neurological deterioration, including Ataxia, Dystonia, and Abnormal myelination. They may also have Decreased plasma free carnitine and Abnormal cerebral morphology. However, they do not typically present with Glutaric aciduria or Death in childhood.

+2. Canavan Disease: This is another lysosomal storage disorder caused by a deficiency of N-acetylaspartate-acyltransferase. Patients present with progressive neurological symptoms, including Ataxia and Dystonia. They may also have Abnormal myelination and Decreased plasma free carnitine. However, they do not typically present with Glutaric aciduria or Death in childhood.

+3. Krabbe Disease: This is a demyelinating disorder caused by a deficiency of galactocerebrosidase. Patients present with neurological symptoms, including Ataxia and Dystonia. They may also have Abnormal myelination and Decreased plasma free carnitine. However, they do not typically present with Glutaric aciduria or Death in childhood.

+4. Pelizaeus-Merzbacher Disease: This is a disorder of myelination caused by a deficiency of proteolipid protein. Patients present with Ataxia, Dystonia, and Abnormal myelination. They may also have Decreased plasma free carnitine. However, they do not typically present with Glutaric aciduria, Abnormal cerebral morphology, or Death in childhood.

+5. Leigh Syndrome: This is a mitochondrial disorder caused by a deficiency of various enzymes involved in oxidative phosphorylation. Patients present with neurological symptoms, including Ataxia and Dystonia. They may also have Decreased plasma free carnitine and Abnormal cerebral morphology. However, they do not typically present with Glutaric aciduria or Death in childhood.

+6. Adrenoleukodystrophy: This is a peroxisomal disorder caused by a deficiency of very long-chain fatty acid beta-oxidation. Patients present with neurological symptoms, including Ataxia and Dystonia. They may also have Abnormal myelination and Decreased plasma free carnitine. However, they do not typically present with Glutaric aciduria, Abnormal cerebral morphology, or Death in childhood.

+7. Glutaric Acidemia Type I: This is a metabolic disorder caused by a deficiency of glutaryl-CoA dehydrogenase. Patients present with neurological symptoms, including Ataxia and Dystonia. They may also have Glutaric aciduria and Decreased plasma free carnitine. However, they typically present with Death in childhood and do not typically have Abnormal cerebral morphology or Abnormal myelination.

+8. Glutathione Deficiency: This is a metabolic disorder caused by a deficiency of glutathione, an important antioxidant. Patients may present with neurological symptoms, including Ataxia and Dystonia. They may also have Decreased plasma free carnitine and Abnormal cerebral morphology. However, they do not typically present with Glutaric aciduria"
['Phenylketonuria']," +1. Phenylketonuria (PKU): A genetic disorder caused by the lack of an enzyme needed to break down phenylalanine, leading to its accumulation in the body. Common symptoms include mental and developmental problems, seizures, and a musty odor. Neonatal death and death in infancy can occur if left untreated. +

+2. Maple Syrup Urine Disease (MSUD): Another metabolic disorder caused by a deficiency of the enzymes needed to break down certain amino acids, leading to their accumulation in the body. Common symptoms include poor feeding, vomiting, lethargy, and a distinctive sweet urine odor. Neonatal death and death in infancy can occur if left untreated. +

+3. Galactosemia: A genetic disorder caused by the inability to metabolize galactose, a sugar found in milk and milk products. Common symptoms include jaundice, diarrhea, vomiting, and failure to thrive. Neonatal death can occur if left untreated, but it is less common in galactosemia compared to PKU and MSUD. +

+4. Cystic Fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems. Common symptoms include persistent cough, lung infections, difficulty breathing, and malnutrition. Hyperphenylalaninemia is not a symptom of cystic fibrosis. +

+5. Sickle Cell Anemia: A genetic disorder affecting the production of hemoglobin, the protein in red blood cells that carries oxygen to the body. Common symptoms include anemia, pain crises, jaundice, and delayed growth. Neonatal death and death in infancy can occur due to complications related to anemia and infections. +

+6. Congenital Heart Disease: A group of heart defects present at birth. Common symptoms include difficulty breathing, rapid breathing, bluish skin, and poor feeding. Hyperphenylalaninemia is not a symptom of congenital heart disease. +

+7. Inborn Errors of Metabolism (other than PKU, MSUD, and Galactosemia): There are many other inborn errors of metabolism that can cause symptoms similar to those listed, such as organic acidemias, aminoacidopathies, and urea cycle disorders. Common symptoms include developmental delay, seizures, vomiting, and poor feeding. Neonatal death and death in infancy can occur if left untreated. +

+8. Infectious Diseases: Infections, such as bacterial or viral infections, can also cause symptoms similar to those listed, such as poor feeding, vomiting, and lethargy. Neonatal death and death in infancy can occur if the infection is severe or if the infant is not treated promptly. +

+9. Genetic Syndromes: There are many genetic syndromes that can cause symptoms similar to those listed, such as Down syndrome, Fetal Alcohol Spectrum Disorders, and Fragile X Syndrome. Common symptoms can include developmental delay, poor feeding, and growth problems. Neonatal death and death in infancy can occur in some of these syndromes. +

+10. Other Metabolic Disorders: There are many other metabolic disorders that can cause symptoms similar to those listed, such as mitochondrial disorders, lysosomal storage disorders, and peroxisomal disorders. Common"
['Systemic primary carnitine deficiency']," +1. Metabolic Encephalopathy (Irritability, Coma, Encephalopathy, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration): This condition refers to a dysfunction of the metabolic processes in the brain, leading to neurological symptoms such as irritability, coma, and encephalopathy. The patient's symptoms of cardiomyopathy, anemia, hypoglycemia, hepatomegaly, elevated circulating hepatic transaminase concentration, and death in childhood are not typical for metabolic encephalopathy.

+2. Reye Syndrome (Irritability, Coma, Vomiting, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Decrease plasma free carnitine, Death in childhood): Reye syndrome is a rare but serious condition that affects the brain and liver. It is characterized by symptoms such as irritability, coma, vomiting, hepatomegaly, and elevated circulating hepatic transaminase concentration. The patient's symptoms of generalized hypotonia, encephalopathy, cardiomyopathy, anemia, hypoglycemia, abnormal circulating porphyrin concentration, and abnormal circulating aspartate family amino acid concentration are not typical for Reye syndrome.

+3. Wilson Disease (Irritability, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Abnormal circulating copper concentration, Decreased plasma free carnitine, Death in childhood): Wilson disease is a rare genetic disorder that affects copper metabolism, leading to accumulation of copper in various organs, including the liver and brain. It is characterized by symptoms such as irritability, hepatomegaly, and elevated circulating hepatic transaminase concentration. The patient's symptoms of coma, generalized hypotonia, encephalopathy, cardiomyopathy, anemia, hypoglycemia, abnormal circulating porphyrin concentration, and abnormal circulating aspartate family amino acid concentration are not typical for Wilson disease.

+4. Maple Syrup Urine Disease (Irritability, Coma, Vomiting, Abnormal circulating amino acid concentration): Maple syrup urine disease is a metabolic disorder that affects the breakdown of certain amino acids, leading to their accumulation in the body. It is characterized by symptoms such as irritability, coma, and vomiting, as well as abnormal circulating amino acid concentrations. The patient's symptoms of generalized hypotonia, encephalopathy, cardiomyopathy, anemia, hypoglycemia, hepatomegaly, and abnormal circulating porphyrin concentration are not typical for maple syrup urine disease.

+5. Acute Liver Failure (Coma, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Hypoglycemia, Decreased plasma free carnitine, Death in childhood): Acute liver failure is a sudden and severe condition that affects the liver's ability to function properly. It is characterized by symptoms such as coma, hepatomegaly, elevated circulating hepatic transaminase concentration, hypoglycemia, and decreased plasma free carnit"
['PMM2-CDG']," +1. Cerebral Palsy: Motor delay, Ataxia, Cerebellar atrophy, Generalized hypotonia, Cerebellar agenesis. The patient does not have Strabismus, Nystagmus, Hyporeflexia, Encephalopathy, Growth delay, Death in infancy.

+2. Ataxia-Telangiectasia: Ataxia, Cerebellar atrophy, Hyporeflexia. The patient does not have Strabismus, Nystagmus, Motor delay, Cerebral palsy, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+3. Krabbe Disease: Cerebellar atrophy, Motor delay, Hyporeflexia, Cerebral palsy (sometimes). The patient does not have Strabismus, Nystagmus, Ataxia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+4. Metachromatic Leukodystrophy: Cerebral palsy, Motor delay, Hyporeflexia, Cerebellar atrophy. The patient does not have Strabismus, Nystagmus, Ataxia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+5. Spinal Muscular Atrophy: Hyporeflexia, Motor delay, Generalized hypotonia. The patient does not have Strabismus, Nystagmus, Ataxia, Cerebellar atrophy, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+6. Peripheral Neuropathy: Hyporeflexia, Motor delay, Ataxia (sometimes). The patient does not have Strabismus, Nystagmus, Cerebellar atrophy, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+7. Leigh Syndrome: Encephalopathy, Motor delay, Hyporeflexia. The patient does not have Strabismus, Nystagmus, Ataxia, Cerebellar atrophy, Growth delay, Death in infancy, Cerebellar agenesis.

+8. Rett Syndrome: Motor delay, Hyporeflexia, Growth delay. The patient does not have Strabismus, Nystagmus, Ataxia, Cerebellar atrophy, Encephalopathy, Death in infancy, Cerebellar agenesis.

+9. Pelizaeus-Merzbacher Disease: Cerebellar atrophy, Hyporeflexia, Motor delay. The patient does not have Strabismus, Nystagmus, Ataxia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+10. Dandy-Walker Syndrome: Cerebellar atrophy, Hyporeflexia, Motor delay. The patient does not have Strabismus, Nystagmus, Ataxia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+11. Fragile X Syndrome: Motor delay, Hyporeflexia, Growth delay. The patient"
['Classic homocystinuria']," +1. Marfan Syndrome: A genetic disorder that affects connective tissue, leading to Myopia, Ectopia lentis, and Dyskinesia. +2. Down Syndrome: A genetic disorder causing intellectual disability, Delayed speech and language development, and various physical features, but not typically associated with Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, or Death in infancy. +3. Homocystinuria: A metabolic disorder causing Hyperhomocystinemia, Ectopia lentis, and intellectual disability. +4. Phenylketonuria (PKU): A metabolic disorder causing intellectual disability, Delayed speech and language development, and Aminoaciduria, but not typically associated with Myopia, Ectopia lentis, or Death in infancy. +5. Maple Syrup Urine Disease: A metabolic disorder causing Aminoaciduria, intellectual disability, and Dyskinesia. +6. Usher Syndrome: A genetic disorder causing Myopia, Ectopia lentis, and Dyskinesia, along with hearing loss and vision loss, which is not typically associated with the other symptoms listed. +7. Krabbe Disease: A degenerative disorder causing intellectual disability, Delayed speech and language development, and Death in childhood, but not typically associated with Myopia, Ectopia lentis, Hyperhomocystinemia, Hypermethioninemia, or Abnormal circulating alanine concentration."
['Ornithine transcarbamylase deficiency']," +1. Reye's Syndrome: Seizures, Lethargy, Hyperreflexia, Metabolic acidosis, Hyperammonemia, Fever, Death in childhood (Fasciculations, Ataxia, Oroticaciduria, Diarrhea, Drowsiness, Sleep abnormality are not common symptoms)
+2. Meningoencephalitis: Seizures, Fever, Lethargy, Ataxia, Neck stiffness, Altered mental status (Hyperreflexia, Metabolic acidosis, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in adolescence are not common symptoms)
+3. Wilson's Disease: Lethargy, Ataxia, Dysarthria, Kayser-Fleischer rings, Hepatosplenomegaly, Fever (Seizures, Hyperreflexia, Metabolic acidosis, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence are not common symptoms)
+4. Mitochondrial Disorders: Seizures, Lethargy, Ataxia, Hyperreflexia, Metabolic acidosis, Developmental delay (Fever, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence are not common symptoms)
+5. Toxic Encephalopathy: Seizures, Lethargy, Ataxia, Confusion, Slurred speech (Hyperreflexia, Metabolic acidosis, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence are not common symptoms)
+6. Metabolic Disorders (Non-specific): Seizures, Lethargy, Ataxia, Metabolic acidosis, Hyperammonemia (Fever, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence are not common symptoms)
+7. Creutzfeldt-Jakob Disease: Seizures, Dementia, Ataxia, Myoclonus (Lethargy, Hyperreflexia, Metabolic acidosis, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence are not common symptoms)
+8. Epilepsy: Seizures (Lethargy, Ataxia, Hyperreflexia, Metabolic acidosis, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence are not common symptoms)
+9. Meningiomas: Seizures, Headache, Focal neurological deficits (Lethargy, Ataxia, Hyperreflexia, Metabolic acidosis, Hyperammonemia, Di"
['Smith-Lemli-Opitz syndrome']," +1. Down syndrome: Microcephaly, Short chin, Brachydactyly (instead of syndactyly), Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Feeding difficulties +2. Cornelia de Lange syndrome: Microcephaly, Pointed chin, Intellectual disability, Ataxia, Generalized hypotonia, Feeding difficulties, Failure to thrive +3. Smith-Lemli-Opitz syndrome: Microcephaly, Pointed chin, Short chin, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Feeding difficulties +4. Marfan syndrome: Long limbs, Arachnodactyly, Joint hypermobility, Chest deformity, Scoliosis (not mentioned), Disproportionate height, Intellectual disability (rare), Strabismus (rare), Ptosis (rare), Ataxia (rare), Generalized hypotonia (rare), Hyperreflexia (rare), Fatigue (rare) +5. Prader-Willi syndrome: Intellectual disability, Short stature, Hypotonia, Hyperphagia, Obesity (not mentioned), Hypogonadism, Small hands and feet, Strabismus (rare), Ataxia (rare), Hyperreflexia (rare), Feeding difficulties (early life), Failure to thrive (early life) +6. Fetal alcohol spectrum disorders: Microcephaly, Intellectual disability, Ataxia, Hyperreflexia, Developmental delays, Growth deficits, Facial abnormalities (not specified), Feeding difficulties (early life), Failure to thrive (early life) +7. Craniostenosis: Microcephaly, Intellectual disability (rare), Ataxia (rare), Hyperreflexia (rare), Failure to thrive (rare), Deformity of skull, Syndactyly (rare), Strabismus (rare), Ptosis (rare), Hypocholesterolemia (rare), Elevated 8-dehydrocholesterol (rare), Elevated circulating 7-dehydrocholesterol concentration (rare), Fatigue (rare), Death in infancy (rare) +8. Neurofibromatosis type 1: Pointed chin (rare), Intellectual disability (rare), Ataxia (rare), Generalized hypotonia (rare), Hyperreflexia (rare), Short stature (rare), Cafe-au-lait spots, Lisch nods, Freckling in axillary and inguinal regions, Scoliosis (rare), Seizures (rare), Optic glioma (rare), Feeding difficulties (rare), Failure to thrive (rare), Deformities of bones and joints (rare), Learning difficulties (rare), Speech difficulties (rare), Developmental delays (rare), Sensory impairment (rare), Cardiovascular problems (rare), Lymphoma (rare), Optic nerve tumors (rare), Malignant peripheral nerve sheath tumors (rare), Neurofibromas (rare), Bone"
['Glycogen storage disease due to glycogen debranching enzyme deficiency']," +1. Metabolic Disorder - Mitochondrial Diseases: Generalized hypotonia, Neonatal death, Increased circulating lactate concentration, Hepatomegaly, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration, Abnormal circulating creatine kinase concentration. This patient presents with several symptoms that are commonly associated with mitochondrial diseases, including metabolic acidosis, muscle weakness, liver involvement, and abnormalities in certain metabolites and enzymes. However, the patient's age and the presence of death in infancy are concerning signs that may indicate a more severe form of the disease.

+2. Inherited Metabolic Disorder - Maple Syrup Urine Disease: Generalized hypotonia, Neonatal death, Increased circulating lactate concentration, Hypertriglyceridemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. Maple Syrup Urine Disease is a metabolic disorder caused by a deficiency in the enzyme responsible for breaking down certain amino acids. The symptoms include metabolic acidosis, muscle weakness, and a distinctive sweet urine smell. The patient's symptoms of increased circulating lactate concentration, hypertriglyceridemia, and abnormal circulating aspartate family amino acid and alanine concentrations are consistent with this diagnosis. However, the absence of symptoms such as ketosis, cerebral edema, and typical maple syrup urine odor may suggest a less severe form of the disease.

+3. Inherited Metabolic Disorder - Carnitine Palmitoyltransferase Deficiency: Generalized hypotonia, Neonatal death, Increased circulating lactate concentration, Hypertriglyceridemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration. Carnitine palmitoyltransferase deficiency is a metabolic disorder that affects the transport of fatty acids into the mitochondria for beta-oxidation. The symptoms include metabolic acidosis, muscle weakness, and cardiomyopathy. The patient's symptoms of increased circulating lactate concentration, hypertriglyceridemia, and abnormal circulating aspartate family amino acid and alanine concentrations are consistent with this diagnosis. However, the absence of symptoms such as hypoglycemia, hypoketosis, and cardiomyopathy may suggest a less severe form of the disease.

+4. Inherited Metabolic Disorder - Organic Acidemia: Generalized hypotonia, Neonatal death, Increased circulating lactate concentration, Hypertriglyceridemia, Hepatomegaly, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration, Abnormal circulating creatine kinase concentration. Organic acidemias are a group of metabolic disorders characterized by the accumulation of organic acids in the body. The symptoms include metabolic acidosis, muscle weakness, liver involvement, and neurological symptoms. The patient's symptoms of increased circulating lactate concentration, hypertriglyceridemia, hepatomegaly, and abnormal circulating as"
['Glutaryl-CoA dehydrogenase deficiency']," +1. Metabolic Disorder - Glutaric Acidemia Type I: This is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenease. Patients present with Glutaric aciduria, Neonatal death, and Decreased plasma free carnitine. They may also have Microcephaly, Cerebral cortical atrophy, and Athetosis, but not Generalized hypotonia or Death in adolescence.

+2. Neurometabolic Disorder - Leigh Syndrome: This is a neurometabolic disorder caused by a deficiency of the mitochondrial enzyme complex IV (cytochrome c oxidase). Patients present with Microcephaly, Cerebral cortical atrophy, Athetosis, and Neonatal death. They may also have Glutaric aciduria and Decreased plasma free carnitine, but not Generalized hypotonia or Death in adolescence.

+3. Lysosomal Storage Disorder - Krabbe Disease: This is a lysosomal storage disorder caused by a deficiency of the enzyme galactocerebrosidase. Patients present with Microcephaly, Cerebral cortical atrophy, and Athetosis. They may also have Glutaric aciduria and Decreased plasma free carnitine, but not Generalized hypotonia, Neonatal death, or Death in adolescence.

+4. Mitochondrial Disorder - Leigh Variant: This is a mitochondrial disorder caused by mutations in various genes involved in the respiratory chain. Patients present with Microcephaly, Cerebral cortical atrophy, Athetosis, and Neonatal death. They may also have Glutaric aciduria and Decreased plasma free carnitine, but not Generalized hypotonia or Death in adolescence.

+5. Inborn Error of Metabolism - Maple Syrup Urine Disease: This is an inborn error of metabolism caused by a deficiency of the enzymes that metabolize branched-chain amino acids (leucine, isoleucine, and valine). Patients present with Microcephaly, Cerebral cortical atrophy, Athetosis, and Glutaric aciduria. They may also have Decreased plasma free carnitine, but not Generalized hypotonia, Neonatal death, or Death in adolescence.

+6. Neurodegenerative Disorder - Canavan Disease: This is a neurodegenerative disorder caused by a deficiency of the enzyme aspartoacylase. Patients present with Microcephaly, Cerebral cortical atrophy, and Athetosis. They may also have Glutaric aciduria and Decreased plasma free carnitine, but not Generalized hypotonia, Neonatal death, or Death in adolescence.

+7. Neurotransmitter Disorder - Dystonia: This is a neurotransmitter disorder characterized by involuntary muscle contractions leading to repetitive movements or abnormal postures. Patients present with Athetosis. They do not have Microcephaly, Cerebral cortical atrophy, Neonatal death, Decreased plasma free carnitine, or Death in adolescence.

+8. Neurological"
['Propionic acidemia']," +1. Urea Cycle Disorders (Northern Hemiplegia, Seizures, Vomiting, Hyperammonemia, Hyperornithine, Hyperalaninemia): The patient presents with symptoms of hyperammonemia and hyperalaninemia, which are common features of urea cycle disorders. However, the absence of other typical symptoms such as lethargy, irritability, and developmental delay makes the diagnosis less certain.

+2. Maple Syrup Urine Disease (MSUD) (Hyperammonemia, Hyperglycinuria, Vomiting, Abnormal circulating carnitine concentration): The patient exhibits symptoms of hyperammonemia, hyperglycinuria, and abnormal circulating carnitine concentration, which are common in maple syrup urine disease. However, the absence of other symptoms such as ketoacidosis, lethargy, and muscle weakness makes the diagnosis less definitive.

+3. Organic Acidemias (Vomiting, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid): The patient presents with symptoms of vomiting, abnormal circulating carnitine concentration, and elevated urinary carboxylic acid, which are common features of organic acidemias. However, the absence of other symptoms such as lethargy, developmental delay, and metabolic acidosis makes the diagnosis less certain.

+4. Carnitine Deficiency (Vomiting, Abnormal circulating carnitine concentration): The patient exhibits symptoms of vomiting and abnormal circulating carnitine concentration, which are common in carnitine deficiency. However, the absence of other symptoms such as muscle weakness, myoglobinuria, and cardiac involvement makes the diagnosis less definitive.

+5. Reye Syndrome (Vomiting, Hyperammonemia, Death in childhood): The patient presents with symptoms of vomiting, hyperammonemia, and death in childhood, which are common features of Reye syndrome. However, the absence of other symptoms such as lethargy, irritability, and hepatic encephalopathy makes the diagnosis less definitive.

+6. Ichthyosis (Skin rash, Ichthyosis): The patient exhibits a skin rash and ichthyosis, which are characteristic features of ichthyosis. However, the absence of other symptoms such as hyperkeratosis, scaling, and dryness makes the diagnosis less definitive.

+7. Galactosemia (Death in infancy, Vomiting, Lactose intolerance): The patient presents with symptoms of death in infancy, vomiting, and lactose intolerance, which are common features of galactosemia. However, the absence of other symptoms such as jaundice, cataracts, and hepatomegaly makes the diagnosis less definitive.

+8. Glutaric Acidemia Type I (Vomiting, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid): The patient exhibits symptoms of vomiting, abnormal circulating carnitine concentration, and elevated urinary carboxylic acid, which are common features of glutaric acidemia type I. However, the absence of other symptoms such as lethargy, developmental delay, and myoglobinuria makes the diagnosis less definitive.

+9. Glucose-Galactose Malabsorption (Vomiting, Lactose intoler"
['Succinic semialdehyde dehydrogenase deficiency']," +1. Mucopolysaccharidosis Type I: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood (some subtypes), Abnormal circulating monosaccharides and mucopolysaccharides, Elevated urinary glycosaminoglycans.
+2. Craniometaphyseal Dysplasia: Intellectual disability (rare), Motor delay, Abnormal facial shape, Abnormal calvaria morphology, No known association with monocarboxylic acid or carboxylic acid abnormalities.
+3. Propionic Acidemia: Intellectual disability, Motor delay, No known association with abnormal facial shape or calvaria morphology, Abnormal circulating propionic acid, Elevated urinary propionic acid.
+4. Zellweger Spectrum Disorders: Intellectual disability, Motor delay, Abnormal facial shape, No known association with calvaria morphology, No known association with monocarboxylic acid or carboxylic acid abnormalities.
+5. Cornelia de Lange Syndrome: Intellectual disability, Motor delay, Abnormal facial shape, No known association with calvaria morphology, No known association with monocarboxylic acid or carboxylic acid abnormalities.
+6. Krebsplus or Glutaric Acidemia Type I: Intellectic disability, Motor delay, No known association with abnormal facial shape or calvaria morphology, Abnormal circulating 3-hydroxyglutaric acid, Elevated urinary 3-hydroxyglutaric acid.
+7. Isovaleric Acidemia: Intellectual disability, Motor delay, No known association with abnormal facial shape or calvaria morphology, Abnormal circulating isovaleric acid, Elevated urinary isovaleric acid.
+8. Maple Syrup Urine Disease: Intellectual disability, Motor delay, No known association with abnormal facial shape or calvaria morphology, Abnormal circulating branched-chain amino acids, Elevated urinary branched-chain amino acids.
+9. Menkes Disease: Intellectual disability, Motor delay, Abnormal facial shape (premature aging, kinky hair), Abnormal copper metabolism, No known association with calvaria morphology, No known association with monocarboxylic acid or carboxylic acid abnormalities.
+10. Usher Syndrome: Intellectual disability (rare), Motor delay, Abnormal facial shape (progressive hearing loss, retinitis pigmentosa), No known association with calvaria morphology, No known association with monocarboxylic acid or carboxylic acid abnormalities."
['Classic galactosemia']," +1. Down syndrome: Delayed speech and language development, Intellectual disability, Motor delay (+)
+2. Fetal Alcohol Spectrum Disorders: Intellectual disability, Developmental delays, Growth deficities, Facial abnormalities (No Diarrhea, No Hepatic failure, No Abnormality of galactoside metabolism)
+3. Cerebral Palsy: Motor delay, Developmental delay (No Hepatic failure, No Intellectual disability, No Diarrhea)
+4. Metabolic Disorders (e.g., Pompe disease, Hurler syndrome): Delayed speech and language development, Intellectual disability, Motor delay, Abnormal circulating metabolic concentrations (Varying presence of Hepatic failure, Diarrhea, Neonatal death, Death in childhood)
+5. Hepatic encephalopathy: Hepatic failure, Intellectual disability, Delayed speech and language development, Motor delay (No Diarrhea, No Premature birth)
+6. Sickle Cell Anemia: Intellectual disability (Mild), Delayed speech and language development (Mild), Motor delay (Mild), Neonatal death (Rare), Death in childhood (Rare) (No Diarrhea, No Hepatic failure, No Abnormality of galactoside metabolism)
+7. Galactosemia: Delayed speech and language development, Intellectual disability, Motor delay, Abnormality of galactoside metabolism (No Diarrhea, No Hepatic failure, No Premature birth)
+8. Hemolytic Disease of the Newborn: Neonatal death, Death in childhood (No Delayed speech and language development, No Intellectual disability, No Motor delay, No Diarrhea, No Hepatic failure)
+9. Inborn Errors of Metabolism: Delayed speech and language development, Intellectual disability, Motor delay, Abnormal circulating metabolic concentrations (Varying presence of Hepatic failure, Diarrhea, Neonatal death, Death in childhood)
+10. Wilson's Disease: Intellectual disability, Motor delay, Abnormal circulating copper metabolism (No Diarrhea, No Hepatic failure, No Premature birth)
+11. Mitochondrial Disorders: Delayed speech and language development, Intellective disability, Motor delay, Neonatal death, Death in childhood (No Diarrhea, No Hepatic failure, No Abnormality of galactoside metabolism)
+12. Rare Inherited Metabolic Disorders: Delayed speech and language development, Intellectual disability, Motor delay, Abnormal circulating metabolic concentrations (Varying presence of Hepatic failure, Diarrhea, Neonatal death, Death in childhood)
+13. Neurological Disorders: Delayed speech and language development, Intellectual disability, Motor delay (No Hepatic failure, No Diarrhea, No Premature birth)
+14. Congenital Disorders of Glycosylation: Delayed speech and language development, Intellectual disability, Motor delay, Abnormality of glycosylation (No Diarrhea, No Hepatic failure, No Premature birth)
+15. Lysosomal Storage Disorders: Delayed speech and language development, Intellectual disability, Motor delay, Ab"
['Neonatal intrahepatic cholestasis due to citrin deficiency']," +1. Urea Cycle Disorders: Abnormality of prenatal development or birth, Hyperammonemia, Aminoaciduria, Elevated plasma citrulline. The patient does not have symptoms of Neonatal death and Death in childhood.

+2. Maple Syrup Urine Disease: Abnormality of prenatal development or birth, Aminoaciduria, Elevated plasma citrulline. The patient does not have symptoms of Death in infancy, Neonatal death, and Death in childhood.

+3. Phenylketonuria (PKU): Abnormality of prenatal development or birth, Aminoaciduria. The patient does not have symptoms of Hyperammonemia, Neonatal death, and Death in childhood.

+4. Organic Acidemias: Abnormality of prenatal development or birth, Aminoaciduria, Elevated plasma citrulline. The patient does not have symptoms of Hyperammonemia, Neonatal death, and Death in childhood.

+5. Homocystinuria: Abnormality of prenatal development or birth, Elevated plasma citrulline. The patient does not have symptoms of Hyperammonemia, Aminoaciduria, Neonatal death, and Death in childhood.

+6. Propionic Acidemia: Abnormality of prenatal development or birth, Aminoaciduria, Elevated plasma citrulline. The patient does not have symptoms of Hyperammonemia, Neonatal death, and Death in childhood.

+7. Citrullinemia: Abnormality of prenatal development or birth, Elevated plasma citrulline. The patient does not have symptoms of Hyperammonemia, Aminoaciduria, Neonatal death, and Death in childhood.

+8. Tyrosinemia: Not indicated by the given symptoms.

+9. Galactosemia: Not indicated by the given symptoms.

+10. Cystic Fibrosis: Not indicated by the given symptoms.

+11. Sickle Cell Disease: Not indicated by the given symptoms.

+12. Thalassemia: Not indicated by the given symptoms.

+13. Down Syndrome: Abnormality of prenatal development or birth. The patient does not have symptoms of Hyperammonemia, Aminoaciduria, Neonatal death, and Death in childhood.

+14. Fanconi Syndrome: Aminoaciduria. The patient does not have symptoms of Abnormality of prenatal development or birth, Hyperammonemia, Neonatal death, and Death in childhood.

+15. Tuberous Sclerosis Complex: Not indicated by the given symptoms.

+16. Cystinosis: Not indicated by the given symptoms.

+17. Gaucher Disease: Not indicated by the given symptoms.

+18. Krabbe Disease: Not indicated by the given symptoms.

+19. Pompe Disease: Not indicated by the given symptoms.

+20. Mucopolysaccharidoses: Not indicated by the given symptoms.

+21. Lysosomal Storage Diseases: Not indicated by the given symptoms.

+22. Neuromuscular Disorders"
['Phenylketonuria']," +1. Sepsis: Fever, Recurrent viral infections, Death in infancy, Death in childhood, Death in adolescence. This condition is characterized by a severe response to an infection, leading to organ failure and potentially death. It does not involve Hypertyrosinemia, Hyperphenylalaninemia, Abnormal circulating porphyrin concentration, or Elevated urinary carboxylic acid.

+2. Hemochromatosis: Decreased circulating ferritin concentration, Death in adolescence. This is a condition where the body absorbs too much iron from the diet, leading to iron overload and potential organ damage. It does not involve Hypertyrosinemia, Hyperphenylalaninemia, Abnormal circulating porphyrin concentration, Fever, Death in infancy, Death in childhood, or Elevated urinary carboxylic acid.

+3. Phenylketonuria (PKU): Hyperphenylalaninemia, Elevated urinary carboxylic acid. This is a genetic disorder where the body cannot break down the amino acid phenylalanine, leading to its accumulation in the blood and urine. It does not involve Hypertyrosinemia, Abnormal circulating porphyrin concentration, Fever, Death in infancy, Death in childhood, or Death in adolescence.

+4. Tyrosinemia: Hypertyrosinemia, Fever, Death in infancy, Death in childhood. This is a metabolic disorder where the body cannot break down the amino acid tyrosine, leading to its accumulation in the body and potential toxicity. It does not involve Hyperphenylalaninemia, Abnormal circulating porphyrin concentration, Death in adolescence, or Elevated urinary carboxylic acid.

+5. Porphyria: Abnormal circulating porphyrin concentration, Elevated urinary carboxylic acid. This is a group of disorders where the body cannot produce enough of certain enzymes needed to make heme, leading to the accumulation of porphyrins and their precursors. It does not involve Hypertyrosinemia, Hyperphenylalaninemia, Fever, Death in infancy, Death in childhood, or Death in adolescence.

+6. Maple Syrup Urine Disease: Hyperphenylalaninemia, Elevated urinary carboxylic acid. This is a metabolic disorder where the body cannot break down the amino acids leucine, isoleucine, and valine, leading to their accumulation in the blood and urine. It does not involve Hypertyrosinemia, Abnormal circulating porphyrin concentration, Fever, Death in infancy, Death in childhood, or Death in adolescence.

+7. Menkes Disease: Decreased circulating ferritin concentration, Death in infancy. This is a genetic disorder where the body cannot absorb and utilize copper properly, leading to neurological and developmental problems and potentially death in infancy. It does not involve Hypertyrosinemia, Hyperphenylalaninemia, Abnormal circulating porphyrin concentration, Fever, Death in childhood, or Death in adolescence."
['Maple syrup urine disease']," +1. Metabolic Disorder (Maple Syrup Urine Disease): Lethargy, Generalized hypotonia, Tremor, Elevated urinary carboxylic acid, Abnormal circulating leucine concentration, Neonatal death.
+2. Neurological Disorder (Cerebral Palsy): Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality.
+3. Mitochondrial Disorder: Lethargy, Generalized hypotonia, Tremor, Drowsiness, Sleep abnormality.
+4. Inherited Metabolic Disorder (Phenylketonuria): Lethargy, Generalized hypotonia, Tremor, Elevated urinary carboxylic acid, Abnormal circulating amino acid concentration, Body odor.
+5. Neurological Disorder (Infantile Spasms): Lethargy, Generalized hypotonia, Opisthotonus, Tremor, Sleep abnormality.
+6. Inherited Metabolic Disorder (Organic Acidemia): Lethargy, Generalized hypotonia, Tremor, Elevated urinary carboxylic acid, Abnormal circulating organic acid concentration.
+7. Neurological Disorder (Menkes Disease): Lethargy, Generalized hypotonia, Tremor, Drowsiness, Body odor.
+8. Inherited Metabolic Disorder (Maple Syrup Urine Disease Type 2): Lethargy, Generalized hypotonia, Tremor, Elevated urinary carboxylic acid, Abnormal circulating leucine concentration.
+9. Neurological Disorder (Rett Syndrome): Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Neonatal death.
+10. Inherited Metabolic Disorder (Propionic Acidemia): Lethargy, Generalized hypotonia, Tremor, Elevated urinary carboxylic acid, Abnormal circulating organic acid concentration.

Note: This list is not exhaustive and further diagnostic tests are required to confirm a definitive diagnosis."
['Phenylketonuria']," +1. Down syndrome: Generalized hypotonia, may have premature birth, but does not typically cause anemia, Hypertyrosinemia, Neonatal or childhood death, Hyperphenylalaninemia, or decreased circulating ferritin concentration.

+2. Sickle cell anemia: Anemia, may have decreased circulating ferritin concentration, but does not typically cause generalized hypotonia, premature birth, Neonatal or childhood death, Hypertyrosinemia, or Hyperphenylalaninemia.

+3. Phenylketonuria (PKU): Hyperphenylalaninemia, but does not typically cause generalized hypotonia, premature birth, Anemia, Neonatal or childhood death, Hypertyrosinemia, or decreased circulating ferritin concentration.

+4. Vitamin D deficiency: Abnormality of vitamin D metabolism, but does not typically cause generalized hypotonia, premature birth, Anemia, Neonatal or childhood death, Hypertyrosinemia, or Hyperphenylalaninemia.

+5. Congenital hypothyroidism: Not directly related to the given symptoms, but it can cause generalized hypotonia, developmental delay, and may be associated with decreased circulating ferritin concentration. It does not typically cause premature birth, anemia, Neonatal or childhood death, Hypertyrosinemia, or Hyperphenylalaninemia.

+6. Cystic fibrosis: Not directly related to the given symptoms, but it can cause chronic lung infections, pancreatic insufficiency, and may be associated with decreased circulating ferritin concentration. It does not typically cause generalized hypotonia, premature birth, anemia, Neonatal or childhood death, Hypertyrosinemia, or Hyperphenylalaninemia.

+7. Inborn errors of metabolism: A group of genetic disorders that can cause various symptoms, including anemia, developmental delay, and metabolic abnormalities. Some inborn errors of metabolism can cause generalized hypotonia, premature birth, Neonatal or childhood death, Hypertyrosinemia, or Hyperphenylalaninemia. However, the specific diagnosis would depend on the identification of the underlying metabolic disorder."
['Smith-Lemli-Opitz syndrome']," +1. Down syndrome: Hypertelorism, Anteverted nares, Intellectual disability, Delayed speech and language development, Motor delay, Syndactyly + Some people with Down syndrome may have Self-mutilation and Seizure, but not all. They do not have Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, or Death in childhood.

+2. Smith-Lemli-Opitz syndrome: Hypertelorism, Intellectual disability, Delayed speech and language development, Motor delay, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration + This condition is characterized by Hypertelorism, Intellectual disability, Delayed speech and language development, Motor delay, and Syndactyly. Some people with Smith-Lemli-Opitz syndrome may have Self-mutilation and Seizure, but not all. They do not have Anteverted nares, Abnormal foot morphology, Severe hearing impairment, Neonatal death, or Death in childhood.

+3. Fetal Alcohol Spectrum Disorders: Intellectual disability, Delayed speech and language development, Motor delay, Self-mutilation + Fetal Alcohol Spectrum Disorders can present with Intellectual disability, Delayed speech and language development, and Motor delay. Some individuals may also exhibit Self-mutilation. They do not have Hypertelorism, Anteverted nares, Syndactyly, Seizure, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, or Death in childhood.

+4. Prader-Willi syndrome: Intellectual disability, Delayed speech and language development, Hypotonia, Hyperphagia + Prader-Willi syndrome is characterized by Intellectual disability, Delayed speech and language development, and Hypotonia (low muscle tone). Some individuals may also have Hyperphagia (excessive hunger). They do not have Hypertelorism, Anteverted nares, Self-mutilation, Syndactyly, Seizure, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, or Death in childhood.

+5. Cri-du-chat syndrome: Intellectual disability, Delayed speech and language development, High-pitched cry + Cri-du-cat syndrome is characterized by Intellectual disability, Delayed speech and language development, and a high-pitched cry. They do not have Hypertelorism, Anteverted nares, Self-mutilation, Syndactyly, Seizure, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, or Death in childhood.

+6. Marfan syndrome: Hypertelorism, Long limbs, Chest deformity, Dislocated lenses, Flexible joints + Marfan syndrome is characterized by Hypertelorism, Long limbs, Chest deformity, Dislocated lenses, and Flexible joints. They do not have Intellectual disability, Delayed speech and language development, Self-mutil"
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic Acidemia: This is a metabolic disorder caused by a deficiency of methylmalonic acid mutase. The patient presents with symptoms such as delayed speech and language development, intellectual disability, metabolic acidosis, hypoglycemia, hyperammonemia, and methylmalonic aciduria. They do not have microcephaly, anemia, acute kidney injury, or splenomegaly.

+2. Methylmalonic Aciduria: This is a metabolic disorder caused by a deficiency of methylmalonic acid mutase or a deficiency of the cofactor adenosine triphosphate (ATP) for the enzyme. The patient presents with symptoms such as delayed speech and language development, intellectual disability, metabolic acidosis, hypoglycemia, hyperammonemia, and methylmalonic aciduria. They do not have microcephaly, anemia, acute kidney injury, or splenomegaly.

+3. Inborn Errors of Metabolism: This is a group of genetic disorders that affect the body's ability to process certain nutrients. The patient presents with symptoms such as intellectual disability, developmental delay, and metabolic acidosis. They may also have symptoms such as hypoglycemia, hyperammonemia, and hyperuricemia. They do not have microcephaly, anemia, or splenomegaly.

+4. Congenital Disorders of Glycosylation: This is a group of disorders caused by the deficiency or absence of specific enzymes involved in the synthesis or degradation of glycoproteins and glycolipids. The patient presents with symptoms such as intellectual disability, developmental delay, and hypotonia. They may also have symptoms such as hepatomegaly, splenomegaly, and decreased plasma free carnitine. They do not have microcephaly, anemia, or acute kidney injury.

+5. Lysosomal Storage Disorders: This is a group of disorders caused by the deficiency of specific enzymes involved in the breakdown of complex molecules within lysosomes. The patient presents with symptoms such as intellectual disability, developmental delay, and hypotonia. They may also have symptoms such as hepatomegaly, splenomegaly, and gastrointestinal inflammation. They do not have microcephaly, anemia, or acute kidney injury.

+6. Organic Acidemias: This is a group of metabolic disorders caused by a deficiency of enzymes involved in the metabolism of organic acids. The patient presents with symptoms such as intellectual disability, developmental delay, and metabolic acidosis. They may also have symptoms such as hypoglycemia, hyperammonemia, and hyperuricemia. They do not have microcephaly, anemia, or splenomegaly.

+7. Neurodegenerative Disorders: This is a group of disorders that affect the nervous system and result in progressive degeneration of nerve cells. The patient presents with symptoms such as intellectual disability, developmental delay, and motor delay. They may also have symptoms such as seizures, feeding difficulties, and decreased methylmalonyl-CoA mutase activity. They do not have microcephaly, anemia, or acute kidney injury.

+8. Mitochondrial Disorders:"
[]," +1. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids. Common symptoms include ataxia, lethargy, hypotonia, and developmental delay. Urinary abnormalities, such as uraciluria, are also common in this condition. However, death in infancy is a more severe symptom typically associated with the classic form of MSUD, which may not be present in all cases.

+2. Menkes Disease: This is a rare X-linked recessive disorder caused by mutations in the ATP7A gene. Symptoms include ataxia, hypotonia, and developmental delay. Lethargy and drowsiness are also common. However, Menkes disease is not typically associated with abnormal circulating pyrimidine concentrations or sleep abnormalities.

+3. Krabbe Disease: This is a degenerative disorder of the central nervous system caused by a deficiency of the enzyme galactocerebrosidase. Symptoms include ataxia, hypotonia, and developmental delay. Lethargy, drowsiness, and sleep abnormalities are also common. Urinary abnormalities, such as uraciluria, are not typically associated with Krabbe disease.

+4. Smith-Lemli-Opitz Syndrome (SLOS): This is a genetic disorder caused by a deficiency of the enzyme 7-dehydrocholesterol reductase. Symptoms include ataxia, hypotonia, and developmental delay. Lethargy, drowsiness, and sleep abnormalities are also common. Abnormal circulating pyrimidine concentrations are not typically associated with SLOS, but uraciluria may be present in some cases.

+5. Urea Cycle Disorders: This group of disorders includes conditions such as Ornithine Transcarbamylase Deficiency and Argininosuccinic Acidemia. Symptoms include ataxia, hypotonia, and developmental delay. Lethargy, drowsiness, and sleep abnormalities are also common. Abnormal circulating pyrimidine concentrations are not typically associated with urea cycle disorders, but uraciluria may be present in some cases. Symptoms of death in infancy are more common in severe cases of these disorders."
['Isovaleric acidemia']," +1. Urea Cycle Disorders: Abnormality of prenatal development or birth, Neonatal death, Hyperammonemia, Abnormal circulating glycine concentration.
+2. Organic Acidemias: Abnormality of prenatal development or birth, Neonatal death, Hyperammonemia, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration.
+3. Maple Syrup Urine Disease: Abnormality of prenatal development or birth, Neonatal death, Hyperammonemia, Abnormal circulating glycine concentration.
+4. Propionic Acidemia: Abnormality of prenatal development or birth, Neonatal death, Hyperammonemia, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration.
+5. Mitochondrial Disorders: Abnormality of prenatal development or birth, Neonatal death, Death in infancy, Death in childhood.
+6. Lysosomal Storage Disorders: Abnormality of prenatal development or birth, Neonatal death, Death in infancy, Death in childhood (some types).
+7. Inborn Errors of Metabolism: Abnormality of prenatal development or birth, Neonatal death, Death in infancy, Death in childhood, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration.
+8. Congenital Disorders of Glycosylation: Abnormality of prenatal development or birth, Neonatal death (rare), Death in infancy, Death in childhood (rare).

Please note that the above list is not exhaustive and a definitive diagnosis should be made by a healthcare professional based on clinical evaluation, laboratory tests, and genetic analysis."
['Biotinidase deficiency']," +1. Metabolic Disorder (Organic Acidemia): Seizures, Generalized hypotonia, and Elevated urinary carboxylic acid are common symptoms. Death in infancy is also a possible symptom in some types of organic acidemia.
+2. Mitochondrial Disorder: Seizures and Generalized hypotonia are common symptoms. Elevated urinary carboxylic acid is not typically associated with mitochondrial disorders.
+3. Epilepsy: Seizures are the primary symptom. Generalized hypotonia and Elevated urinary carboxylic acid are not common symptoms of epilepsy.
+4. Muscular Dystrophy: Generalized hypotonia is a common symptom. Seizures and Elevated urinary carboxylic acid are not typically associated with muscular dystrophies.
+5. Inborn Error of Metabolism: Seizures, Generalized hypotonia, and Elevated urinary carboxylic acid are common symptoms. Death in infancy is also a possible symptom in some types of inborn errors of metabolism.
+6. Neurodegenerative Disorder: Seizures and Generalized hypotonia are possible symptoms. Elevated urinary carboxylic acid is not typically associated with neurodegenerative disorders.
+7. Renal Disorder: Elevated urinary carboxylic acid is a common symptom. Seizures and Generalized hypotonia are not typically associated with renal disorders.
+8. Liver Disorder: Elevated urinary carboxylic acid is a possible symptom. Seizures and Generalized hypotonia are not typically associated with liver disorders.
+9. Genetic Disorder: Seizures, Generalized hypotonia, and Elevated urinary carboxylic acid are possible symptoms. Death in infancy is also a possible symptom in some types of genetic disorders.
+10. Toxic Substance Exposure: Seizures and Elevated urinary carboxylic acid are possible symptoms. Generalized hypotonia is not typically associated with toxic substance exposure."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorder - Pompe Disease: Delayed speech and language development, Abnormality of prenatal development or birth, Decreased 3-hydroxyacyl-CoA dehydrogenase level.
+2. Metabolic Disorder - Carnitine Uptake Deficiency: Decreased plasma free carnitine.
+3. Metabolic Disorder - Organic Acidemia: Delayed speech and language development, Decreased 3-hydroxyacyl-CoA dehydrogenase level.
+4. Metabolic Disorder - Maple Syrup Urine Disease: Decreased 3-hydroxyacyl-CoA dehydrogenase level.
+5. Neurological Disorder - Cerebral Palsy: Delayed speech and language development.
+6. Genetic Disorder - Down Syndrome: Delayed speech and language development, Abnormality of prenatal development or birth.
+7. Metabolic Disorder - Zellweger Syndrome: Abnormality of prenatal development or birth, Neonatal death.
+8. Metabolic Disorder - Mitochondrial Disorder: Delayed speech and language development, Decreased 3-hydroxyacyl-CoA dehydrogenase level.
+9. Metabolic Disorder - Propionic Acidemia: Decreased 3-hydroxyacyl-CoA dehydrogenase level, Death in infancy.
+10. Metabolic Disorder - Glutaric Acidemia Type I: Decreased 3-hydroxyacyl-CoA dehydrogenase level, Death in infancy.
+11. Metabolic Disorder - Krabbe Disease: Abnormality of prenatal development or birth, Death in infancy or childhood.
+12. Metabolic Disorder - Tay-Sachs Disease: Delayed speech and language development, Death in childhood.
+13. Metabolic Disorder - Canavan Disease: Delayed speech and language development, Death in infancy or childhood.
+14. Metabolic Disorder - Hurler Syndrome: Abnormality of prenatal development or birth, Decreased 3-hydroxyacyl-CoA dehydrogenase level.
+15. Metabolic Disorder - Usher Syndrome: Delayed speech and language development, but no Decreased 3-hydroxyacyl-CoA dehydrogenase level."
['Maple syrup urine disease']," +1. Metabolic Disorders (e.g., Maple Syrup Urine Disease, MSUD): Seizures, Metabolic acidosis, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties, Body odor.
+2. Spinal Muscular Atrophy (SMA): Motor delay, Spastic diplegia, Generalized hypotonia, Opisthotonus, Spastic tetraplegia (in severe cases), Neonatal death (in severe cases).
+3. Mitochondrial Disorders: Seizures, Motor delay, Generalized hypotonia, Metabolic acidosis, Dyspnea, Apnea.
+4. Leigh Syndrome: Seizures, Motor delay, Generalized hypotonia, Metabolic acidosis, Dyspnea, Apnea.
+5. Krabbe Disease: Seizures, Spastic diplegia, Motor delay, Generalized hypotonia, Opisthotonus, Feeding difficulties.
+6. Pompe Disease: Motor delay, Generalized hypotonia, Feeding difficulties.
+7. Menkes Disease: Motor delay, Spastic diplegia, Generalized hypotonia, Body odor.
+8. Citrullinemia: Seizures, Metabolic acidosis, Hyperammonemia (instead of metabolic acidosis caused by organic acids).

Please note that this list is not exhaustive, and further diagnostic tests are required to confirm a definitive diagnosis. The symptoms mentioned by the patient should be evaluated in the context of their medical history, family history, and other clinical findings."
['Propionic acidemia']," +1. Intellectual disability: The patient presents with this symptom, which is characterized by below-average intelligence or mental ability. They may have difficulty learning and performing tasks that are normally easy for others. They do not have psychosis, osteoporosis, anemia, hyperammonemia, cerebral atrophy, hyperglycinemia, kyphoscoliosis, increased blood urea nitrogen, elevated circulating creatinine concentration, hyperalaninemia, abnormal circulating porphyrin concentration, abnormal circulating carnitine concentration, death in adolescence, severe hearing impairment, death in early adulthood, or body odor.

+2. Anemia: The patient does not have psychosis, osteoporosis, intellectual disability, hyperammonemia, cerebral atrophy, hyperglycinemia, kyphoscoliosis, increased blood urea nitrogen, elevated circulating creatinine concentration, hyperalaninemia, severe short stature, abnormal circulating porphyrin concentration, abnormal circulating carnitine concentration, death in adolescence, severe hearing impairment, death in early adulthood, or body odor, but they do have anemia, which is a condition characterized by a decrease in the number of red blood cells or the amount of hemoglobin in the blood.

+3. Hyperammonemia: The patient does not have psychosis, osteoporosis, intellectual disability, anemia, cerebral atrophy, hyperglycinemia, kyphoscoliosis, increased blood urea nitrogen, elevated circulating creatinine concentration, hyperalaninemia, severe short stature, abnormal circulating porphyrin concentration, abnormal circulating carnitine concentration, death in adolescence, severe hearing impairment, or body odor, but they do have hyperammonemia, which is a condition characterized by an excessive amount of ammonia in the blood. This can lead to neurological symptoms such as confusion, lethargy, and seizures.

+4. Cerebral atrophy: The patient does not have psychosis, osteoporosis, intellectual disability, anemia, hyperammonemia, hyperglycinemia, kyphoscoliosis, increased blood urea nitrogen, elevated circulating creatinine concentration, hyperalaninemia, severe short stature, abnormal circulating porphyrin concentration, abnormal circulating carnitine concentration, death in adolescence, severe hearing impairment, or body odor, but they do have cerebral atrophy, which is a condition characterized by the shrinkage of the brain tissue. This can lead to symptoms such as memory loss, difficulty with thinking and reasoning, and problems with coordination and balance.

+5. Hyperglycinemia: The patient does not have psychosis, osteoporosis, intellectual disability, anemia, cerebral atrophy, hyperammonemia, kyphoscoliosis, increased blood urea nitrogen, elevated circulating creatinine concentration, hyperalaninemia, severe short stature, abnormal circulating porphyrin concentration, abnormal circulating carnitine concentration, death in adolescence, severe hearing impairment, or body odor, but they do have hyperglycinemia, which is a condition characterized by an excessive amount of glycine in the blood. This can lead to"
['L-2-hydroxyglutaric aciduria']," +1. Epilepsy: Seizure is a common symptom. Intellectual disability, Ataxia, Tremor, and Death in childhood are not necessarily associated with Epilepsy.
+2. Ataxia-Telangiectasia: Ataxia and Telangiectasias (not mentioned in the symptoms) are characteristic features. Intellectual disability, Seizure, and Tremor can occur but are not essential.
+3. Huntington's Disease: Intellectual disability and Chorea (a type of involuntary movement, similar to Tremor) are common symptoms. Seizure and Ataxia are not typical for Huntington's Disease.
+4. Metachromatic Leukodystrophy: Intellective disability, Ataxia, and Seizure are common symptoms. Tremor is not a typical symptom for Metachromatic Leukodystrophy.
+5. L-2-hydroxyglutaric aciduria: Intellectual disability, Seizure, and L-2-hydroxyglutaric aciduria are present in this condition. Ataxia and Tremor are not necessarily associated with L-2-hydroxyglutaric aciduria.
+6. Rett Syndrome: Intellectual disability, Ataxia, and Seizure are common symptoms. Tremor is not a typical symptom for Rett Syndrome.
+7. Krabbe Disease: Intellectual disability, Ataxia, and Seizure are common symptoms. Tremor is not a typical symptom for Krabbe Disease.
+8. Canavan Disease: Intellectual disability, Ataxia, and Seizure are common symptoms. Tremor is not a typical symptom for Canavan Disease.
+9. Pompe Disease: Intellectual disability, Ataxia, and Seizure are not typical symptoms for Pompe Disease. However, Pompe Disease can present with Tremor and L-2-hydroxyglutaric aciduria is a metabolic finding in Pompe Disease.

It is important to note that this list is not exhaustive, and a proper diagnosis should be made by a qualified medical professional based on a thorough clinical evaluation, laboratory tests, and imaging studies."
['Canavan disease']," +1. Metabolic Disorder - Maple Syrup Urine Disease: Motor delay, Abnormal circulating aspartate family amino acid concentration (Leucine, Isoleucine, and Valine). This condition is characterized by an inability to metabolize certain amino acids, leading to their accumulation in the body and causing neurological symptoms. The patient does not present with Death in infancy, which is a common symptom in severe cases.

+2. Neurological Disorder - Spinal Muscular Atrophy: Motor delay, no Death in infancy. This condition is characterized by the progressive degeneration and loss of motor neurons, leading to muscle weakness and atrophy. Abnormal circulating aspartate family amino acid concentration is not a common symptom.

+3. Metabolic Disorder - Phenylketonuria: Motor delay, Abnormal circulating aspartate family amino acid concentration (Phenylalanine). This condition is characterized by an inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body and causing neurological symptoms. The patient does not present with Death in infancy, which is a common symptom in severe cases.

+4. Genetic Disorder - Down Syndrome: Motor delay, no Abnormal circulating aspartate family amino acid concentration. This condition is characterized by the presence of an extra chromosome 21, leading to developmental delays, intellectual disability, and characteristic physical features. Abnormal circulating aspartate family amino acid concentration is not a common symptom.

+5. Metabolic Disorder - Organic Acidemia: Motor delay, Abnormal circulating aspartate family amino acid concentration (Various organic acids). This condition is characterized by an inability to metabolize certain organic acids, leading to their accumulation in the body and causing neurological symptoms. The patient does not present with Death in infancy, which is a common symptom in severe cases.

+6. Neurological Disorder - Cerebral Palsy: Motor delay, no Abnormal circulating aspartate family amino acid concentration. This condition is characterized by impaired motor function and posture, often caused by damage to the developing brain. Abnormal circulating aspartate family amino acid concentration is not a common symptom.

+7. Metabolic Disorder - Urea Cycle Disorder: Motor delay, Abnormal circulating aspartate family amino acid concentration (Ammonia). This condition is characterized by an inability to metabolize ammonia, leading to its accumulation in the body and causing neurological symptoms. The patient does not present with Death in infancy, which is a common symptom in severe cases.

+8. Genetic Disorder - Fragile X Syndrome: Motor delay, no Abnormal circulating aspartate family amino acid concentration. This condition is caused by a mutation in the FMR1 gene, leading to intellectual disability, developmental delays, and characteristic physical features. Abnormal circulating aspartate family amino acid concentration is not a common symptom."
['Citrullinemia type I']," +1. Urea Cycle Disorders (UCD): This group of metabolic disorders affects the urea cycle, leading to the accumulation of ammonia in the blood. Symptoms include Neonatal death, Hyperammonemia, and Elevated plasma citrulline. +2. Methemoglobinemia: A condition where the oxygen-carrying capacity of blood is reduced due to the presence of methemoglobin. While it does not directly cause Hyperammonemia or Increased total bilirubin, it shares the symptom of Neonatal death. +3. Galactosemia: A metabolic disorder caused by the deficiency of the enzyme galactose-1-phosphate uridyltransferase. It results in the inability to metabolize galactose, leading to symptoms such as Hyperammonemia, Elevated total bilirubin, and Neonatal death. +4. Crigler-Najjar Syndrome: A rare genetic disorder that affects the liver's ability to conjugate bilirubin, leading to a buildup of unconjugated bilirubin in the blood. Symptoms include Increased total bilirubin and Neonatal death. +5. Maple Syrup Urine Disease (MSUD): A metabolic disorder caused by a deficiency of the enzymes that break down certain amino acids, leading to their accumulation in the blood and urine. Symptoms include Hyperammonemia, Elevated plasma citrulline, and Neonatal death. +6. Tyrosinemia: A metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites in the body. Symptoms include Neonatal death, but not Hyperammonemia or Increased total bilirubin."
['3-hydroxy-3-methylglutaric aciduria']," +1. Reye's Syndrome: Lethargy, Vomiting, Hepatomegaly, Drowsiness, Sleep abnormality, Metabolic acidosis, Dicarboxylic aciduria, Elevated urinary carboxylic acid. (Symptoms of Reye's Syndrome include Lethargy, Vomiting, Hepatomegaly, Drowsiness, and Sleep abnormality. This condition is characterized by swelling of the liver and brain damage, often occurring after a viral infection. It can lead to coma and death in infancy or childhood.)

+2. Maple Syrup Urine Disease: Lethargy, Vomiting, Hypoglycemia, Hyperammonemia, Dicarboxylic aciduria, 3-Methylglutaric aciduria, Death in infancy or childhood. (This metabolic disorder is characterized by an inability to break down certain amino acids, leading to the accumulation of toxic substances in the body. Symptoms include Lethargy, Vomiting, Hypoglycemia, Hyperammonemia, and Dicarboxylic aciduria. It can also cause 3-Methylglutaric aciduria and can lead to death in infancy or childhood.)

+3. Galactosemia: Lethargy, Vomiting, Hypoglycemia, Galactose intolerance, Jaundice, Hepatomegaly, Dicarboxylic aciduria. (This metabolic disorder is caused by a deficiency of the enzyme needed to metabolize galactose, a sugar found in milk and milk products. Symptoms include Lethargy, Vomiting, Hypoglycemia, and Galactose intolerance. Galactosemia can also cause Jaundice, Hepatomegaly, and Dicarboxylic aciduria.)

+4. Zellweger Syndrome: Lethargy, Hypotonia, Seizures, Hepatomegaly, Dysmorphic features, Death in infancy. (This genetic disorder affects the development of the peroxisomes, which are organelles involved in the breakdown of certain fats and other substances. Symptoms include Lethargy, Hypotonia, Seizures, Hepatomegaly, and Dysmorphic features. It can lead to death in infancy.)

+5. Tyrosinemia: Lethargy, Vomiting, Hepatomegaly, Hyperammonemia, Dicarboxylic aciduria, Death in infancy or childhood. (This metabolic disorder is caused by a deficiency of the enzyme needed to break down the amino acid tyrosine. Symptoms include Lethargy, Vomiting, Hepatomegaly, Hyperammonemia, and Dicarboxylic aciduria. It can lead to death in infancy or childhood.)

+6. Urea Cycle Disorders: Lethargy, Vomiting, Hypoglycemia, Hyperammonemia, Dicarboxylic aciduria, Death in infancy or childhood. (This group of metabolic disorders affects the body's ability to process ammonia, a waste product of protein metabolism. Symptoms include Lethargy,"
['Cystinuria']," +1. Meningoencephalitis: Inflammation of the brain and meninges, can cause seizures and respiratory insufficiency. Splenomegaly is not a common symptom. Death in infancy is not a typical symptom for this disease.

+2. Sepsis: A life-threatening condition caused by the body's response to infection. Seizures and respiratory insufficiency are common symptoms. Splenomegaly can occur in some cases. Death in infancy is not uncommon in severe cases.

+3. Leukemia: A type of cancer that affects the blood and bone marrow. Seizures and splenomegaly are not common symptoms, but can occur in some cases. Respiratory insufficiency is a possible symptom, especially in advanced stages. Death in infancy is not uncommon in acute leukemia.

+4. Sickle cell disease: A genetic disorder that affects the production of hemoglobin in the red blood cells. Seizures and death in infancy are not typical symptoms, but can occur in some cases. Splenomegaly is a common symptom, as the spleen tries to filter out abnormal red blood cells. Respiratory insufficiency can occur due to complications such as pneumonia or lung damage.

+5. Cystic fibrosis: A genetic disorder that affects the respiratory and digestive systems. Seizures are not a typical symptom, but can occur in some cases due to respiratory infections. Splenomegaly is not a common symptom. Death in infancy is not uncommon, especially in severe cases. Respiratory insufficiency is a hallmark symptom of the disease."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Pompe Disease: Intellectual disability, Motor delay, Generalized hypotonia, Hypertrophic cardiomyopathy (may not have), Death in infancy (may have), Vomiting (may have), Hypoproteinemia (may have), Increased blood urea nitrogen (may have), Hyperammonemia (has), Feeding difficulties (may have)

+2. Maple Syrup Urine Disease: Intellectual disability, Motor delay, Generalized hypotonia (may not have), Death in infancy (may have), Hyperammonemia (has), Vomiting (may have), Hypoproteinemia (may have), Increased blood urea nitrogen (may have), Hyperthreoninemia (has), Neonatal death (may have), Recurrent viral infections (may have), Hypervalinemia (has), Abnormal circulating isoleucine concentration (has), Abnormal circulating leucine concentration (has), Abnormal circulating carnitine concentration (may have)

+3. Urea Cycle Disorders: Intellectual disability, Motor delay, Generalized hypotonia (may have), Death in infancy (may have), Hyperammonemia (has), Vomiting (may have), Hypoproteinemia (may have), Increased blood urea nitrogen (has), Hyperthreoninemia (may have), Neonatal death (may have), Death in childhood (may have), Recurrent viral infections (may have), Hypervalinemia (may have), Abnormal circulating isoleucine concentration (may have), Abnormal circulating carnitine concentration (may have), Feeding difficulties (may have), Decreased serum creatinine (may not have), Methylmalonic aciduria (may not have)

+4. Congenital Hypothyroidism: Intellectual disability (may have), Motor delay (may have), Generalized hypotonia (may not have), Death in infancy (rare), Hyperammonemia (no), Vomiting (may have), Hypoproteinemia (may have), Increased blood urea nitrogen (no), Hyperthreoninemia (no), Neonatal death (rare), Death in childhood (rare), Recurrent viral infections (no), Hypervalinemia (no), Abnormal circulating isoleucine concentration (no), Abnormal circulating carnitine concentration (no), Feeding difficulties (may have), Decreased serum creatinine (no), Methylmalonic aciduria (no)

+5. Muscular Dystrophies: Intellectual disability (rare), Motor delay (yes), Generalized hypotonia (yes), Death in infancy (rare), Hyperammonemia (no), Vomiting (no), Hypoproteinemia (no), Increased blood urea nitrogen (no), Hyperthreoninemia (no), Neonatal death (rare), Death in childhood (rare), Recurrent viral infections (no), Hypervalinemia (no), Abnormal circulating isoleucine concentration (no), Abnormal circulating carnitine concentration (no), Feeding difficulties (no), Decreased serum creatinine (no), Methylmalonic aciduria (no)"
['Phenylketonuria']," +1. Metabolic Disorders (specifically, Inherited Metabolic Disorders): These are a group of disorders caused by genetic factors that affect the body's ability to process certain nutrients. Symptoms include: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia, and Elevated urinary carboxylic acids. Recurrent viral infections are not typically associated with this group of diseases.

+2. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids (leucine, isoleucine, and valine). Symptoms include: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia, and Elevated urinary carboxylic acids. Recurrent viral infections are not typically associated with MSUD.

+3. Tyrosinemia Type 1: This is a metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites in the body. Symptoms include: Death in infancy, Death in childhood, Hypertyrosinemia, and Elevated urinary carboxylic acids. Recurrent viral infections are not typically associated with Tyrosinemia Type 1.

+4. Phenylketonuria (PKU): This is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body. Symptoms include: Death in infancy, Death in childhood, Hyperphenylalaninemia, and Elevated urinary carboxylic acids. Recurrent viral infections are not typically associated with PKU.

+5. Organic Acidemias: This is a group of metabolic disorders caused by a deficiency of enzymes involved in the metabolism of certain organic acids. Symptoms include: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia, and Elevated urinary carboxylic acids. Recurrent viral infections are not typically associated with organic acidemias.

+6. Reye's Syndrome: This is a rare, but serious condition that affects the liver and brain. Symptoms include: Death in infancy or childhood, and Recurrent viral infections (usually preceded by a viral infection). Hypertyrosinemia, Hyperphenylalaninemia, and Elevated urinary carboxylic acids are not typically associated with Reye's Syndrome.

+7. Menkes Disease: This is a rare, X-linked recessive disorder caused by a deficiency of copper transport in the body. Symptoms include: Death in infancy or childhood, and Neurological symptoms such as seizures, developmental delays, and poor muscle coordination. Hypertyrosinemia, Hyperphenylalaninemia, and Elevated urinary carboxylic acids are not typically associated with Menkes Disease.

+8. Maple Syrup Urine Disease with Recurrent Infections: It is possible that the patient has MSUD with an additional predisposition to recurrent infections. Sym"
['Phenylketonuria']," +1. Down Syndrome: Strabismus, Abnormality of prenatal development or birth, Intellectual disability +3.
+2. Cystic Fibrosis: Obesity is not a common symptom, other symptoms include persistent cough, lung infections, and difficulty breathing +4.
+3. Phenylketonuria (PKU): Hyperphenylalaninemia, Neonatal death, Death in infancy +5.
+4. Thalassemia: No symptoms of Strabismus or Death in infancy, anemia, jaundice, and slow growth are common +5.
+5. Sickle Cell Anemia: No symptoms of Strabismus or Intellectual disability, anemia, jaundice, and pain crises are common +6.
+6. Marfan Syndrome: No symptoms of Intellectual disability or Obesity, tall stature, joint flexibility, and vision problems are common +7.
+7. Huntington's Disease: No symptoms of Strabismus, Abnormality of prenatal development or birth, or Obesity, progressive brain degeneration and involuntary movements are common +8.
+8. Hemochromatosis: No symptoms of Strabismus, Intellectual disability, or Hypertyrosinemia, excessive absorption of iron leading to organ damage is common +9.
+9. Diabetes Mellitus: No symptoms of Strabismus, Abnormality of prenatal development or birth, or Neonatal death, high blood sugar levels and increased urination are common."
['Ornithine transcarbamylase deficiency']," +1. Hemorrhagic Disease of the Newborn (Vitamin K Deficiency): Abnormal bleeding, Death in infancy, Oroticaciduria (in some cases), Vomiting (rare) : The patient presents with symptoms of abnormal bleeding and death in infancy, which are common in this condition. However, not all cases of Hemorrhagic Disease of the Newborn present with hyperammonemia or orotic aciduria.

+2. Hemophilia: Abnormal bleeding, Coagulation cascade abnormality : The patient's symptoms of abnormal bleeding and coagulation cascade abnormality are consistent with Hemophilia. However, Hemophilia does not typically present with hyperammonemia or orotic aciduria.

+3. Urea Cycle Disorders: Hyperammonemia, Oroticaciduria : The patient's symptoms of hyperammonemia and orotic aciduria suggest a possible Urea Cycle Disorder. However, not all cases of Urea Cycle Disorders present with abnormal bleeding or vomiting.

+4. Disseminated Intravascular Coagulation (DIC): Abnormal bleeding, Coagulation cascade abnormality : The patient's symptoms of abnormal bleeding and coagulation cascade abnormality are consistent with DIC. However, DIC does not typically present with hyperammonemia or orotic aciduria.

+5. Reye's Syndrome: Vomiting, Hyperammonemia : The patient's symptoms of vomiting and hyperammonemia suggest a possible Reye's Syndrome. However, not all cases of Reye's Syndrome present with abnormal bleeding or orotic aciduria.

+6. Liver Disease: Abnormal bleeding, Hyperammonemia : The patient's symptoms of abnormal bleeding and hyperammonemia suggest a possible Liver Disease. However, not all cases of Liver Disease present with orotic aciduria or vomiting.

+7. Sepsis: Abnormal bleeding, Fever, Vomiting : The patient's symptoms of abnormal bleeding, vomiting, and fever suggest a possible Sepsis. However, Sepsis does not typically present with hyperammonemia or orotic aciduria.

+8. Leukemia: Abnormal bleeding, Anemia, Fatigue : The patient's symptoms of abnormal bleeding and anemia suggest a possible Leukemia. However, Leukemia does not typically present with hyperammonemia or orotic aciduria.

+9. Vitamin C Deficiency: Scurvy, Fatigue, Bleeding gums : The patient's symptoms do not appear to be consistent with any of the above conditions. However, it is important to consider Vitamin C Deficiency as a possibility, as it can present with symptoms such as fatigue, bleeding gums, and joint pain, but not hyperammonemia, orotic aciduria, or vomiting."
['L-2-hydroxyglutaric aciduria']," +1. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-1,4-glucosidase, leading to progressive muscle weakness, hypotonia, and intellectual disability. + Symptoms: Intellectual disability, Generalized hypotonia, Hyperreflexia, +Abnormal myelination.

+2. Krabbe Disease: A metabolic disorder caused by the deficiency of galactocerebrosidase, leading to demyelination, hypotonia, and intellectual disability. + Symptoms: Intellectual disability, Generalized hypotonia, Abnormal cerebral morphology, +Abnormal myelination, +Death in childhood.

+3. Leigh Syndrome: A mitochondrial disorder caused by various mutations, leading to progressive neurological symptoms, including intellectual disability, hypotonia, and hyperreflexia. + Symptoms: Intellectual disability, Generalized hypotonia, Hyperreflexia, +Hyperammonemia.

+4. Maple Syrup Urine Disease: An inherited metabolic disorder caused by a deficiency of the branched-chain ketoacid dehydrogenase complex, leading to intellectual disability, hypotonia, and characteristic urine odor. + Symptoms: Intellectual disability, Generalized hypotonia, +Hyperammonemia, +Abnormal cerebral morphology.

+5. Canavan Disease: A metabolic disorder caused by a deficiency of N-acetylaspartate-acyltransferase, leading to intellectual disability, hypotonia, and progressive neurological symptoms. + Symptoms: Intellectual disability, Generalized hypotonia, +Abnormal cerebral morphology.

+6. Lissencephaly: A congenital brain malformation characterized by the absence or underdevelopment of the cerebellar folia, leading to intellectual disability, hypotonia, and ataxia. + Symptoms: Intellectual disability, Generalized hypotonia, +Abnormal cerebral morphology.

+7. L-2-hydroxyglutaric Aciduria: A metabolic disorder caused by a deficiency of the L-2-hydroxyglutarate dehydrogenase enzyme, leading to intellectual disability, hypotonia, and hyperreflexia. + Symptoms: Intellectual disability, Generalized hypotonia, Hyperreflexia, +L-2-hydroxyglutaric acidemia.

+8. Prader-Willi Syndrome: A genetic disorder caused by the deletion or uniparental disomy of the paternal 15q11-q13 region, leading to intellectual disability, hypotonia, and hyperphagia. + Symptoms: Intellectual disability, Generalized hypotonia, +Hyperphagia, +Death in childhood (if complications arise).

+9. Rett Syndrome: A neurodevelopmental disorder caused by mutations in the MECP2 gene, leading to intellectual disability, hypotonia, and characteristic hand movements. + Symptoms: Intellectual disability, Generalized hypotonia, +Abnormal cerebral morphology, +Stereotypic hand movements.

+10. Usher Syndrome: A genetic disorder characterized by progressive hearing loss, vision loss, and intellectual disability. + Symptoms: Intellectual disability, Generalized hypotonia, +Intel"
['PMM2-CDG']," +1. Friedreich's Ataxia: A genetic disorder characterized by progressive degeneration of the cerebellum and sensory nerves, leading to ataxia, muscle weakness, and cardiac and skeletal abnormalities. : Intellectual disability -, Death in infancy -, Thromboembolism +, Stroke-like episode +, Cerebellar agenesis -, Cerebellar atrophy +
+2. Krabbe Disease: A metabolic disorder caused by the deficiency of galactocerebrosidase, leading to the accumulation of galactosylsphingosine in the central nervous system, causing demyelination and progressive neurological deterioration. : Intellectual disability +, Ataxia +, Cerebellar atrophy +, Death in infancy -, Thromboembolism -, Stroke-like episode -, Cerebellar agenesis -
+3. Canavan Disease: A metabolic disorder caused by the deficiency of N-acetylaspartic acid aminotransferase, leading to the accumulation of N-acetylaspartic acid in the brain, causing progressive neurological deterioration, intellectual disability, and hypotonia. : Intellectual disability +, Ataxia +, Cerebellar atrophy +, Death in infancy -, Thromboembolism -, Stroke-like episode -, Cerebellar agenesis -
+4. Pelizaeus-Merzbacher Disease: A genetic disorder caused by mutations in the proteolipid protein gene, leading to the demyelination of the central nervous system, causing progressive neurological deterioration, ataxia, and intellectual disability. : Intellectual disability +, Ataxia +, Cerebellar atrophy +, Death in infancy -, Thromboembolism -, Stroke-like episode -, Cerebellar agenesis -
+5. Leigh Syndrome: A metabolic disorder caused by mutations in various genes involved in the oxidative metabolism of the brain, leading to the degeneration of the brainstem and basal ganglia, causing progressive neurological deterioration, intellectual disability, and ataxia. : Intellectual disability +, Ataxia +, Cerebellar atrophy +, Death in infancy -, Thromboembolism -, Stroke-like episode -, Cerebellar agenesis -
+6. Rett Syndrome: A genetic disorder caused by mutations in the MECP2 gene, leading to the impairment of brain development and function, causing intellectual disability, ataxia, and breathing abnormalities. : Intellectual disability +, Ataxia +, Cerebellar atrophy +, Death in infancy -, Thromboembolism -, Stroke-like episode -, Cerebellar agenesis -
+7. Marfan Syndrome: A genetic disorder caused by mutations in the FBN1 gene, leading to the impairment of connective tissue, causing intellectual disability, ataxia, and cardiovascular abnormalities. : Intellectual disability +, Ataxia +, Cerebellar atrophy -, Death in infancy -, Thromboembolism +, Stroke-like episode -, Cerebellar agenesis -
+8. Wilson Disease: A metabolic disorder caused by the impaired copper metabolism, leading to the accumulation of copper in the liver and brain, causing intellectual disability"
['Phenylketonuria']," +1. Metabolic Disorders (Gaucher Disease, Krabbe Disease, Pompe Disease): The patient presents with symptoms related to metabolic disorders, including Neonatal death and Metabolic issues (Hypertyrosinemia, Hyperphenylalaninemia).
+2. Inherited Metabolic Disorders (Maple Syrup Urine Disease, Galactosemia): The patient exhibits symptoms of Inherited Metabolic Disorders, such as Neonatal death, Premature birth, and Metabolic issues (Hypertyrosinemia, Hyperphenylalaninemia).
+3. Tyrosinemia: The patient shows symptoms of Tyrosinemia, which includes Neonatal death, Premature birth, and Metabolic issues (Hypertyrosinemia, Hyperphenylalaninemia).
+4. Phenylketonuria (PKU): The patient presents with symptoms of PKU, including Neonatal death, Premature birth, and Metabolic issues (Hyperphenylalaninemia). However, the patient does not have Death in infancy exclusively, unlike PKU.
+5. Tyrosinemia Type 1: The patient exhibits symptoms of Tyrosinemia Type 1, which includes Neonatal death, Premature birth, and Metabolic issues (Hypertyrosinemia). The patient does not have Death in infancy exclusively, unlike Tyrosinemia Type 1.
+6. Neonatal Onset Metabolic Disorders: The patient shows symptoms of various Neonatal Onset Metabolic Disorders, including Neonatal death, Premature birth, and Metabolic issues (Hypertyrosinemia, Hyperphenylalaninemia).
+7. Organic Acidemias: The patient presents with symptoms of Organic Acidemias, which includes Neonatal death, Premature birth, and Metabolic issues (Hypertyrosinemia, Hyperphenylalaninemia).
+8. Urea Cycle Disorders: The patient exhibits symptoms of Urea Cycle Disorders, such as Neonatal death, Premature birth, and Metabolic issues (Hypertyrosinemia). However, the patient does not have Death in infancy exclusively, unlike some Urea Cycle Disorders."
['Propionic acidemia']," +1. Metabolic Disorders (Gaucher Disease, Mucopolysaccharidoses, Pompe Disease, Krabbe Disease, Hurler Syndrome): Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Seizure, Lethargy, Vomiting, Increased circulating lactate concentration, Hyperammonemia, Hyperglycinemia, Hypervalinemia, Abnormal circulating carnitine concentration, Hypoglycinemia.
+2. Inborn Errors of Metabolism (Phenylketonuria, Maple Syrup Urine Disease, Homocystinuria): Delayed speech and language development, Intellectual disability, Hyperammonemia, Vomiting, Seizure, Lethargy, Difficulty walking, Difficulty climbing stairs, Recurrent viral inctions.
+3. Neurological Disorders (Cerebral Palsy, Muscular Dystrophies): Motor delay, Generalized hypotonia, Difficulty walking, Difficulty running.
+4. Epilepsy: Seizure, Lethargy, Difficulty walking.
+5. Gastrointestinal Disorders (Gastroesophageal Reflux Disease, Celiac Disease): Gastroesophageal reflux, Vomiting.
+6. Infections (Meningitis, Encephalitis): Fever, Lethargy, Seizure, Tachypnea.
+7. Respiratory Disorders (Cystic Fibrosis, Bronchopulmonary Dysplasia): Pneumonia, Tachypnea.
+8. Endocrine Disorders (Hypothyroidism, Diabetes Mellitus): Difficulty walking, Difficulty climbing stairs, Drowsiness, Increased blood urea nitrogen.
+9. Cardiac Disorders: Lethargy, Difficulty walking, Difficulty climbing stairs.
+10. Liver Disorders (Biliary Atresia, Galactosemia): Jaundice (not mentioned in symptoms), Vomiting, Increased blood urea nitrogen, Increased circulating lactate concentration.
+11. Renal Disorders: Increased blood urea nitrogen, Difficulty walking, Difficulty climbing stairs.
+12. Genetic Disorders (Down Syndrome, Fragile X Syndrome): Delayed speech and language development, Intellectual disability, Motor delay, Facial features (not mentioned in symptoms).
+13. Toxic Substance Exposure: Vomiting, Lethargy, Tremor, Seizure.
+14. Inherited Metabolic Disorders with Neurologic Manifestations (Leigh Syndrome, Canavan Disease): Delayed speech and language development, Intellectual disability, Seizure, Lethargy, Motor delay, Difficulty walking, Drowsiness.
+15. Lysosomal Storage Disorders (Niemann-Pick Disease, Fabry Disease): Generalized hypotonia, Lethargy, Hepatosplenomegaly (not mentioned in symptoms), Tremor.
+16. Lysosomal Storage Disorders with Neurologic Manifestations (Hunter Syndrome, Sanfilippo Syndrome): Delayed speech and language development, Intellectual disability"
['Wilson disease']," +1. Wilson's Disease: This is a genetic disorder characterized by the accumulation of copper in various body tissues due to an impaired copper transport system. Patients with Wilson's Disease typically present with symptoms such as polydipsia, tremors, speech difficulties, and liver damage (elevated transaminase levels). Decreased circulating ceruloplasmin concentration is a hallmark of this disease. Contrary to your patient's presentation, Wilson's Disease does not typically cause death in adolescence.

+2. Hemochromatosis: This is a genetic disorder characterized by excessive absorption of dietary iron, leading to iron overload. Patients with hemochromatosis may present with symptoms such as polydipsia due to secondary diabetes mellitus, but they do not typically have liver damage or decreased circulating ceruloplasmin concentration. Decreased circulating copper concentration is not a feature of hemochromatosis.

+3. Alcoholic Liver Disease: This is a condition caused by excessive alcohol consumption, leading to liver damage. Patients with alcoholic liver disease may present with symptoms such as polydipsia, elevated transaminase levels, and decreased circulating ceruloplasmin concentration. However, they do not typically have decreased circulating copper concentration.

+4. Primary Biliary Cirrhosis: This is a chronic liver condition characterized by the destruction of small bile ducts in the liver. Patients with primary biliary cirrhosis may present with symptoms such as polydipsia, pruritus, and elevated transaminase levels. They may also have decreased circulating ceruloplasmin concentration, but they do not typically have decreased circulating copper concentration.

+5. Primary Sclerosing Cholangitis: This is a chronic inflammatory condition of the bile ducts. Patients with primary sclerosing cholangitis may present with symptoms such as polydipsia, jaundice, and elevated transaminase levels. They may also have decreased circulating ceruloplasmin concentration, but they do not typically have decreased circulating copper concentration.

+6. Hepatitis: This is an inflammation of the liver, which can be caused by various viruses or other factors. Patients with hepatitis may present with symptoms such as polydipsia, jaundice, and elevated transaminase levels. They may also have decreased circulating ceruloplasmin concentration, but they do not typically have decreased circulating copper concentration.

+7. Cirrhosis: This is a condition characterized by the replacement of normal liver tissue with scar tissue. Patients with cirrhosis may present with symptoms such as polydipsia, jaundice, and elevated transaminase levels. They may also have decreased circulating ceruloplasmin concentration, but they do not typically have decreased circulating copper concentration.

+8. Budd-Chiari Syndrome: This is a condition characterized by the obstruction of the hepatic veins or the inferior vena cava, leading to liver congestion. Patients with Budd-Chiari Syndrome may present with symptoms such as polydipsia, abdominal pain, and elevated transaminase levels. They may also have decreased circulating ceruloplasmin concentration, but they do not typically have decreased circulating copper concentration.

+9. Wilson-Mikulicz Syndrome: This is a rare condition characterized by the triad of dacryocystitis, salivary gland en"
['Ornithine transcarbamylase deficiency']," +1. Epilepsy: Seizures, Lethargy, Drowsiness, Sleep abnormality.
+2. Metabolic Disorder (e.g., Leigh Syndrome): Seizures, Lethargy, Generalized hypotonia, Neonatal death, Hyperglutaminemia.
+3. Reye Syndrome: Seizures, Vomiting, Lethargy, Drowsiness, Sleep abnormality.
+4. Menkes Disease: Neonatal death, Seizures, Lethargy, Generalized hypotonia.
+5. Maple Syrup Urine Disease: Oroticaciduria, Lethargy, Vomiting, Drowsiness, Sleep abnormality.
+6. Krabbe Disease: Neonatal death, Seizures, Lethargy, Generalized hypotonia.
+7. Pompe Disease: Generalized hypotonia, Lethargy, Drowsiness, Sleep abnormality, Hyperglutaminemia.
+8. Zellweger Syndrome: Neonatal death, Seizures, Lethargy, Generalized hypotonia.
+9. Biotinidase Deficiency: Vomiting, Lethargy, Drowsiness, Sleep abnormality.
+10. Mitochondrial Disorder: Seizures, Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality.
+11. Pyruvate Dehydrogenase Complex Deficiency: Seizures, Lethargy, Vomiting, Drowsiness, Sleep abnormality, Hyperglutaminemia.
+12. Organic Acidemia: Oroticaciduria, Vomiting, Lethargy, Drowsiness, Sleep abnormality.
+13. Urea Cycle Disorder: Vomiting, Lethargy, Drowsiness, Sleep abnormality, Hyperglutaminemia.
+14. Lysosomal Storage Disease: Generalized hypotonia, Lethargy, Drowsiness, Sleep abnormality.
+15. Congenital Disorders of Glycosylation: Neonatal death, Seizures, Lethargy, Generalized hypotonia."
['Classic galactosemia']," +1. Mucopolysaccharidosis: Microcephaly, Delayed speech and language development, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties +2. Down syndrome: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia +3. Fetal Alcohol Spectrum Disorders: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties (Microcephaly is not a common symptom) +4. Prader-Willi syndrome: Intellectual disability, Motor delay, Hypotonia, Feeding difficulties, Obesity +5. Sickle cell anemia: Anemia, Decreased circulating ferritin concentration, Decreased serum iron (Microcephaly, Delayed speech and language development, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Obesity, Neonatal death, Death in infancy, Death in childhood are not symptoms of sickle cell anemia) +6. Gaucher disease: Abnormality of galactoside metabolism, Elevated circulating alkaline phosphatase concentration (Microcephaly, Delayed speech and language development, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Obesity, Anemia, Neonatal death, Death in infancy, Death in childhood are not symptoms of Gaucher disease) +7. Porphyria: Abnormal circulating porphyrin concentration (Microcephaly, Delayed speech and language development, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Obesity, Anemia, Neonatal death, Death in infancy, Death in childhood, Abnormality of galactoside metabolism are not symptoms of porphyria)"
['Biotinidase deficiency']," +1. Methylmalonic Acidemia (Obesity, Abnormal foot morphology, Hyperammonemia, Childhood onset): This is a genetic disorder that affects the body's ability to break down certain proteins and fats. Patients may experience metabolic acidosis, developmental delays, and neurological symptoms. Obesity and abnormal foot morphology are not typical symptoms, but they have been reported in some cases.

+2. Sotos Syndrome (Obesity, Abnormal foot morphology): This genetic condition is characterized by overgrowth during fetal development and rapid growth in childhood. Patients may have distinctive facial features, large hands and feet, and intellectual disability. Hyperammonemia and death in childhood are not common symptoms.

+3. Morquio A Syndrome (Obesity, Abnormal foot morphology, Hyperammonemia): This is a lysosomal storage disorder caused by a deficiency of the enzyme iduronate-2-sulfatase. Patients may experience skeletal abnormalities, joint stiffness, and corneal clouding. Obesity and hyperammonemia are not typical symptoms, but they have been reported in some cases.

+4. Usher Syndrome (Obesity, Abnormal foot morphology, Hyperammonemia, Death in childhood): This is a genetic disorder that affects both vision and hearing. Patients may experience progressive vision loss and hearing impairment. Obesity and abnormal foot morphology are not typical symptoms, but they have been reported in some cases. Hyperammonemia and death in childhood are more common in the more severe forms of the disorder.

+5. Zellweger Spectrum Disorder (Obesity, Abnormal foot morphology, Hyperammonemia): This is a group of disorders caused by a deficiency of peroxisomes, which are small organelles that play a role in breaking down certain fats and other substances. Patients may experience developmental delays, hypotonia, and liver problems. Obesity and abnormal foot morphology are not typical symptoms, but they have been reported in some cases. Hyperammonemia is a common symptom due to the impaired metabolism of certain amino acids.

+6. Pompe Disease (Obesity, Hyperammonemia, Death in childhood): This is a lysosomal storage disorder caused by a deficiency of the enzyme acid alpha-glucosidase. Patients may experience muscle weakness, respiratory problems, and heart problems. Abnormal foot morphology is not a typical symptom.

+7. Maple Syrup Urine Disease (Obesity, Abnormal foot morphology, Hyperammonemia): This is a metabolic disorder caused by a deficiency of the enzymes that break down certain amino acids. Patients may experience metabolic acidosis, developmental delays, and neurological symptoms. Obesity and abnormal foot morphology are not typical symptoms, but they have been reported in some cases.

+8. Crigler-Najjar Syndrome (Obesity, Hyperammonemia): This is a rare genetic disorder that affects the liver's ability to break down bilirubin, a waste product of red blood cell breakdown. Patients may experience jaundice, kernicterus, and neurological symptoms. Obesity and abnormal foot morphology are not typical symptoms.

+9. Gau"
['Canavan disease']," +1. Metabolic Disorder (Phenylketonuria): Hyperactivity, Feeding difficulties, Abnormal circulating amino acid concentration (phenylalanine). No common symptoms: Death in infancy, Abnormal myelination.
+2. Neurological Disorder (Cerebral Palsy): Hyperactivity, Feeding difficulties, No common symptoms: Death in infancy, Abnormal circulating aspartate family amino acid concentration, Abnormal myelination.
+3. Metabolic Disorder (Maple Syrup Urine Disease): Hyperactivity, Feeding difficulties, Abnormal circulating amino acid concentration (leucine, isoleucine, valine). No common symptoms: Death in infancy (usually not present), Abnormal myelination.
+4. Neurological Disorder (Rett Syndrome): Feeding difficulties, Abnormal myelination. No common symptoms: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration.
+5. Metabolic Disorder (Canavan Disease): Abnormal myelination, Feeding difficulties. No common symptoms: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration.
+6. Neurological Disorder (Huntington's Disease): No common symptoms: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration, Feeding difficulties, Abnormal myelination.
+7. Metabolic Disorder (Urea Cycle Disorder): Hyperactivity, Feeding difficulties, Abnormal circulating amino acid concentration (ammonia). No common symptoms: Death in infancy, Abnormal myelination.
+8. Neurological Disorder (Spinal Muscular Atrophy): Feeding difficulties, No common symptoms: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration, Abnormal myelination.
+9. Metabolic Disorder (Homocystinuria): Hyperactivity, Feeding difficulties, Abnormal circulating amino acid concentration (homocysteine). No common symptoms: Death in infancy, Abnormal myelination.
+10. Neurological Disorder (Friedreich's Ataxia): No common symptoms: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration, Feeding difficulties, Abnormal myelination.

Please note that this list is not exhaustive and further diagnostic tests are required to confirm a definitive diagnosis. The symptoms provided may be indicative of multiple conditions, and a thorough medical evaluation is necessary to determine the underlying cause."
['Phenylketonuria']," +1. Phenylketonuria (PKU): A genetic disorder caused by the lack of an enzyme needed to break down phenylalanine, leading to its accumulation in the body. This results in mental and developmental problems if left untreated. Common symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and developmental delays. Neonatal death and death in infancy can occur if PKU is not diagnosed and treated early.

+2. Down syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. Common symptoms include developmental delays, characteristic facial features, and short stature. While abnormality of prenatal development or birth and neonatal death can occur, hyperphenylalaninemia is not a symptom of Down syndrome.

+3. Cystic fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems. Common symptoms include persistent coughing, lung infections, difficulty gaining weight, and infertility. While abnormality of prenatal development or birth and neonatal death can occur, hyperphenylalaninemia is not a symptom of cystic fibrosis.

+4. Tay-Sachs disease: A genetic disorder caused by the lack of the enzyme hexosaminidase A, leading to the accumulation of a fatty substance in the brain. Common symptoms include progressive loss of motor skills, vision loss, and intellectual decline. While abnormality of prenatal development or birth and neonatal death can occur, hyperphenylalaninemia is not a symptom of Tay-Sachs disease.

+5. Sickle cell anemia: A genetic disorder affecting the production of hemoglobin, leading to the formation of abnormal red blood cells. Common symptoms include anemia, pain crises, and frequent infections. While abnormality of prenatal development or birth and neonatal death can occur, hyperphenylalaninemia is not a symptom of sickle cell anemia."
['Phenylketonuria']," +1. Down Syndrome: Delayed speech and language development, Abnormality of prenatal development or birth +2. Cystic Fibrosis: No symptoms in common with given list, primarily affects respiratory and digestive systems +3. Sickle Cell Anemia: No symptoms in common with given list, primarily affects production of hemoglobin in red blood cells +4. Tay-Sachs Disease: Neonatal death, Death in childhood, Hypertyrosinemia +5. Phenylketonuria (PKU): Hyperphenylalaninemia, Delayed speech and language development (if left untreated) +6. Thalassemia: No symptoms in common with given list, primarily affects production of hemoglobin in red blood cells +7. Huntington's Disease: No symptoms in common with given list, primarily affects nervous system and progresses in adulthood."
[]," +1. Nephritis: Kidney inflammation. Common symptoms: none. The patient does not have kidney-related symptoms.
+2. Generalized hypotonia: Muscle weakness and decreased tone. Common symptoms: Generalized hypotonia.
+3. Death in infancy: Death occurring before the age of one. Common symptoms: Death in infancy.
+4. Ventricular septal defect: A hole in the wall separating the left and right ventricles of the heart. Common symptoms: None. The patient does not have heart-related symptoms.
+5. Cardiomyopathy: Heart muscle disease. Common symptoms: None. The patient does not have heart-related symptoms.
+6. Pulmonic stenosis: Narrowing of the pulmonic valve in the heart. Common symptoms: None. The patient does not have breathing-related symptoms."
['Phenylketonuria']," +1. Metachromatic Leukodystrophy: Irritability, Spasticity, Hyperreflexia, Neonatal death, Death in childhood, Recurrent viral infections, Hyperphenylalaninemia : Hypertyrosinemia, Death in infancy, Death in adolescence
+2. Krabbe Disease: Irritability, Spasticity, Hyperreflexia, Neonatal death, Recurrent viral infections : Hypertyrosinemia, Death in infancy, Death in adolescence, Hyperreflexia, Hyperphenylalaninemia
+3. Canavan Disease: Irritability, Spasticity, Hyperreflexia, Recurrent viral infections : Hypertyrosinemia, Death in infancy, Death in adolescence, Hyperreflexia, Hyperphenylalaninemia, Neonatal death, Death in childhood
+4. Pompe Disease: Irritability, Spasticity, Hyperreflexia : Hypertyrosinemia, Death in infancy, Death in adolescence, Hyperreflexia, Hyperphenylalaninia, Neonatal death, Death in childhood, Recurrent viral inctions, Hyperreflexia
+5. Mucopolysaccharidosis: Irritability, Spasticity, Hyperreflexia, Recurrent viral infections : Hypertyrosinemia, Death in infancy, Death in adolescence, Hyperreflexia, Hyperphenylalaninia, Neonatal death, Death in childhood, Hyperreflexia

These are some potential diseases based on the given symptoms. However, it's important to note that a definitive diagnosis can only be made through medical tests and evaluations by a healthcare professional. The symptoms listed here are common to certain genetic disorders, but there may be other possible causes for the symptoms as well. It's always best to consult with a doctor for an accurate diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorders (Includes inborn errors of metabolism): Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+2. Carnitine Deficiency: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
+3. Organic Acidemias: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration (some types).
+4. Lysosomal Storage Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+5. Mitochondrial Disorders: Abnormality of prenatal development or birth (in some cases), Neonatal death (in some cases).
+6. Congenital Heart Diseases: Abnormality of prenatal development or birth, Neonatal death (in some cases) (not directly related to the given symptoms).
+7. Inborn Errors of Immunity: Death in infancy (in some cases), Neonatal death (in some cases) (not directly related to the given symptoms).
+8. Sepsis: Neonatal death (in some cases) (not directly related to the given symptoms).
+9. Respiratory Distress Syndrome: Neonatal death (in some cases) (not directly related to the given symptoms).
+10. Congenital Infections: Neonatal death (in some cases) (not directly related to the given symptoms).

Please note that the given symptoms are not exclusive to any single disease, and a proper diagnosis would require further testing and evaluation by a healthcare professional."
['Phenylketonuria']," +1. Down syndrome: Delayed speech and language development, Abnormality of prenatal development or birth, Generalized hypotonia.
+2. Cerebral palsy: Delayed speech and language development, Generalized hypotonia. (Does not typically present with Death in infancy, Neonatal death, or Death in childhood, Hypertyrosinemia, or Hyperphenylalaninemia.)
+3. Fetal Alcohol Spectrum Disorders: Delayed speech and language development, Abnormality of prenatal development or birth. (Does not typically present with Generalized hypotonia, Death in infancy, Neonatal death, or Death in childhood, Hypertyrosinemia, or Hyperphenylalaninemia.)
+4. Hypothyroidism: Delayed speech and language development. (Does not typically present with Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Neonatal death, or Death in childhood, Hypertyrosinemia, or Hyperphenylalaninemia.)
+5. Rett Syndrome: Delayed speech and language development, Generalized hypotonia. (Does not typically present with Abnormality of prenatal development or birth, Death in infancy, Neonatal death, or Death in childhood, Hypertyrosinemia, or Hyperphenylalaninemia.)
+6. Muscular Dystrophies: Delayed speech and language development, Generalized hypotonia. (Does not typically present with Abnormality of prenatal development or birth, Death in infancy, Neonatal death, or Death in childhood, Hypertyrosinemia, or Hyperphenylalaninemia.)
+7. Sickle Cell Anemia: Not typically associated with Delayed speech and language development, Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Neonatal death, or Death in childhood. However, it can present with delayed growth and development due to anemia and infections. It is not related to Hypertyrosinemia or Hyperphenylalaninemia.
+8. Inborn Errors of Metabolism: Can present with Delayed speech and language development, Abnormality of prenatal development or birth, and can be associated with Hypertyrosinemia or Hyperphenylalaninemia. However, not all inborn errors of metabolism present with Generalized hypotonia, Death in infancy, Neonatal death, or Death in childhood. Other symptoms and diagnostic tests are required for a definitive diagnosis."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Glutaric Acidemia Type I: This is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenease. Patients with this condition have seizures, encephalopathy, and elevated circulating glutaric acid concentration. They may also experience death in infancy or childhood, opisthotonus, decreased plasma free carnitine, and elevated urinary carboxylic acids.

+2. Mitochondrial Encephalopathy: This is a group of disorders caused by dysfunctional mitochondria, which are the energy-producing structures in cells. Patients with mitochondrial encephalopathy may have seizures, encephalopathy, and death in childhood. However, they do not typically have glutaric aciduria or opisthotonus.

+3. Reye Syndrome: This is a rare but serious condition that affects the liver and brain. Patients with Reye syndrome may have seizures, encephalopathy, and death in childhood. They may also have elevated circulating glutaric acid concentration and decreased plasma free carnitine, but they do not typically have glutaric aciduria or opisthotonus.

+4. Menkes Disease: This is a rare genetic disorder that affects the absorption and utilization of copper. Patients with Menkes disease may have seizures, encephalopathy, and death in infancy or childhood. They may also have decreased plasma free carnitine and elevated urinary carboxylic acids, but they do not typically have glutaric aciduria or opisthotonus.

+5. Maple Syrup Urine Disease: This is a metabolic disorder caused by a deficiency of the enzymes that break down certain amino acids. Patients with maple syrup urine disease may have seizures, encephalopathy, and death in infancy or childhood. They may also have glutaric aciduria and elevated urinary carboxylic acids, but they do not typically have opisthotonus or decreased plasma free carnitine."
[]," +1. Cerebral Palsy (Spastic diplegia, Motor delay, Intellectual disability, Seizure, Opisthotonus): This is a group of disorders that affect muscle tone, movement, and posture. The patient presents with motor delay, intellectual disability, and seizures, which are common symptoms of cerebral palsy. Strabismus and nystagmus are also possible symptoms, but not all individuals with cerebral palsy have these conditions.

+2. Metabolic Disorders (Metabolic acidosis, Hypoglycemia, Hyperkalemia, Hepatomegaly): Metabolic disorders can cause a wide range of symptoms, including metabolic acidosis, hypoglycemia, hyperkalemia, and hepatomegaly. The patient presents with metabolic acidosis and hepatomegaly, making metabolic disorders a potential diagnosis. However, the patient does not have symptoms such as fair or white hair, which are common in some metabolic disorders.

+3. Neurological Disorders (Cerebral Palsy, Intellectual disability, Seizure, Spastic tetraplegia, Opisthotonus): Neurological disorders can cause a wide range of symptoms, including motor impairments, intellectual disability, and seizures. The patient presents with several neurological symptoms, making this a potential diagnosis. However, the patient does not have symptoms such as cyanosis, edema, or death in infancy, which are common in some neurological disorders.

+4. Respiratory Disorders (Pneumonia, Dyspnea, Stridor): Respiratory disorders can cause symptoms such as pneumonia, dyspnea, and stridor. The patient presents with dyspnea and stridor, making respiratory disorders a potential diagnosis. However, the patient does not have symptoms such as seizure, intellectual disability, or spasticity, which are not common in respiratory disorders.

+5. Endocrine Disorders (Hypocalcemia, Hyperkalemia): Endocrine disorders can cause symptoms such as hypocalcemia and hyperkalemia. The patient presents with hypocalcemia, making endocrine disorders a potential diagnosis. However, the patient does not have symptoms such as metabolic acidosis, hepatomegaly, or intellectual disability, which are not common in endocrine disorders.

+6. Infectious Diseases (Pneumonia, Diarrhea): Infectious diseases can cause a wide range of symptoms, including pneumonia and diarrhea. The patient presents with pneumonia, making infectious diseases a potential diagnosis. However, the patient does not have symptoms such as seizure, intellectual disability, or spasticity, which are not common in infectious diseases.

+7. Cardiovascular Disorders (Death in infancy, Hypokalemia): Cardiovascular disorders can cause symptoms such as death in infancy and hypokalemia. The patient does not have symptoms such as strabismus, nystagmus, or hyperactivity, which are not common in cardiovascular disorders. Therefore, cardiovascular disorders are a less likely diagnosis based on the given symptoms.

+8. Genetic Disorders (Intellectual disability, Fair hair, Severe hearing impairment): Genetic disorders can cause a wide range of symptoms, including intellectual disability, fair hair, and severe hearing impairment. The patient presents with intellectual disability, making genetic disorders a potential diagnosis. However, the patient"
['PMM2-CDG']," +1. Intellectual disability: The patient presents with a significant limitation in the ability to learn or apply skills, resulting in impaired academic achievement or social skills. The patient does not have Strabismus, Ataxia, Motor delay, Cerebellar atrophy, Cirrhosis, Hepatic fibrosis, Thromboembolism, Reduced antithrombin III activity, Cerebellar agenesis.

+2. Motor delay: The patient exhibits a delay in achieving developmental motor milestones, such as sitting, standing, or walking. The patient does not have Strabismus, Intellectual disability, Ataxia, Cerebellar atrophy, Cirrhosis, Hepatic fibrosis, Thromboembolism, Reduced antithrombin III activity, Death in infancy, Lipodystrophy, Cerebellar agenesis.

+3. Ataxia: The patient experiences impaired coordination and balance, affecting their ability to perform fine and gross motor tasks. The patient does not have Strabismus, Intellectual disability, Motor delay, Cirrhosis, Hepatic fibrosis, Thromboembolism, Reduced antithrombin III activity, Death in infancy, Lipodystrophy, Cerebellar agenesis.

+4. Cerebellar atrophy: The patient shows a decrease in size of the cerebellum, leading to motor coordination and balance issues. The patient does not have Strabismus, Intellectual disability, Motor delay, Ataxia, Cirrhosis, Hepatic fibrosis, Thromboembolism, Reduced antithrombin III activity, Death in infancy, Lipodystrophy, Death in childhood, Cerebellar agenesis.

+5. Cirrhosis: The patient has a chronic liver disease characterized by the replacement of normal liver tissue with scar tissue. The patient does not have Strabismus, Intellectual disability, Motor delay, Ataxia, Cerebellar atrophy, Thromboembolism, Reduced antithrombin III activity, Death in infancy, Lipodystrophy, Death in childhood, Cerebellar agenesis.

+6. Hepatic fibrosis: The patient has the formation of excess fibrous connective tissue in the liver, which can lead to cirrhosis if left untreated. The patient does not have Strabismus, Intellectual disability, Motor delay, Ataxia, Cerebellar atrophy, Cirrhosis, Thromboembolism, Reduced antithrombin III activity, Death in infancy, Lipodystrophy, Death in childhood, Cerebellar agenesis.

+7. Thromboembolism: The patient has a blood clot that forms in a blood vessel, obstructing blood flow, and can lead to serious complications such as stroke or pulmonary embolism. The patient does not have Strabismus, Intellectual disability, Motor delay, Ataxia, Cerebellar atrophy, Cirrhosis, Hepatic fibrosis, Reduced antithrombin III activity, Death in infancy, Lipodystrophy, Death in childhood, Cerebellar agenesis.

+8. Reduced antithrombin III activity: The patient has a lower than normal level of antithrombin III, a protein that helps prevent blood clots. The patient does not have Strabismus, Intellectual disability, Motor delay, Ataxia, Cerebellar atrophy, Cir"
['Canavan disease']," +1. Metabolic Disorder (Maple Syrup Urine Disease): Irritability, Seizure, Opisthotonus, Abnormal circulating aspartate family amino acid concentration. This condition is characterized by an inability to metabolize certain amino acids, leading to an accumulation of toxic substances in the body. Patients may experience irritability, seizures, and opisthotonus. Feeding difficulties and death in infancy are also common symptoms. Generalized hypotonia and hyperreflexia are not typically associated with this condition.

+2. Neurological Disorder (Cerebral Palsy): Irritability, Generalized hypotonia, Feeding difficulties. Cerebral palsy is a group of disorders that affect muscle tone, movement, and coordination. Patients may experience irritability, generalized hypotonia (low muscle tone), and feeding difficulties. Seizures, opisthotonus, and death in infancy are not typical symptoms of cerebral palsy.

+3. Inherited Metabolic Disorder (Phenylketonuria): Irritability, Seizure, Feeding difficulties, Abnormal circulating aspartate family amino acid concentration. Phenylketonuria is a genetic disorder that affects the metabolism of the amino acid phenylalanine. Patients may experience irritability, seizures, feeding difficulties, and an abnormal circulating aspartate family amino acid concentration. Generalized hypotonia and hyperreflexia are not typically associated with this condition. Opisthotonus and death in infancy can occur if the condition is not properly managed.

+4. Neurological Disorder (Tetanus): Irritability, Seizure, Opisthotonus, Trismus (lockjaw), Feeding difficulties. Tetanus is a bacterial infection that causes severe muscle stiffness and spasms. Patients may experience irritability, seizures, opisthotonus (stiffening of the back and neck), trismus (lockjaw), and feeding difficulties. Generalized hypotonia and hyperreflexia are not typically associated with tetanus. Death can occur if the condition is not properly treated.

+5. Inherited Metabolic Disorder (Pompe Disease): Irritability, Generalized hypotonia, Feeding difficulties, Cardiomegaly (enlarged heart). Pompe disease is a lysosomal storage disorder that affects the breakdown of glycogen. Patients may experience irritability, generalized hypotonia (low muscle tone), feeding difficulties, and cardiomegaly (enlarged heart). Seizures, opisthotonus, and death in infancy are not typical symptoms of Pompe disease."
['Phenylketonuria']," +1. Cystic Fibrosis: A genetic disorder that causes persistent lung infections and difficulty in digesting food due to thick and sticky mucus. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Gastrointestinal inflammation. -Symptoms: Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia

+2. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. +Symptoms: Abnormality of prenatal development or birth, Neonatal death. -Symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation

+3. Maple Syrup Urine Disease: An inherited metabolic disorder that affects the breakdown of certain amino acids. +Symptoms: Neonatal death, Hyperphenylalaninemia. -Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Gastrointestinal inflammation, Death in infancy

+4. Tay-Sachs Disease: A genetic disorder that causes progressive damage to the nervous system. +Symptoms: Neonatal death. -Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation, Death in infancy

+5. Phenylketonuria (PKU): An inherited metabolic disorder that affects the way the body processes phenylalanine. +Symptoms: Hyperphenylalaninemia. -Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Neonatal death, Gastrointestinal inflammation, Death in infancy

+6. Tyrosinemia: An inherited metabolic disorder that affects the breakdown of the amino acid tyrosine. +Symptoms: Hypertyrosinemia. -Symptoms: Abnormality of prenatal development or birth, Neonatal death, Hyperphenylalaninemia, Gastrointestinal inflammation, Death in infancy."
['Maple syrup urine disease']," +1. Metabolic Disorders (e.g., Leukodystrophies): Ataxia, Abnormal cerebral white matter morphology, Metabolic acidosis, Death in childhood, Hyperleucinemia
+2. Mitochondrial Disorders: Ataxia, Metabolic acidosis, Cerebral edema, Death in childhood
+3. Creutzfeldt-Jakob Disease: Ataxia, Coma, Cerebral edema, Death in adolescence
+4. Wilson's Disease: Ataxia, Alopecia, Metabolic acidosis, Death in adolescence (does not have: Coma, Reduced tendon reflexes, Recurrent viral infections, Hyperleucinemia)
+5. Canavan Disease: Ataxia, Abnormal cerebral white matter morphology, Metabolic acidosis, Death in childhood (does not have: Coma, Alopecia, Recurrent viral infections, Hyperleucinemia)
+6. Krabbe Disease: Ataxia, Abnormal cerebral white matter morphology, Metabolic acidosis, Death in childhood (does not have: Coma, Alopecia, Recurrent viral infections, Hyperleucinemia)
+7. Adrenoleukodystrophy: Ataxia, Abnormal cerebral white matter morphology, Metabolic acidosis, Death in childhood (does not have: Coma, Alopecia, Recurrent viral infections, Hyperleucinemia)
+8. Pelizaeus-Merzbacher Disease: Ataxia, Abnormal cerebral white matter morphology, Death in childhood (does not have: Coma, Alopecia, Metabolic acidosis, Recurrent viral infections, Hyperleucinemia)
+9. Rett Syndrome: Ataxia, Alopecia, Death in childhood (does not have: Coma, Metabolic acidosis, Cerebral edema, Recurrent viral infections, Hyperleucinemia)
+10. Krabbe Disease with Psychosis: Ataxia, Coma, Death in adolescence (does not have: Alopecia, Metabolic acidosis, Cerebral edema, Recurrent viral infections, Hyperleucinemia)
+11. Multiple Sclerosis: Ataxia, Alopecia (does not have: Coma, Metabolic acidosis, Cerebral edema, Death in childhood, Recurrent viral infections, Hyperleucinemia)
+12. Vitamin B12 Deficiency: Ataxia, Alopecia (does not have: Coma, Metabolic acidosis, Cerebral edema, Death in childhood, Recurrent viral infections, Hyperleucinemia)
+13. Subdural Hematoma: Ataxia, Coma (does not have: Alopecia, Metabolic acidosis, Cerebral edema, Death in childhood, Recurrent viral infections, Hyperleucinemia)
+14. Brain Tumor: Ataxia, Coma, Cerebral edema (does not have: Alopecia, Metabolic acidosis, Death in childhood,"
['Acute intermittent porphyria']," +1. Reye's Syndrome: Abdominal pain, Elevated urinary delta-aminolevulinic acid (a metabolic disorder) : Death in childhood (commonly affects children)
+2. Wilson's Disease: Abdominal pain, Elevated urinary delta-aminolevulinic acid (a metabolic disorder), Liver disease : Death in childhood (rare, but can lead to severe complications and death if left untreated)
+3. Tylenol (Acetaminophen) Overdose: Abdominal pain, Elevated urinary delta-aminolevulinic acid (a toxic byproduct of acetaminophen metabolism) : Death in childhood (rare, but high doses can be fatal, especially in children)
+4. Sickle Cell Anemia: Abdominal pain (common complication), Elevated urinary delta-aminolevulinic acid (not a primary symptom) : Death in childhood (can lead to complications and premature death if left untreated)
+5. Lead Poisoning: Abdominal pain, Elevated urinary delta-aminolevulinic acid (a symptom of lead toxicity) : Death in childhood (can be fatal if lead levels are extremely high)
+6. Maple Syrup Urine Disease: Abdominal pain (a complication), Elevated urinary delta-aminolevulinic acid (a symptom) : Death in childhood (can lead to severe complications and death if left untreated)
+7. Fanconi Syndrome: Abdominal pain (a symptom), Elevated urinary delta-aminolevulinic acid (not a primary symptom) : Death in childhood (rare, but can lead to complications and premature death if left untreated)
+8. Galactosemia: Abdominal pain (a complication), Elevated urinary delta-aminolevulinic acid (not a primary symptom) : Death in childhood (can lead to complications and premature death if left untreated)
+9. Tyrosinemia: Abdominal pain (a complication), Elevated urinary delta-aminolevulinic acid (not a primary symptom) : Death in childhood (can lead to complications and premature death if left untreated)

Please note that this list is not exhaustive and further diagnostic tests are required to confirm a definitive diagnosis. The symptoms provided may be indicative of multiple conditions, and it is essential to consider the patient's medical history, physical examination, and other diagnostic tests to make an accurate diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic Acidemia (MMA): This is an inherited metabolic disorder caused by a deficiency of methylmalonic acid (MMA) metabolism. Patients with MMA present with symptoms such as metabolic acidosis, seizures, developmental delay, and sometimes neonatal death. Methylmalonic aciduria is a hallmark of this condition.

+2. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency in the breakdown of certain amino acids (leucine, isoleucine, and valine). Patients with MSUD can present with symptoms such as metabolic acidosis, seizures, developmental delay, and a distinctive sweet urine smell. Neonatal death can occur if left untreated. Methylmalonic aciduria is not a feature of MSUD.

+3. Phenylketonuria (PKU): This is an inherited metabolic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase. Patients with PKU cannot metabolize phenylalanine, leading to its accumulation in the body. Symptoms include developmental delay, seizures, and mental retardation. Neonatal death is rare, and metabolic acidosis is not a feature of PKU. Methylmalonic aciduria is also not a feature of PKU.

+4. Homocystinuria: This is an inherited metabolic disorder caused by a deficiency in the enzyme cystathionine beta-synthase. Patients with homocystinuria present with symptoms such as mental retardation, seizures, and ectopia lentis (dislocation of the lens in the eye). Neonatal death is rare, and metabolic acidosis is not a feature of homocystinuria. Methylmalonic aciduria is not a feature of homocystinuria.

+5. Organic Acidemia: This is a broad category of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms can vary widely but may include metabolic acidosis, seizures, developmental delay, and neonatal death. Methylmalonic aciduria is a feature of some organic acidemias, such as propionic acidemia and methylglutaconic aciduria. The specific diagnosis would depend on further testing to identify the specific organic acid involved."
['Alkaptonuria']," +1. Metabolic Disorders (e.g., Inborn Errors of Metabolism): Seizures, Lethargy, Generalized hypotonia, Growth delay, Dark urine.
+2. Mitochondrial Disorders: Seizures, Lethargy, Generalized hypotonia, Growth delay.
+3. Hepatitis: Dark urine, Lethargy, Drowsiness, Sleep abnormality.
+4. Sepsis: Seizures, Lethargy, Fever, Dark urine.
+5. Hypothyroidism: Lethargy, Growth delay, Drowsiness, Sleep abnormality.
+6. Neurological Disorders (e.g., Epilepsy, Muscular Dystrophies): Seizure, Generalized hypotonia, Lethargy, Growth delay.
+7. Renal Diseases: Dark urine, Growth delay, Lethargy.
+8. Sepsis with Hepatic Involvement: Seizures, Lethargy, Dark urine, Fever.
+9. Wilson's Disease: Seizures, Lethargy, Generalized hypotonia, Dark urine, Drowsiness.
+10. Lead Poisoning: Seizures, Lethargy, Growth delay, Abdominal pain, Dark urine.

Please note that this list is not exhaustive and further diagnostic tests are required to confirm a definitive diagnosis."
['Maple syrup urine disease']," +1. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids (leucine, isoleucine, and valine). Patients with MSUD may experience seizures, developmental delay, and a distinctive sweet urine odor. They may also have a history of neonatal seizures and death if not diagnosed and treated early. +

+2. Reye Syndrome: This is a rare but serious condition that affects the brain and liver. It is often triggered by viral infections, particularly the influenza virus. Symptoms include vomiting, lethargy, confusion, seizures, and in severe cases, coma and death. Aminoaciduria is a common finding in Reye syndrome, but it is not specifically related to leucine, isoleucine, or valine. +

+3. Phenylketonuria (PKU): This is an inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Patients with PKU cannot metabolize phenylalanine, leading to its accumulation in the blood and urine. Symptoms include developmental delay, seizures, and a musty odor to the urine and breath. PKU is not typically associated with abnormal circulating concentrations of leucine, isoleucine, or valine. +

+4. Homocystinuria: This is an inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Patients with homocystinuria cannot metabolize homocysteine, leading to its accumulation in the blood and urine. Symptoms include developmental delay, seizures, mental retardation, and a distinctive odor to the urine. Homocystinuria is not specifically related to abnormal circulating concentrations of leucine, isoleucine, or valine. +

+5. Urea Cycle Disorders: This group of inherited metabolic disorders includes conditions such as ornithine transcarbamylase deficiency and argininosuccinic aciduria. Patients with urea cycle disorders cannot properly process ammonia, leading to its accumulation in the blood. Symptoms include vomiting, lethargy, seizures, and developmental delay. Urea cycle disorders are not specifically related to abnormal circulating concentrations of leucine, isoleucine, or valine. +

+6. Mitochondrial Disorders: This group of disorders affects the mitochondria, the energy-producing structures in cells. Symptoms can vary widely, but may include seizures, developmental delay, and metabolic abnormalities. Mitochondrial disorders are not specifically related to abnormal circulating concentrations of leucine, isoleucine, or valine. +

+7. Inborn Errors of Metabolism (IEMs) not otherwise specified: This category includes a wide range of metabolic disorders that do not fit neatly into any specific diagnostic category. Some IEMs may be associated with abnormal circulating concentrations of leucine, isoleucine, or valine, while others may not. Symptoms can vary widely and may include seizures, developmental delay, and metabolic abnormalities. +

+8. Toxic Substance Exposure: Exposure to certain toxins, such as heavy metals"
['Very long chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorder (Mitochondrial Disease): Cardiomegaly, Hepatomegaly, Increased circulating lactate concentration, Neonatal death, Recurrent viral infections, + Abnormal circulating carnitine concentration: This disorder is characterized by impaired energy production due to dysfunctional mitochondria. Patients may present with cardiac and hepatic involvement, metabolic acidosis, and recurrent infections. Hypoglycemia and death in infancy or childhood are also common in some forms of this disease. Dicarboxylic aciduria is not a typical symptom.

+2. Reye's Syndrome: Cardiomegaly, Hepatomegaly, Hypoglycemia, Increased circulating lactate concentration, Neonatal death, Death in childhood: Reye's syndrome is a rare, life-threatening condition that affects the liver and brain. It is characterized by vomiting, lethargy, and encephalopathy. Cardiomegaly and hepatomegaly are common findings, and metabolic acidosis, hypoglycemia, and death in infancy or childhood are also typical. Dicarboxylic aciduria is not a symptom of Reye's syndrome.

+3. Maple Syrup Urine Disease: Hepatomegaly, Increased circulating lactate concentration, Dicarboxylic aciduria, Neonatal death, Death in childhood: Maple Syrup Urine Disease is an inherited metabolic disorder caused by a deficiency of the enzyme responsible for breaking down certain amino acids. Patients present with metabolic acidosis, neurological symptoms, and a characteristic sweet-smelling urine. Hepatomegaly and death in infancy or childhood are also common. Cardiomegaly and hypoglycemia are not typical symptoms.

+4. Galactosemia: Hepatomegaly, Hypoglycemia, Neonatal death: Galactosemia is an inherited metabolic disorder caused by a deficiency of the enzyme responsible for breaking down galactose. Patients present with hypoglycemia, jaundice, and hepatomegaly. Neonatal death is a common complication. Cardiomegaly, increased circulating lactate concentration, and dicarboxylic aciduria are not typical symptoms.

+5. Sepsis: Tachypnea, Dicarboxylic aciduria, Recurrent viral infections: Sepsis is a life-threatening condition caused by a severe infection. Patients present with fever, tachypnea, and metabolic acidosis. Dicarboxylic aciduria and recurrent viral infections are common in sepsis, especially in immunocompromised individuals. Cardiomegaly, hepatomegaly, hypoglycemia, and death in infancy or childhood are not typical symptoms.

+6. Cystic Fibrosis: Recurrent viral infections: Cystic Fibrosis is an inherited disorder that affects the respiratory and digestive systems. Patients present with recurrent respiratory infections, chronic cough, and difficulty gaining weight. Cardiomegaly, hepatomegaly, hypoglycemia, increased circulating lactate concentration, and death in infancy or childhood are not typical"
['3-hydroxy-3-methylglutaric aciduria']," +1. Metabolic Encephalopathy (Lethargy, Seizure, Progressive neurologic deterioration, Metabolic acidosis, Hypoglycemia): This condition refers to a dysfunction of the metabolic processes in the brain, leading to neurological symptoms such as seizures, lethargy, and progressive deterioration. The patient's symptoms of metabolic acidosis and hypoglycemia align with this diagnosis.

+2. Reye's Syndrome (Lethargy, Seizure, Vomiting, Metabolic acidosis, Hypoglycemia): This is a rare but serious condition that affects the brain and liver, often occurring after a viral infection. The patient's symptoms of lethargy, seizure, vomiting, metabolic acidosis, and hypoglycemia are common in Reye's Syndrome.

+3. Mitochondrial Disorders (Lethargy, Seizure, Progressive neurologic deterioration, Metabolic acidosis, Hypoglycemia): A group of genetic disorders that affect the mitochondria, the energy-producing structures in cells. The patient's symptoms of lethargy, seizure, progressive neurologic deterioration, metabolic acidosis, and hypoglycemia can be associated with mitochondrial disorders.

+4. Inborn Errors of Metabolism (Lethargy, Seizure, Metabolic acidosis, Hypoglycemia, Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid): A group of genetic disorders that affect the body's ability to process certain substances, leading to the accumulation of toxic metabolites. The patient's symptoms of lethargy, seizure, metabolic acidosis, hypoglycemia, glutaric aciduria, 3-methylglutaric aciduria, abnormal circulating glycine concentration, and elevated urinary carboxylic acid align with this diagnosis.

+5. Meningoencephalitis (Fever, Seizure, Lethargy, Vomiting): An inflammation of the meninges (the protective covering of the brain and spinal cord) and the brain itself, often caused by a viral or bacterial infection. The patient's symptoms of fever, seizure, lethargy, and vomiting are common in meningoencephalitis.

+6. Meningitis (Fever, Seizure, Lethargy, Neurologic symptoms): An inflammation of the meninges, often caused by a bacterial or viral infection. The patient's symptoms of fever, seizure, lethargy, and neurologic symptoms align with this diagnosis.

+7. Encephalitis (Fever, Seizure, Lethargy, Neurologic symptoms): An inflammation of the brain, often caused by a viral or bacterial infection. The patient's symptoms of fever, seizure, lethargy, and neurologic symptoms align with this diagnosis.

+8. Sepsis (Fever, Seizure, Lethargy, Metabolic acidosis): A life-threatening condition caused by the body's response to an infection"
['MODY']," +1. Diabetes Mellitus: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration may be observed in Diabetes Mellitus. This condition is characterized by high blood sugar levels over a prolonged period. However, the abnormal circulating porphyrin concentration is not a typical symptom of Diabetes Mellitus, but it can occur in some cases due to secondary hemolytic anemia.

+2. Hepatitis: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration may be seen in Hepatitis. Hepatitis is an inflammation of the liver that can cause various symptoms, including jaundice, abdominal pain, and fatigue. The abnormal circulating porphyrin concentration is a common finding in patients with hepatocellular damage.

+3. Renal Disease: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration may be present in Renal Disease. Renal disease refers to any damage or dysfunction of the kidneys. The symptoms can vary depending on the severity and cause of the disease. Hypoglycemia and glycosuria can occur due to impaired renal function. The abnormal circulating porphyrin concentration can be a sign of hemolytic anemia, which can occur in some renal diseases.

+4. Porphyria: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration are common symptoms of Porphyria. Porphyria is a group of metabolic disorders characterized by the accumulation of porphyrins or their precursors in the body. The specific type of porphyria depends on the enzyme deficiency involved.

+5. Alcoholism: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration can occur in Alcoholism. Alcoholism is a chronic condition characterized by the excessive consumption of alcohol. The symptoms can include liver damage, which can lead to hypoglycemia and glycosuria. The abnormal circulating porphyrin concentration can be a sign of hemolytic anemia, which can occur due to alcohol-induced damage to red blood cells.

+6. Malnutrition: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration can be seen in Malnutrition. Malnutrition is a condition caused by a lack of essential nutrients in the diet. Hypoglycemia can occur due to a lack of food intake or insulin production. Glycosuria can occur due to a lack of insulin or a defect in the kidneys' ability to reabsorb glucose. The abnormal circulating porphyrin concentration can be a sign of anemia, which can occur due to malnutrition.

+7. Sepsis: Hypoglycemia, Glycosuria, and Abnormal circulating porphyrin concentration can occur in Sepsis. Sepsis is a life-threatening condition caused by the body's response to an infection. The symptoms can include fever, chills, and organ failure. Hypoglycemia can occur due to insulin release in response to stress. Glycosuria can occur due to insulin resistance or kidney damage. The abnormal circulating"
['Phenylketonuria']," +1. Phenylketonuria (PKU): A genetic disorder caused by the lack of an enzyme needed to break down phenylalanine, leading to its accumulation in the body. This results in mental and developmental problems, if left untreated. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Hyperphenylalaninemia
+2. Down syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is characterized by physical growth delays, characteristic facial features, and mild to moderate intellectual disability. +Symptoms: Abnormality of prenatal development or birth, not typically associated with Death in infancy or Hyperphenylalaninemia
+3. Cystic fibrosis: A genetic disorder that affects the respiratory, digestive, and reproductive systems, causing persistent lung infections and difficulty digesting food. +Symptoms: Not typically associated with Abnormality of prenatal development or birth, not typically associated with Hyperphenylalaninemia, may present with Death in infancy or Neonatal death due to respiratory complications.
+4. Tay-Sachs disease: A genetic disorder caused by the deficiency of the enzyme hexosaminidase A, leading to the accumulation of a fatty substance in nerve cells. +Symptoms: Neonatal death, not typically associated with Abnormality of prenatal development or birth, not typically associated with Hyperphenylalaninemia.
+5. Sickle cell anemia: A genetic disorder caused by a mutation in the hemoglobin gene, leading to the production of abnormal hemoglobin that can cause red blood cells to become misshapen and break down easily. +Symptoms: Not typically associated with Abnormality of prenatal development or birth, not typically associated with Hyperphenylalaninemia, may present with Death in infancy or Neonatal death due to complications from anemia or infections."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Hydrocephalus: Enlargement of the head due to excessive accumulation of cerebrospinal fluid in the ventricles. Common symptoms: Hydrocephalus, Macrocephaly. Not common: Seizure, Hyperhidrosis, Anemia, Fever, Vomiting, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Recurrent viral infections, Chronic pulmonary obstruction, Death in infancy, Death in childhood, Death in adolescence, Increased CSF protein concentration, Glutaric aciduria.

+2. Macrocephaly: Abnormally large head size. Common symptoms: Hydrocephalus, Macrocephaly. Not common: Seizure, Hyperhidrosis, Anemia, Fever, Vomiting, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Recurrent viral infections, Chronic pulmonary obstruction, Death in infancy, Death in childhood, Death in adolescence, Increased CSF protein concentration, Glutaric aciduria.

+3. Hyperhidrosis: Excessive sweating, often unprovoked. Not common: Hydrocephalus, Macrocephaly, Seizure, Anemia, Fever, Vomiting, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Recurrent viral infections, Chronic pulmonary obstruction, Death in infancy, Death in childhood, Death in adolescence, Increased CSF protein concentration, Glutaric aciduria.

+4. Seizure: A sudden, uncontrolled electrical disturbance in the brain. Not common: Hydrocephalus, Macrocephaly, Hyperhidrosis, Anemia, Fever, Vomiting, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Recurrent viral infections, Chronic pulmonary obstruction, Death in infancy, Death in childhood, Death in adolescence, Increased CSF protein concentration, Glutaric aciduria.

+5. Dystonia: A neurological movement disorder characterized by involuntary muscle contractions, often causing twisting and repetitive movements or abnormal postures. Not common: Hydrocephalus, Macrocephaly, Hyperhidrosis, Seizure, Anemia, Fever, Vomiting, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Recurrent viral infections, Chronic pulmonary obstruction, Death in infancy, Death in childhood, Death in adolescence, Increased CSF protein concentration, Glutaric aciduria.

+6. Hyperreflexia: Overactive reflexes. Not common: Hydrocephalus, Macrocephaly, Hyperhidrosis, Seizure, Anemia, Fever, Vomiting, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obst"
['Phenylketonuria']," +1. Hemangioma: A common benign tumor of infancy, usually presents as a red or blue swelling in the skin or mucous membranes, does not typically cause prenatal abnormalities or death in infancy or childhood, but can lead to neonatal death if large and obstructing vital organs.

+2. Down syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21, can cause prenatal development abnormalities, may lead to neonatal death, and can cause intellectual and developmental delays, but does not typically cause Hyperphenylalaninemia or Hypertyrosinemia.

+3. Cystic fibrosis: A genetic disorder that affects the respiratory, digestive, and reproductive systems, can cause persistent coughing, frequent lung infections, and difficulty gaining weight, does not typically cause prenatal development abnormalities or Hypertyrosinemia, but can lead to neonatal death if severe.

+4. Sickle cell disease: A genetic disorder that affects the production of hemoglobin, can cause anemia, pain crises, and organ damage, does not typically cause prenatal development abnormalities or Hyperphenylalaninemia, but can lead to neonatal death if severe.

+5. Tay-Sachs disease: A genetic disorder that causes the progressive degeneration of the central nervous system, typically presents with symptoms in infancy or early childhood, can cause intellectual and developmental delays, muscle weakness, and vision and hearing loss, does not typically cause prenatal development abnormalities or Hypertyrosinemia, but can lead to neonatal death.

+6. Maple syrup urine disease: An inherited metabolic disorder that affects the breakdown of certain amino acids, can cause a distinctive sweet urine odor, muscle weakness, and developmental delays, can lead to Hyperphenylalaninemia and Hypertyrosinemia, and can cause neonatal death if not diagnosed and treated promptly.

+7. Krabbe disease: A genetic disorder that affects the protective covering of nerve fibers, can cause symptoms such as irritability, seizures, and developmental delays, can lead to neonatal death if not diagnosed and treated promptly, does not typically cause prenatal development abnormalities or Hyperphenylalaninemia, but can cause Hypertyrosinemia.

+8. Gaucher disease: A lysosomal storage disorder that affects the breakdown of a lipid called glucocerebroside, can cause enlarged liver and spleen, bone pain, and bruising, does not typically cause prenatal development abnormalities or Hyperphenylalaninemia, but can lead to neonatal death if severe.

+9. Niemann-Pick disease: A lysosomal storage disorder that affects the breakdown of cholesterol and other lipids, can cause hepatosplenomegaly, lung involvement, and neurological symptoms, does not typically cause prenatal development abnormalities or Hyperphenylalaninemia, but can lead to neonatal death if severe.

+10. Pompe disease: A lysosomal storage disorder that affects the breakdown of glycogen, can cause muscle weakness, respiratory distress, and heart problems, does not typically cause prenatal development abnormalities or Hyperphenylalaninemia, but can lead to neon"
['Phenylketonuria']," +1. Hypertyrosinemia: A rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites in the body. Common symptoms include: fatty liver, muscle weakness, and neurological problems. The patient does not have common symptoms of jaundice and fetal distress.

+2. Hyperphenylalaninemia: A genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body. Common symptoms include: mental retardation, seizures, and a musty odor. The patient does not have common symptoms of jaundice and fetal distress.

+3. Preeclampsia: A pregnancy complication characterized by high blood pressure and damage to organs such as the liver and kidneys. Common symptoms include: swelling, protein in the urine, and severe headaches. The patient does not have common symptoms of fatty liver and does not have to be in pregnancy.

+4. Death in early adulthood: A broad term that can be caused by various diseases and conditions. Common symptoms include: premature death. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia.

+5. Cystic Fibrosis: A genetic disorder that affects the respiratory, digestive, and reproductive systems. Common symptoms include: persistent cough, frequent lung infections, and difficulty gaining weight. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia.

+6. Hemochromatosis: A genetic disorder that causes the body to absorb too much iron from the diet, leading to iron overload. Common symptoms include: joint pain, abdominal pain, and fatigue. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia.

+7. Sickle Cell Anemia: A genetic disorder that affects the production of hemoglobin in the red blood cells, leading to the formation of sickle-shaped cells. Common symptoms include: pain crises, fatigue, and jaundice. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia.

+8. Huntington's Disease: A genetic disorder that causes the progressive degeneration of nerve cells in the brain. Common symptoms include: uncontrolled movements, emotional problems, and cognitive decline. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia.

+9. Diabetes Mellitus: A chronic condition that affects how the body processes sugar. Common symptoms include: increased thirst, frequent urination, and fatigue. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia.

+10. Multiple Sclerosis: A chronic autoimmune disorder that affects the central nervous system. Common symptoms include: muscle weakness, numbness, and vision problems. The patient does not have common symptoms of Hypertyrosinemia, Hyperphenylalaninemia, and Preeclampsia."
['Phenylketonuria']," +1. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids, leading to their accumulation in the body. Symptoms include abnormalities of prenatal development or birth, neonatal death, and elevated urinary carboxylic acids. The patient does not have symptoms of hyperphenylalaninemia or hypertyrosinemia.

+2. Tyrosinemia Type 1: This is a rare, inherited metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms include abnormalities of prenatal development or birth, neonatal death, and elevated urinary carboxylic acids. The patient does not have symptoms of hyperphenylalaninemia or hypertyrosinemia.

+3. Phenylketonuria (PKU): This is an inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms include mental retardation, seizures, and developmental delays if left untreated. The patient does not have symptoms of abnormalities of prenatal development or birth, neonatal death, or hypertyrosinemia.

+4. Homocystinuria: This is an inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms include mental retardation, developmental delays, and skeletal abnormalities. The patient does not have symptoms of abnormalities of prenatal development or birth, neonatal death, or hyperphenylalaninemia.

+5. Organic Acidemias: This is a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to a deficiency of an enzyme involved in the metabolism of certain amino acids or other organic compounds. Symptoms can include abnormalities of prenatal development or birth, neonatal death, and elevated urinary carboxylic acids. The specific symptoms depend on the underlying cause of the organic acidemia. The patient does not have symptoms of hyperphenylalaninemia or hypertyrosinemia.

+6. Wilson's Disease: This is an inherited metabolic disorder caused by a deficiency of ceruloplasmin, leading to the accumulation of copper in various tissues. Symptoms can include liver damage, neurological symptoms, and psychiatric symptoms. The patient does not have symptoms of abnormalities of prenatal development or birth, neonatal death, or hyperphenylalaninemia.

+7. Galactosemia: This is an inherited metabolic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase. Symptoms include vomiting, diarrhea, and jaundice after consuming milk or milk products. The patient does not have symptoms of abnormalities of prenatal development or birth, neonatal death, or hyperphenylalaninemia.

+8. Cystic Fibrosis: This is an inherited genetic disorder that affects the respiratory, digestive, and reproductive systems. Symptoms include persistent coughing, lung infections, and difficulty digesting food. The patient does not have symptoms of abnormalities"
['Phenylketonuria']," +1. Hemangioma NVD: A common benign vascular birth defect, not typically associated with prenatal abnormalities or death. +Symptoms in common: Abnormality of prenatal development or birth.
+2. Cystic Fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems, causing persistent lung infections and difficulty digesting food. +Symptoms in common: Death in childhood.
+3. Tay-Sachs Disease: A rare, inherited metabolic disorder causing progressive degeneration of the central nervous system, leading to blindness, deafness, and eventual death. +Symptoms in common: Neonatal death, Death in infancy.
+4. Sickle Cell Anemia: A genetic disorder causing the production of abnormal hemoglobin, leading to red blood cells that are crescent-shaped and prone to clumping, resulting in anemia and various complications. +Symptoms in common: Death in childhood.
+5. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21, leading to developmental delays, physical growth delays, and characteristic facial features. +Symptoms in common: Abnormality of prenatal development or birth.
+6. Phenylketonuria (PKU): A metabolic disorder caused by the inability to metabolize phenylalanine, leading to its accumulation in the body and causing intellectual disability, seizures, and other complications. +Symptoms in common: Hyperphenylalaninemia.
+7. Maple Syrup Urine Disease: A metabolic disorder caused by the inability to break down certain amino acids, leading to their accumulation in the body and causing neurological symptoms, including developmental delay, seizures, and coma. +Symptoms in common: Hyperammonemia, Hyperphenylalaninemia.
+8. Zellweger Syndrome: A rare, genetic disorder affecting the synthesis of certain proteins in the endoplasmic reticulum, leading to multiple organ dysfunctions and developmental delays. +Symptoms in common: Neonatal death.
+9. Krabbe Disease: A metabolic disorder caused by the inability to produce a myelin protein, leading to demyelination of nerve fibers and causing neurological symptoms, including developmental delay, seizures, and vision and hearing loss. +Symptoms in common: Neonatal death, Death in infancy.
+10. Canavan Disease: A metabolic disorder caused by the inability to break down the amino acid N-acetylaspartic acid, leading to its accumulation in the brain and causing neurological symptoms, including developmental delay, seizures, and vision and hearing loss. +Symptoms in common: Neonatal death, Death in infancy."
['Hereditary orotic aciduria']," +1. Scarlet Fever: A bacterial infection caused by Streptococcus pyogenes. Symptoms include: Skin rash (erythematous papules and macules), Fever, and Splenomegaly. The patient does not have symptoms of Lethargy, Generalized hypotonia, Death in infancy, Vomiting, Pneumonia, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, or Erythematous macule.

+2. Sepsis: A life-threatening condition caused by the body's response to an infection. Symptoms include: Fever, Lethargy, and Sepsis-induced hypotonia. The patient does not have symptoms of Skin rash, Death in infancy, Vomiting, Pneumonia, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, or Erythematous macule.

+3. Meningoencephalitis: An inflammation of the meninges (the protective membranes surrounding the brain and spinal cord) and the brain. Symptoms include: Fever, Lethargy, Drowsiness, and Altered mental status. The patient does not have symptoms of Skin rash, Death in infancy, Vomiting, Pneumonia, Hepatomegaly, Splenomegaly, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, or Erythematous macule.

+4. Hepatitis: An inflammation of the liver. Symptoms include: Fever, Jaundice (yellowing of the skin and eyes), Abdominal pain, and Vomiting. The patient does not have symptoms of Skin rash, Lethargy, Generalized hypotonia, Death in infancy, Pneumonia, Hepatomegaly (liver enlargement), Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, or Erythematous macule.

+5. Meningococcal disease: An infection caused by Neisseria meningitidis. Symptoms include: Fever, Headache, Neck stiffness, and Rash (petechial or purpuric). The patient does not have symptoms of Skin rash (other than the rash associated with meningococcal disease), Lethargy, Generalized hypotonia, Death in infancy, Vomiting, Pneumonia, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circul"
['Holocarboxylase synthetase deficiency']," +1. Phenylketonuria (PKU): Cyanosis, Anemia, Neonatal death, Aminoaciduria, Abnormal circulating amino acid concentration, Elevated urinary organic acids
+2. Maple Syrup Urine Disease (MSUD): Cyanosis, Anemia, Neonatal death, Aminoaciduria, Abnormal circulating amino acid concentration, Elevated urinary organic acids, Abnormal circulating branched-chain amino acids
+3. Propionic Acidemia: Anemia, Metabolic acidosis, Hyperammonemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating propionic acid
+4. Urea Cycle Disorders: Anemia, Hyperammonemia, Tachypnea, Decreased pyruvate carboxylase activity, Aminoaciduria, Neonatal death, Abnormal circulating ammonia
+5. Cyanotic Heart Disease: Cyanosis, Tachypnea
+6. Sepsis: Skin rash, Tachypnea, Decreased pyruvate carboxylase activity (due to lactic acidosis), Neonatal death
+7. Methemoglobinemia: Cyanosis, Anemia
+8. Sickle Cell Disease: Anemia, Skin rash, Decreased pyruvate carboxylase activity (due to metabolic acidosis), Neonatal death (in severe cases)
+9. Cystic Fibrosis: Skin rash (in some cases), Decreased pyruvate carboxylase activity (due to metabolic acidosis), Diarrhea, Tachypnea
+10. Ehlers-Danlos Syndrome: Generalized hypotonia, Skin rash

Note: This list is not exhaustive and other diseases may also present with some of the symptoms mentioned. A proper diagnosis should be made by a healthcare professional based on a thorough clinical evaluation and diagnostic testing."
['Ornithine transcarbamylase deficiency']," +1. Reye's Syndrome: A rare but serious condition that affects the brain and liver, often occurring in children and adolescents after a viral infection. Symptoms include Apathy, Ataxia, Lethargy, Hyperammonemia, Vomiting, and Drowsiness. +2. Urea Cycle Disorder: A group of metabolic disorders that affect the body's ability to process ammonia. Symptoms include Hyperammonemia, Vomiting, Lethargy, and sometimes Ataxia. +3. Meningoencephalitis: An inflammation of the brain and meninges, often caused by a viral or bacterial infection. Symptoms include Apathy, Ataxia, Lethargy, Drowsiness, and sometimes Sleep abnormality. +4. Wilson's Disease: A rare inherited disorder that causes copper to build up in the body, leading to liver damage and neurological symptoms. Symptoms include Lethargy, Ataxia, and sometimes Drowsiness and Sleep abnormality. +5. Creutzfeldt-Jakob Disease: A degenerative brain disorder that causes progressive dementia and neurological symptoms. Symptoms include Apathy, Ataxia, Lethargy, Drowsiness, and sometimes Sleep abnormality and Vomiting. +6. Metabolic Encephalopathy: A group of disorders that affect brain function due to metabolic imbalances. Symptoms include Apathy, Lethargy, Drowsiness, and sometimes Ataxia, Sleep abnormality, and Vomiting. +7. Mitochondrial Disorder: A group of disorders that affect the mitochondria, the energy-producing structures in cells. Symptoms include Lethargy, Drowsiness, and sometimes Ataxia, Sleep abnormality, and Vomiting. +8. Brain Tumor: A growth of abnormal cells in the brain. Symptoms include Apathy, Ataxia, Lethargy, Drowsiness, and sometimes Sleep abnormality, Vomiting, and Death in adolescence. +9. Epilepsy: A neurological disorder characterized by recurring seizures. Symptoms include Apathy, Ataxia, Lethargy, Drowsiness, and sometimes Sleep abnormality and Vomiting. +10. Anoxic Brain Injury: Damage to the brain caused by lack of oxygen. Symptoms include Apathy, Ataxia, Lethargy, Drowsiness, and sometimes Sleep abnormality, Vomiting, and Death in adolescence."
[]," +1. Metabolic Disorder: Carnitine Palmitoyltransferase Deficiency (CPT II)
   - Symptoms: Vomiting, Death in childhood, Decreased carnitine concentration
   - Description: This condition is caused by a deficiency of carnitine palmitoyltransferase II, an enzyme that plays a crucial role in the transport of long-chain fatty acids into the mitochondria for beta-oxidation. Patients may experience recurrent vomiting, hypoglycemia, and metabolic acidosis, leading to developmental delay, seizures, and even death in infancy or childhood.

 +2. Metabolic Disorder: Propionic Acidemia
   - Symptoms: Vomiting, Ethylmalonic aciduria, Death in childhood, Decreased 3-hydroxyacyl-CoA dehydrogenase level
   - Description: This condition is caused by a deficiency of propionyl-CoA carboxylase, an enzyme involved in the metabolism of certain amino acids and odd-chain fatty acids. Patients may experience vomiting, metabolic acidosis, and a characteristic odor of their urine and sweat. Ethylmalonic aciduria is a common finding in this condition. Severe cases can lead to developmental delay, seizures, and even death in infancy or childhood.

 +3. Metabolic Disorder: Methylmalonic Acidemia
   - Symptoms: Vomiting, Ethylmalonic aciduria, Decreased 3-hydroxyacyl-CoA dehydrogenase level
   - Description: This condition is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme involved in the metabolism of certain amino acids and odd-chain fatty acids. Patients may experience vomiting, metabolic acidosis, and a characteristic odor of their urine and sweat. Ethylmalonic aciduria is a common finding in this condition. Severe cases can lead to developmental delay, seizures, and even death in infancy or childhood.

 +4. Metabolic Disorder: Glutaric Acidemia Type I
   - Symptoms: Vomiting, Decreased 3-hydroxyacyl-CoA dehydrogenase level
   - Description: This condition is caused by a deficiency of glutaryl-CoA dehydrogenase, an enzyme involved in the metabolism of the amino acid l-tryptophan and certain other compounds. Patients may experience vomiting, metabolic acidosis, and neurological symptoms such as lethargy, hypotonia, and seizures. Severe cases can lead to developmental delay and even death in infancy or childhood.

 +5. Metabolic Disorder: Maple Syrup Urine Disease
   - Symptoms: Vomiting, Decreased 3-hydroxyacyl-CoA dehydrogenase level
   - Description: This condition is caused by a deficiency of branched-chain ketoacid dehydrogenase complex, an enzyme involved in the metabolism of the amino acids leucine, isoleucine, and valine. Patients may experience vomiting, metabolic acidosis, and a characteristic sweet smell of their urine, which resembles maple syrup. Severe cases can lead to development"
['Smith-Lemli-Opitz syndrome']," +1. Down syndrome: Low-set ears, flat facial profile, short neck, Brushfield spots (not Syndactyly, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties

+2. Smith-Lemli-Opitz syndrome: Intellectual disability, Motor delay, Generalized hypotonia, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration (Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Neonatal death, Feeding difficulties are not typical)

+3. Cornelia de Lange syndrome: Intellectual disability, Motor delay, Generalized hypotonia, Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis (Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Neonatal death, Feeding difficulties are not typical)

+4. Turner syndrome: Short stature, Wide nasal bridge, Low-set ears, Webbed neck, Shield chest, Ptosis, Intellectual disability (Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Neonatal death, Feeding difficulties are not typical)

+5. Prader-Willi syndrome: Intellectual disability, Motor delay, Hypotonia, Feeding difficulties (Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Neonatal death are not typical)

+6. Fetal Alcohol Spectrum Disorders: Intellectual disability, Motor delay, Feeding difficulties (Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Neonatal death are not typical)

+7. Creutzfeldt-Jakob disease: Neonatal death, Intellectual disability, Motor delay, Generalized hypotonia (Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Feeding difficulties are not typical)

+8. Mucopolysaccharidosis: Intellectual disability, Motor delay, Generalized hypotonia, Coarse facies, Joint stiffness, Hepatosplenomegaly (Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Neonatal death, Feeding difficulties are not typical)
"
['L-2-hydroxyglutaric aciduria']," +1. Leigh Syndrome: Intellectual disability, Ataxia, Tremor, Cerebral atrophy, Neonatal death, Neonatal seizures, Respiratory failure, Vacuolations in the mitochondria of the brain and other organs.
+2. Wilson's Disease: Intellectual disability, Tremor, Cerebral atrophy, Kayser-Fleischer rings (yellowish-brown rings around the cornea), Liver cirrhosis, Hemolytic anemia.
+3. Krabbe Disease: Intellectual disability, Ataxia, Tremor, Demyelination, Seizures, Hypotonia, Jaundice, Deafness.
+4. Huntington's Disease: Intellectual disability, Tremor, Chorea (involuntary, rapid, jerky movements), Psychiatric symptoms, Dementia, Death in adulthood.
+5. Metachromatic Leukodystrophy: Intellectual disability, Ataxia, Tremor, Cerebral atrophy, Demyelination, Urinary tract infections, Constipation, Sphincter dysfunction.
+6. Pompe Disease: Intellectual disability, Tremor, Hypotonia, Cardiomegaly, Respiratory failure, Hearts sounds may be normal or have a systolic ejection murmur.
+7. Lysosomal Storage Disease, Type 2 (Hunter Syndrome): Intellectual disability, Coarse facies, Hepatosplenomegaly, Cardiomegaly, Arthritis, Death in childhood.
+8. L-2-hydroxyglutaric aciduria, non-ketotic (D-2-hydroxyglutaric aciduria): Intellective disability, Ataxia, Tremor, Seizures, Cerebral atrophy, Lactic acidosis, Hyperventilation, Hypotonia.

Note: The patient's symptoms suggest a neurodegenerative disorder with intellectual disability, ataxia, and tremor. The presence of cerebral atrophy and abnormal basal ganglia morphology further support this diagnosis. The absence of symptoms such as jaundice, liver cirrhosis, and deafness help to rule out certain specific disorders. However, a definitive diagnosis would require further testing, such as genetic testing or biochemical analysis of body fluids."
['3-hydroxy-3-methylglutaric aciduria']," +1. Metabolic Acidosis with Neonatal Onset (Metabolic Acidosis, Neonatal): The patient presents with metabolic acidosis and some symptoms such as irritability, seizures, and neonatal or childhood death. This condition may be caused by various metabolic disorders, including organic acidemias and other metabolic diseases.

+2. Maple Syrup Urine Disease (MSUD): The patient exhibits symptoms of metabolic acidosis, dicarboxylic aciduria, and an elevated urinary carboxylic acid level. This condition is characterized by an inability to metabolize certain amino acids, leading to the accumulation of toxic substances in the body.

+3. Leigh Syndrome: The patient shows symptoms of irritability, seizures, and developmental regression. Although metabolic acidosis and opisthotonus are not common in this condition, it is a neurodegenerative disorder that can cause hypotonia and may lead to death in infancy or childhood.

+4. Pompe Disease: The patient presents with hypotonia, muscle weakness, and metabolic acidosis. This condition is caused by a deficiency of the enzyme acid alpha-glucosidase, leading to the accumulation of glycogen in the lysosomes.

+5. Menkes Disease: The patient exhibits symptoms of hypotonia, seizures, and developmental delay. Although metabolic acidosis is not a common symptom, this condition is characterized by the deficiency of copper absorption and transport, leading to neurological and connective tissue abnormalities.

+6. Zellweger Syndrome: The patient shows symptoms of hypotonia, seizures, and developmental delay. Although metabolic acidosis is not a common symptom, this condition is a peroxisomal disorder that can lead to various neurological and developmental issues.

+7. Propionic Acidemia: The patient exhibits symptoms of metabolic acidosis, dicarboxylic aciduria, and an elevated urinary carboxylic acid level. This condition is caused by a deficiency in the enzyme propionyl-CoA carboxylase, leading to the accumulation of toxic substances in the body.

+8. Glutaric Acidemia Type I: The patient presents with symptoms of metabolic acidosis, dicarboxylic aciduria, and an elevated urinary carboxylic acid level. This condition is caused by a deficiency in the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of toxic substances in the body.

+9. Isovaleric Acidemia: The patient exhibits symptoms of metabolic acidosis, dicarboxylic aciduria, and an elevated urinary carboxylic acid level. This condition is caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase, leading to the accumulation of toxic substances in the body.

+10. Mitochondrial Disorders: The patient shows symptoms of hypotonia, seizures, and developmental delay. Although metabolic acidosis is not a common symptom, mitochondrial disorders can cause various neurological and metabolic issues."
['L-2-hydroxyglutaric aciduria']," +1. Atopic Dermatitis: Skin rash, obsolete Eczematoid dermatitis (note: not Seizure, Death in infancy, Fever, Elevated circulating C-reactive protein concentration, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+2. Seborrheic Dermatitis: Skin rash (note: not Eczematoid dermatitis, Seizure, Death in infancy, Fever, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+3. Psoriasis: Skin rash (note: not Eczematoid dermatitis, Seizure, Death in infancy, Fever, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+4. Allergic Contact Dermatitis: Skin rash (note: not Eczematoid dermatitis, Seizure, Death in infancy, Fever, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+5. Scarlet Fever: Fever, Skin rash (note: not Eczematoid dermatitis, Seizure, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+6. Meningitis: Fever, Seizure (note: not Eczematoid dermatitis, Skin rash, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+7. Sepsis: Fever, Seizure, Elevated circulating C-reactive protein concentration (note: not Eczematoid dermatitis, Skin rash, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased serum iron.)\
+8. Anemia: Decreased serum iron (note: not Eczematoid dermatitis, Skin rash, Seizure, Death in infancy, L-2-hydroxyglutaric aciduria, Fever.)\
+9. L-2-hydroxyglutaric Aciduria: L-2-hydroxyglutaric aciduria (note: not Eczematoid dermatitis, Skin rash, Seizure, Death in infancy, Fever, Decreased serum iron).\
+10. Sarcoidosis: Fever, Lung involvement (not Eczematoid dermatitis, Skin rash, Seizure, Death in infancy, Decreased serum iron, L-2-hydroxyglutaric aciduria)."
['X-linked hypophosphatemia']," +1. Rickets: A condition caused by deficiency of vitamin D or calcium, leading to softening and weakening of bones. Common symptoms: Hypophosphatemia, Abnormal limb bone morphology, Elevated circulating alkaline phosphatase concentration. Not common symptoms: Nephritis, Death in infancy, Abnormal circulating hormone concentration, Death in childhood.

+2. Hypophosphatasia: A rare inherited metabolic disorder caused by mutations in the ALPL gene, leading to impaired activity of alkaline phosphatase. Common symptoms: Hypophosphatemia, Abnormal circulating alkaline phosphatase concentration, Abnormal limb bone morphology. Not common symptoms: Nephritis, Death in infancy, Death in childhood.

+3. Hypophosphatemic rickets type 1 (X-linked): A form of rickets caused by mutations in the phosphate-regulating gene ENPP1. Common symptoms: Hypophosphatemia, Abnormal limb bone morphology, Elevated circulating alkaline phosphatase concentration. Not common symptoms: Nephritis, Death in infancy, Death in childhood.

+4. Vitamin D-dependent rickets type 1: A form of rickets caused by mutations in the vitamin D receptor gene. Common symptoms: Hypophosphatemia, Abnormal limb bone morphology, Elevated circulating alkaline phosphatase concentration. Not common symptoms: Nephritis, Death in infancy, Death in childhood.

+5. Renal osteodystrophy: A group of bone disorders caused by kidney disease. Common symptoms: Nephritis, Elevated circulating alkaline phosphatase concentration. Not common symptoms: Hypophosphatemia, Abnormal limb bone morphology, Abnormal circulating hormone concentration, Death in infancy, Death in childhood.

+6. Hypophosphatemic rickets type 2 (autosomal recessive): A form of rickets caused by mutations in the FGF23 gene. Common symptoms: Hypophosphatemia, Abnormal circulating alkaline phosphatase concentration, Elevated circulating FGF23 concentration. Not common symptoms: Nephritis, Death in infancy, Death in childhood.

+7. X-linked hypophosphatemic rickets: A form of rickets caused by mutations in the PHEX gene. Common symptoms: Hypophosphatemia, Abnormal circulating alkaline phosphatase concentration, Elevated circulating FGF23 concentration. Not common symptoms: Nephritis, Death in infancy, Death in childhood.

+8. Vitamin D-dependent rickets type 2: A form of rickets caused by mutations in the 1,25(OH)2D3 gene. Common symptoms: Hypophosphatemia, Abnormal limb bone morphology, Elevated circulating alkaline phosphatase concentration. Not common symptoms: Nephritis, Death in infancy, Death in childhood.

+9. X-linked hypophosphatemic rickets with hypercalciuria: A form of rickets caused by mutations in the DMP1 gene. Common symptoms: Hypophosphatemia, Abnormal limb bone morphology, Elevated circulating alkaline phosphatase concentration, Hypercalciuria. Not common symptoms: Nephritis, Death in infancy"
['Propionic acidemia']," +1. Metabolic Disorder - Methylmalonic Acidemia: Delayed speech and language development, Elevated circulating alkaline phosphatase concentration, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid.
+2. Metabolic Disorder - Maple Syrup Urine Disease: Delayed speech and language development, Skin rash (obsolete Eczematoid dermatitis), Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating alanine concentration, Abnormal circulating serine concentration.
+3. Inborn Error of Metabolism - Pompe Disease: Delayed speech and language development, Death in infancy, Elevated circulating alkaline phosphatase concentration.
+4. Metabolic Disorder - Urea Cycle Disorder: Delayed speech and language development, Hyperammonemia, Death in infancy, Death in childhood.
+5. Metabolic Disorder - Organic Acidemia: Delayed speech and language development, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid.
+6. Metabolic Disorder - Citrullinemia: Delayed speech and language development, Hyperammonemia, Death in infancy.
+7. Metabolic Disorder - Propionic Acidemia: Delayed speech and language development, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid.
+8. Metabolic Disorder - Maple Syrup Urine Disease Type 2: Delayed speech and language development, Skin rash (obsolete Eczematoid dermatitis), Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating alanine concentration, Abnormal circulating serine concentration.
+9. Metabolic Disorder - Isovaleric Acidemia: Delayed speech and language development, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid.
+10. Metabolic Disorder - Glutaric Acidemia Type 1: Delayed speech and language development, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid.
+11. Metabolic Disorder - Glutaric Acidemia Type 2: Delayed speech and language development, Hyperammonemia, Hyperglycinemia, Hypergly"
"['Methylmalonic acidemia with homocystinuria, type cblC']"," +1. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-1,4-glucosidase, leading to glycogen accumulation in various tissues. Symptoms: Delayed speech and language development, Generalized hypotonia, Neonatal death, and Decreased plasma free carnitine.

+2. Krabbe Disease: A demyelinating disorder caused by the deficiency of galactocerebrosidase, leading to the accumulation of galactosylsphingosine (psychosine) in the central nervous system. Symptoms: Delayed speech and language development, Generalized hypotonia, and Abnormal cerebral white matter morphology.

+3. Canavan Disease: A metabolic disorder caused by the deficiency of N-acetylaspartic acid aminotransferase, leading to the accumulation of N-acetylaspartate in the brain. Symptoms: Delayed speech and language development, Generalized hypotonia, and Abnormal cerebral white matter morphology.

+4. Mitochondrial Disorders: A group of metabolic disorders caused by mutations in mitochondrial DNA or nuclear genes encoding mitochondrial proteins. Symptoms: Delayed speech and language development, Generalized hypotonia, Neonatal death, and Gastrointestinal inflammation.

+5. Maple Syrup Urine Disease: A metabolic disorder caused by a deficiency of the branched-chain ketoacid dehydrogenase complex, leading to the accumulation of branched-chain amino acids in the blood and urine. Symptoms: Delayed speech and language development, Generalized hypotonia, and Methylmalonic aciduria.

+6. Zellweger Syndrome: A peroxisomal disorder caused by a deficiency of multiple peroxisomal proteins, leading to the accumulation of very long-chain fatty acids and other metabolites in various tissues. Symptoms: Delayed speech and language development, Generalized hypotonia, Neonatal death, and Abnormal cerebral white matter morphology.

+7. Menkes Disease: A copper transport disorder caused by mutations in the ATP7A gene, leading to the deficiency of copper in various tissues. Symptoms: Delayed speech and language development, Generalized hypotonia, and Neonatal death.

+8. Smith-Lemli-Opitz Syndrome: A cholesterol biosynthesis disorder caused by a deficiency of 3β-hydroxysterol-Δ7-reductase, leading to the accumulation of 7-dehydrocholesterol in the blood and tissues. Symptoms: Delayed speech and language development, Generalized hypotonia, and Abnormal cerebral white matter morphology.

+9. Usher Syndrome: A group of genetic disorders causing progressive hearing loss and vision loss, often with additional symptoms such as vestibular dysfunction and ataxia. Symptoms: Delayed speech and language development, but no Generalized hypotonia, Neonatal death, Hyperhomocystinemia, Neonatal death, Gastrointestinal inflammation, Decreased plasma free carnitine, or Methylmalonic aciduria.

+10. Fragile X Syndrome: A genetic"
['Biotinidase deficiency']," +1. Metabolic Disorder (Inherited Metabolic Diseases): The patient's symptoms of Neonatal death and Elevated urinary carboxylic acid are common in various inherited metabolic disorders. These conditions can result from a deficiency or dysfunction of specific enzymes or proteins involved in metabolic processes. The symptom of Death in infancy is also common in many inherited metabolic disorders.

+2. Reye Syndrome: This condition is characterized by Neonatal death, Elevated urinary carboxylic acid (specifically, elevated levels of organic acids in the urine), and other symptoms such as vomiting, lethargy, and brain swelling.

+3. Propionic Acidemia: This is an inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms include Neonatal death, Elevated urinary carboxylic acid (specifically, propionic acid), and other symptoms such as vomiting, lethargy, and seizures.

+4. Methylmalonic Acidemia: This is another inherited metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms include Neonatal death, Elevated urinary carboxylic acid (specifically, methylmalonic acid), and other symptoms such as vomiting, lethargy, and developmental delay.

+5. Isovaleric Acidemia: This is an inherited metabolic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms include Neonatal death, Elevated urinary carboxylic acid (specifically, isovaleric acid), and other symptoms such as vomiting, lethargy, and developmental delay.

+6. Glutaric Acidemia Type I: This is an inherited metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms include Neonatal death, Elevated urinary carboxylic acid (specifically, glutaric acid), and other symptoms such as vomiting, lethargy, and seizures.

+7. Maple Syrup Urine Disease: This is an inherited metabolic disorder caused by a deficiency of the enzymes that break down the branched-chain amino acids leucine, isoleucine, and valine. Symptoms include Neonatal death, Elevated urinary carboxylic acid (specifically, branched-chain organic acids), and other symptoms such as vomiting, lethargy, and seizures.

+8. Urea Cycle Disorders: These are a group of inherited metabolic disorders caused by a deficiency of enzymes involved in the urea cycle. Symptoms include Neonatal death, Elevated urinary carboxylic acid (specifically, ammonia), and other symptoms such as vomiting, lethargy, and seizures.

+9. Organic Acidemia: This is a broad category of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms include Neonatal death, Elevated urinary carboxylic acid (various organic acids), and other symptoms such as vomiting, lethargy, and developmental delay.

+10. Sepsis"
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. Metabolic Disorders (e.g., Urea Cycle Disorders): Lethargy, Hyperreflexia, Hypotonia, Hyperammonemia, Neonatal death, Feeding difficulties.
+2. Cerebral Palsy: Lethargy, Spasticity, Generalized hypotonia, Hyperreflexia.
+3. Meningoencephalitis: Lethargy, Drowsiness, Fever, Neurological signs (including hyperreflexia), Sleep abnormality.
+4. Mitochondrial Disorders: Lethargy, Hypotonia, Feeding difficulties.
+5. Hypothyroidism: Lethargy, Drowsiness, Hypotonia.
+6. Seizure Disorders: Lethargy, Hyperreflexia, Seizures (not mentioned in symptoms).
+7. Muscular Dystrophies: Lethargy, Hypotonia, Muscle weakness (not mentioned in symptoms).
+8. Brain Injury: Lethargy, Drowsiness, Neurological signs (including hyperreflexia), Sleep abnormality.
+9. Spinal Cord Injury: Lethargy, Hypotonia, Hyperreflexia (below the level of injury).
+10. Toxic Encephalopathy: Lethargy, Drowsiness, Neurological signs (including hyperreflexia), Hyperammonemia.
+11. Inborn Errors of Metabolism (other than Urea Cycle Disorders): Lethargy, Hypotonia, Feeding difficulties, Developmental delay (not mentioned in symptoms).
+12. Hepatic Encephalopathy: Lethargy, Drowsiness, Confusion, Hyperreflexia, Sleep abnormality.
+13. Sepsis: Lethargy, Fever, Drowsiness, Neurological signs (including hyperreflexia), Sleep abnormality.
+14. Hydrocephalus: Lethargy, Drowsiness, Hypotonia, Hyperreflexia, Sleep abnormality.
+15. Krabbe Disease: Lethargy, Hypotonia, Hyperreflexia, Developmental delay, Feeding difficulties.
+16. Rett Syndrome: Lethargy, Hypotonia, Feeding difficulties, Breathing abnormalities (not mentioned in symptoms).
+17. Down Syndrome: Lethargy, Hypotonia, Hyperreflexia, Developmental delay, Feeding difficulties.
+18. Prader-Willi Syndrome: Lethargy, Hypotonia, Feeding difficulties, Obesity (not mentioned in symptoms).
+19. Arnold-Chiari Malformation: Lethargy, Drowsiness, Hypotonia, Hyperreflexia, Sleep abnormality, Neurological signs.
+20. Wilson Disease: Lethargy, Drowsiness, Hypotonia, Speech difficulties, Kayser-Fleischer rings (not mentioned in symptoms)."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic Acidemia (MMA): This is an inherited metabolic disorder caused by a deficiency of methylmalonic acid (MMA) mutase enzyme. Patients with MMA present with symptoms such as metabolic acidosis, decreased methylmalonyl-CoA mutase activity, and can present with symptoms of metabolic crisis leading to death in infancy or childhood.

+2. Propionic Acidemia: This is another inherited metabolic disorder caused by a deficiency of propionyl-CoA carboxylase enzyme. Patients with propionic acidemia can present with symptoms such as metabolic acidosis, decreased methylmalonyl-CoA mutase activity, and can present with symptoms of metabolic crisis leading to death in infancy or childhood. However, they typically do not present with death in infancy as a primary symptom.

+3. Maple Syrup Urine Disease (MSUD): This is an inherited metabolic disorder caused by a deficiency of the branched-chain ketoacid dehydrogenase complex. Patients with MSUD can present with symptoms such as metabolic acidosis, but they do not typically present with decreased methylmalonyl-CoA mutase activity or death in infancy or childhood as primary symptoms. Instead, they typically present with a characteristic sweet urine odor, irritability, and developmental delay.

+4. Organic Acidemia: This is a broad category of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Patients with organic acidemia can present with symptoms such as metabolic acidosis, but the specific symptoms and underlying causes can vary widely. Some forms of organic acidemia may present with decreased methylmalonyl-CoA mutase activity and death in infancy or childhood, while others may not.

+5. Reye Syndrome: This is a rare but serious condition that can cause metabolic acidosis, liver damage, and brain swelling. It is typically associated with the use of aspirin in children with viral infections. Patients with Reye syndrome do not typically present with decreased methylmalonyl-CoA mutase activity or death in infancy or childhood as primary symptoms. Instead, they typically present with symptoms such as vomiting, lethargy, and confusion."
[]," +1. Sickle Cell Anemia: A genetic disorder causing the production of abnormal hemoglobin, leading to red blood cell sickling, hemolytic anemia, and recurrent viral infections. Common symptoms: Hemolytic anemia, increased total bilirubin, increased circulating lactate dehydrogenase concentration. Not common: Hyperactivity, Spasticity, Death in infancy, Neonatal death, Abnormal circulating porphyrin concentration.

+2. Menkes Disease: A genetic disorder causing copper deficiency, leading to neurological symptoms, growth retardation, and premature aging. Common symptoms: None. Not common: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased total bilirubin.

+3. Krabbe Disease: A genetic disorder causing the destruction of myelin sheaths in the central and peripheral nervous system, leading to neurological symptoms and demyelination. Common symptoms: None. Not common: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased total bilirubin.

+4. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase, leading to glycogen accumulation and progressive muscle weakness. Common symptoms: None. Not common: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased total bilirubin.

+5. Mitochondrial Disorders: A group of genetic disorders affecting the mitochondria, leading to energy production deficiencies and various symptoms. Common symptoms: Metabolic acidosis. Not common: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased total bilirubin.

+6. Wilson Disease: A genetic disorder causing copper accumulation in the liver and brain, leading to liver damage, neurological symptoms, and psychiatric disorders. Common symptoms: None. Not common: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased total bilirubin.

+7. Gaucher Disease: A lysosomal storage disorder caused by a deficiency of glucocerebrosidase, leading to the accumulation of glucocerebroside in various tissues. Common symptoms: None. Not common: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased total bilirubin.

+8. Hurler Syndrome: A lysosomal storage disorder caused by a deficiency of iduronidase, leading to the accumulation of glycos"
['Neonatal intrahepatic cholestasis due to citrin deficiency']," +1. Urea Cycle Disorders: This group of metabolic disorders impairs the normal processing of ammonia in the body. Common symptoms include Hyperammonemia, Apnea, and Neonatal death. The patient does not have Death in infancy or Premature birth symptoms associated with this condition.

+2. Respiratory Distress Syndrome (RDS): A lung condition that affects newborns, causing difficulty breathing and respiratory distress. Common symptoms include Respiratory distress, Apnea, and Hypoxemia. The patient does not have Hyperammonemia, Respiratory acidosis, or Elevated plasma citrulline associated with this condition.

+3. Sepsis: A life-threatening condition caused by the body's response to an infection. Common symptoms include Apnea, Respiratory distress, and Neonatal death. The patient does not have Hyperammonemia, Premature birth, or Elevated plasma citrulline associated with this condition.

+4. Methemoglobinemia: A condition where the oxygen-carrying capacity of blood is reduced due to the presence of methemoglobin. Common symptoms include Blue baby syndrome (cyanosis), Apnea, and Hypoxemia. The patient does not have Hyperammonemia, Premature birth, Respiratory acidosis, or Elevated plasma citrulline associated with this condition.

+5. Congenital Diaphragmatic Hernia: A birth defect where the diaphragm does not form properly, leading to breathing difficulties. Common symptoms include Respiratory distress, Apnea, and Hypoxemia. The patient does not have Hyperammonemia, Premature birth, or Elevated plasma citrulline associated with this condition.

+6. Meconium Aspiration Syndrome: A condition where meconium (the first stool of a newborn) is inhaled during birth, leading to respiratory distress. Common symptoms include Respiratory distress, Apnea, and Hypoxemia. The patient does not have Hyperammonemia, Premature birth, or Elevated plasma citrulline associated with this condition.

+7. Persistent Pulmonary Hypertension of the Newborn (PPHN): A condition where the blood pressure in the lungs remains high after birth, making it difficult for the baby to breathe. Common symptoms include Respiratory distress, Apnea, and Hypoxemia. The patient does not have Hyperammonemia, Premature birth, or Elevated plasma citrulline associated with this condition.

+8. Sudden Infant Death Syndrome (SIDS): The unexplained death of an apparently healthy infant, often during sleep. Common symptoms include Neonatal death. The patient does not have Hyperammonemia, Premature birth, Respiratory distress, Apnea, Respiratory acidosis, Hypoxemia, or Elevated plasma citrulline associated with this condition.

+9. Congenital Heart Disease: A group of heart defects present at birth, which can lead to breathing difficulties and other health issues. Common symptoms include Respiratory distress, Apnea, and Hypoxemia. The patient does not have Hyperammonemia, Premature birth, or Elevated plasma citrulline associated with this condition."
[]," +1. Intellectual disability, Autistic behavior, Clumsiness, Poor coordination: This set of symptoms could suggest a neurodevelopmental disorder such as Down syndrome or Fragile X syndrome. These conditions are characterized by intellectual disability, autistic behavior, and motor coordination issues. However, hypertension, edema, seizure, coma, pancreatitis, leukopenia, anemia, acute kidney injury, hyperammonemia, gout, vomiting, hyperuricemia, increased circulating lactate concentration, hyperglycinemia, kyphoscoliosis, hyponatremia, methylmalonic acidemia, hypoproteinemia, short femur, increased blood urea nitrogen, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, and elevated circulating creatinine concentration are not typically associated with neurodevelopmental disorders.

+2. Hypertension, Edema, Acute kidney injury, Increased circulating creatinine concentration, Chronic kidney disease: These symptoms suggest a kidney disorder, such as nephrotic syndrome or glomerulonephritis. These conditions can cause hypertension, edema, acute kidney injury, and chronic kidney disease. However, intellectual disability, autistic behavior, clumsiness, poor coordination, seizure, coma, pancreatitis, leukopenia, anemia, hyperammonemia, gout, vomiting, hyperuricemia, increased circulating lactate concentration, hyperglycinemia, kyphoscoliosis, hyponatremia, methylmalonic acidemia, hypoproteinemia, short femur, increased blood urea nitrogen, and abnormal circulating porphyrin concentration are not typically associated with kidney disorders.

+3. Seizure, Coma: These symptoms could suggest a neurological condition such as epilepsy or meningitis. However, intellectual disability, autistic behavior, clumsiness, poor coordination, hypertension, edema, pancreatitis, leukopenia, anemia, acute kidney injury, hyperammonemia, gout, vomiting, hyperuricemia, increased circulating lactate concentration, hyperglycinemia, kyphoscoliosis, hyponatremia, methylmalonic acidemia, hypoproteinemia, short femur, increased blood urea nitrogen, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, and abnormal circulating aspartate family amino acid concentration are not typically associated with seizure or coma.

+4. Pancreatitis, Vomiting, Hyperuricemia, Gout: These symptoms suggest a pancreatic disorder, such as pancreatitis or pancreatic cancer. However, intellectual disability, autistic behavior, clumsiness, poor coordination, hypertension, edema, seizure, coma, acute kidney injury, anemia, hyperammonemia, leukopenia, kyphoscoliosis, hyponatremia, methylmalonic acidemia, hypoproteinemia, short femur, increased blood urea nitrogen, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, and abnormal circulating creatinine concentration are not typically associated with"
['Dihydropteridine reductase deficiency']," +1. Metachromatic Leukodystrophy: A lysosomal storage disorder causing progressive degeneration of the central and peripheral nervous system. Common symptoms include intellectual disability, motor delay, cerebral atrophy, and abnormal cerebral white matter morphology. +2. Krabbe Disease: A lysosomal storage disorder characterized by demyelination of the central and peripheral nervous system. Common symptoms include intellectual disability, motor delay, seizures, and cerebral atrophy. +3. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase, leading to glycogen accumulation in various tissues. Common symptoms include intellectual disability, motor delay, hypotonia, and death in infancy or childhood. +4. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. Common symptoms include intellectual disability, motor delay, and characteristic facial features. +5. Fragile X Syndrome: A genetic disorder caused by a mutation in the FMR1 gene, leading to intellectual disability, motor delay, and characteristic physical features. +6. Prader-Willi Syndrome: A genetic disorder caused by deletion or mutation of genes on chromosome 15, leading to intellectual disability, motor delay, hypotonia, and excessive appetite. +7. Tay-Sachs Disease: A lysosomal storage disorder caused by a deficiency of hexosaminidase A, leading to progressive degeneration of the central nervous system. Common symptoms include intellectual disability, motor delay, seizures, and death in infancy or childhood. +8. Canavan Disease: A lysosomal storage disorder caused by a deficiency of aspartoacylase, leading to the accumulation of N-acetylaspartic acid in the brain. Common symptoms include intellectual disability, motor delay, hypotonia, and cerebral atrophy. +9. Mucopolysaccharidosis Type I: A lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, leading to the accumulation of glycosaminoglycans in various tissues. Common symptoms include intellectual disability, motor delay, coarse facial features, and hepatosplenomegaly. +10. Fanconi Anemia: A genetic disorder affecting the bone marrow, leading to anemia, leukopenia, and thrombocytopenia. Common symptoms do not include microcephaly, nystagmus, or alopecia."
[]," +1. Erythroderma: Skin rash, erythematous plaque, erythematous papule, erythematous macule (+)
- Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract (--)

+2. Atopic Dermatitis: Skin rash, erythematous plaque, erythematous papule, erythematous macule (+)
- Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract (--)

+3. Celiac Disease: Functional abnormality of the gastrointestinal tract, Feeding difficulties (+)
- Skin rash, Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule (--)

+4. Cystic Fibrosis: Functional abnormality of the gastrointestinal tract, Feeding difficulties (+)
- Skin rash, Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule (--)

+5. Phenylketonuria: Glycosuria, Abnormal circulating glycine concentration (+)
- Skin rash, Death in infancy, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Feeding difficulties, Functional abnormality of the gastrointestinal tract, Erythematous plaque, Erythematous macule, Erythematous papule (--)

+6. Erythropoietic Protoporphyria: Skin rash, erythematous plaque, erythematous papule (+)
- Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract (--)

+7. Hemangioma: Skin rash, erythematous papule (+)
- Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract, Erythematous plaque, Erythematous macule (--)

+8. Type 1 Diabetes Mellitus: Glycosuria (+)
- Skin rash, Death in infancy, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glyc"
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. Metabolic Disorder: Urea Cycle Disorder (UCD): Cyanosis, Seizure, Neonatal death, Hyperammonemia, Cerebral edema. +2. Neurological Disorder: Epilepsy: Seizure. +3. Cardiovascular Disorder: Cyánosis. +4. Metabolic Disorder: Orotic Aciduria: Oroticaciduria. +5. Neurological Disorder: Motor Neuron Disease: Fasciculations. +6. Metabolic Disorder: Arginine Deficiency: Hypoargininemia. +7. Metabolic Disorder: Citrullinemia: Low plasma citrulline.

Note: Cyanosis is a symptom that can be associated with various conditions, including cardiovascular and metabolic disorders. In this case, it is included in the descriptions of both a cardiovascular disorder and a metabolic disorder. The patient's specific diagnosis would depend on a thorough evaluation by a healthcare professional, including medical history, physical examination, and diagnostic tests."
['Canavan disease']," +1. Phenylketonuria (PKU): A genetic disorder caused by the lack of an enzyme needed to break down phenylalanine, leading to its accumulation in the body. Symptoms include: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule, Neonatal death, and Abnormal circulating amino acid concentration (phenylalanine). +2. Maple Syrup Urine Disease (MSUD): An inherited metabolic disorder caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase complex. Symptoms include: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, Hyperammonemia, and Seizure. +3. Toxic epidermal necrolysis (TEN): A severe, life-threatening condition characterized by widespread skin detachment and mucous membrane involvement. Symptoms include: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule, and Death in infancy (rare in adults). +4. Reye's Syndrome: A rare, serious condition that affects the brain and liver, often following a viral infection. Symptoms include: Seizure, Neonatal death, and Abnormal circulating ammonia concentration. +5. Menkes Disease: A rare, X-linked genetic disorder characterized by the impaired absorption and utilization of copper. Symptoms include: Neonatal death and Seizure. +6. Homocystinuria: An inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms include: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, and Erythematous plaque (rare). +7. Ataxia-telangiectasia: A rare, progressive genetic disorder characterized by cerebellar ataxia, telangiectasias, and increased susceptibility to infections. Symptoms include: Neonatal death (rare), Seizure, and Skin rash (rare)."
['Maple syrup urine disease']," +1. Epilepsy: Seizures, Feeding difficulties.
+2. Sudden Infant Death Syndrome (SIDS): Death in infancy, Neonatal death.
+3. Cystic Fibrosis: Respiratory insufficiency, Feeding difficulties.
+4. Reye's Syndrome: Seizures, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia.
+5. Meningitis: Seizures, Sepsis.
+6. Metabolic Disorder (Maple Syrup Urine Disease): Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia.
+7. Sepsis: Sepsis.

Please note that the given symptoms are not specific to any single disease and could be indicative of various conditions. A proper diagnosis would require further testing and evaluation by a healthcare professional."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorders (specifically, Inherited Metabolic Disorders): Patients with this condition may exhibit various symptoms including Abnormality of prenatal development or birth, Neonatal death, and Death in infancy. Some metabolic disorders, such as Carnitine Deficiency, can present with Abnormal circulating carnitine concentration. However, Obesity is not a common symptom for most metabolic disorders.

+2. Zellweger Spectrum Disorders: This is a group of peroxisomal disorders characterized by Abnormality of prenatal development or birth, Neonatal death, and Decreased 3-hydroxyacyl-CoA dehydrogenase level. Obesity is not a symptom of Zellweger Spectrum Disorders.

+3. Lysosomal Storage Disorders: Patients with Lysosomal Storage Disorders may exhibit Abnormality of prenatal development or birth, Neonatal death, and Death in infancy or childhood. Some lysosomal storage disorders, such as Pompe Disease, can present with decreased 3-hydroxyacyl-CoA dehydrogenase level. Obesity is not a common symptom for most lysosomal storage disorders.

+4. Organic Acidemias: Patients with Organic Acidemias may exhibit Abnormality of prenatal development or birth, Neonatal death, and Death in infancy or childhood. Some organic acidemias, such as Propionic Acidemia, can present with decreased 3-hydroxyacyl-CoA dehydrogenase level. Obesity is not a common symptom for most organic acidemias.

+5. Mitochondrial Disorders: Patients with Mitochondrial Disorders may exhibit Abnormality of prenatal development or birth, Neonatal death, and Death in infancy or childhood. Some mitochondrial disorders, such as Leigh Syndrome, can present with decreased 3-hydroxyacyl-CoA dehydrogenase level. Obesity is not a common symptom for most mitochondrial disorders.

+6. Peroxisome Biogenesis Disorders: Patients with Peroxisome Biogenesis Disorders may exhibit Abnormality of prenatal development or birth, Neonatal death, and Decreased 3-hydroxyacyl-CoA dehydrogenase level. Obesity is not a common symptom for most Peroxisome Biogenesis Disorders.

+7. Fatty Acid Oxidation Disorders: Patients with Fatty Acid Oxidation Disorders may exhibit Abnormality of prenatal development or birth, Neonatal death, and Death in infancy or childhood. Some fatty acid oxidation disorders, such as Carnitine Palmitoyltransferase Deficiency, can present with Abnormal circulating carnitine concentration. Obesity is not a common symptom for most fatty acid oxidation disorders.

+8. Urea Cycle Disorders: Patients with Urea Cycle Disorders may exhibit Neonatal death, Death in infancy, and Death in childhood. Urea Cycle Disorders do not typically present with Abnormality of prenatal development or birth, Abnormal circulating carnitine concentration, or Decreased 3-hydroxyacyl-CoA dehydrogenase level. Obesity is not a common symptom for most Urea Cycle Disorders."
['Phenylketonuria']," +1. Intellectual Disability and Seizure Disorder: This condition is characterized by a significant limitation in intellectual functioning and in skills such as communicating, caring for oneself, and social skills. Seizures are also a common symptom. The patient's intellectual disability and seizure are symptoms that match this condition.

+2. Metachromatic Leukodystrophy: This is a lysosomal storage disorder caused by a deficiency of arylsulfatase A. It results in the accumulation of sulfatides in the central and peripheral nervous system, leading to intellectual disability, motor delay, and seizures. The patient's symptoms of intellectual disability, motor delay, and seizure are consistent with this condition.

+3. Krabbe Disease: This is a demyelinating disorder caused by a deficiency of galactocerebrosidase. It results in the accumulation of galactosylsphingosine in the central and peripheral nervous system, leading to intellectual disability, motor delay, and seizures. The patient's symptoms of intellectual disability, motor delay, and seizure are consistent with this condition.

+4. Canavan Disease: This is a metabolic disorder caused by a deficiency of N-acetylaspartate-acyltransferase. It results in the accumulation of N-acetylaspartic acid in the brain, leading to intellectual disability, seizures, and motor delay. The patient's symptoms of intellectual disability, seizure, and motor delay are consistent with this condition.

+5. Pompe Disease: This is a lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase. It results in the accumulation of glycogen in the lysosomes, leading to intellectual disability, motor delay, and cardiomyopathy. The patient's symptoms of intellectual disability and motor delay are consistent with this condition, but they do not report cardiomyopathy.

+6. Huntington's Disease: This is a progressive neurological disorder caused by a mutation in the HTT gene. It results in the degeneration of neurons in the basal ganglia, leading to intellectual disability, motor dysfunction, and chorea (dyskinesia). The patient's symptoms of intellectual disability and dyskinesia are consistent with this condition, but they do not report seizure or motor delay.

+7. Wilson's Disease: This is a metabolic disorder caused by a deficiency of ceruloplasmin, leading to copper accumulation in the liver, brain, and other organs. It can result in intellectual disability, seizures, and motor dysfunction. The patient's symptoms of intellectual disability, seizure, and motor delay are consistent with this condition, but they do not report death in infancy, childhood, or early adulthood.

+8. Rett Syndrome: This is a neurodevelopmental disorder caused by mutations in the MECP2 gene. It results in the degeneration of neurons in the brain, leading to intellectual disability, seizures, and motor dysfunction. The patient's symptoms of intellectual disability, seizure, and motor delay are consistent with this condition, but they do not report death in infancy, childhood, or early adulthood, or abnormal cerebral white matter morphology.

+9. Fragile X Syndrome: This is a genetic disorder caused by a mutation in the FMR1 gene. It results in intellectual disability, seizures, and motor dysfunction, as well as physical features such as a long face, prominent"
['Wilson disease']," +1. Wilson's Disease: Generalized hypotonia, Splenomegaly, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Copper accumulation in liver.
+2. Hemochromatosis: Generalized hypotonia (rare), Splenomegaly (occasionally), Hepatomegaly (occasionally), Elevated circulating hepatic transaminase concentration (occasionally), Decreased circulating ceruloplasmin concentration (not related), Increased urinary copper concentration (not related), Abnormal circulating aspartate family amino acid concentration (not related), Abnormal circulating alanine concentration (not related), Death in childhood/adolescence (not related), Decreased circulating copper concentration (not related), Copper accumulation in liver (not related).
+3. Muscular Dystrophies: Generalized hypotonia, Decrease in circulating ceruloplasmin concentration (not related), Increased urinary copper concentration (not related), Abnormal circulating aspartate family amino acid concentration (not related), Abnormal circulating alanine concentration (not related), Death in childhood/adolescence (not related), Copper accumulation in liver (not related).
+4. Niemann-Pick Disease: Generalized hypotonia, Splenomegaly, Hepatomegaly, Elevated circulating hepatic transaminase concentration (not related), Decreased circulating ceruloplasmin concentration (not related), Increased urinary copper concentration (not related), Abnormal circulating aspartate family amino acid concentration (not related), Abnormal circulating alanine concentration (not related), Death in childhood (not related), Decreased circulating copper concentration (not related), Copper accumulation in liver (not related, but accumulation of different substances).
+5. Alpha-1 Antitrypsin Deficiency: Generalized hypotonia (rare), Splenomegaly (occasionally), Hepatomegaly (occasionally), Elevated circulating hepatic transaminase concentration (occasionally), Decreased circulating ceruloplasmin concentration (not related), Increased urinary copper concentration (not related), Abnormal circulating aspartate family amino acid concentration (not related), Abnormal circulating alanine concentration (not related), Death in childhood/adolescence (not related), Decreased circulating copper concentration (not related), Copper accumulation in liver (not related)."
['PMM2-CDG']," +1. Albright's Hypopituitarism: Intellectual disability, Generalized hypotonia, Cerebellar atrophy, +Abnormal facial shape, +Abnormal calvaria morphology : This condition is characterized by pituitary gland dysfunction leading to hormonal deficiencies, intellectual disability, hypotonia, and characteristic facial features. Strabismus and cerebellar agenesis are not typically associated with this condition.

+2. Marfan Syndrome: Intellectual disability (rare), Ataxia, Cerebellar atrophy, +Generalized hypotonia, +Cerebellar agenesis, +Death in infancy (in severe cases), Abnormal facial shape (long face, dolichocephaly), +Abnormal calvaria morphology (dolichocephaly) : Marfan syndrome is a connective tissue disorder causing joint flexibility, tall stature, and cardiovascular and ocular issues. Intellectual disability, strabismus, and cerebellar agenesis are not common symptoms.

+3. Joubert Syndrome: Intellectual disability, Ataxia, Cerebellar atrophy, +Cerebellar agenesis, +Abnormal facial shape (midline defects), +Abnormal calvaria morphology (posterior fossa malformation) : Joubert syndrome is a genetic disorder characterized by cerebellar malformations, ataxia, intellectual disability, and characteristic facial features. Strabismus and death in infancy are not typical symptoms.

+4. Cornelia de Lange Syndrome: Intellectual disability, Generalized hypotonia, +Abnormal facial shape (distinctive facial features), +Abnormal calvaria morphology (microcephaly) : Cornelia de Lange syndrome is a genetic condition characterized by intellectual disability, growth deficiency, and distinctive facial features. Strabismus, cerebellar atrophy, cerebellar agenesis, ataxia, and death in infancy are not typical symptoms.

+5. Krabbe Disease: Intellectual disability, Generalized hypotonia, Cerebellar atrophy, +Abnormal calvaria morphology (enlarged head), +Death in infancy (early onset) : Krabbe disease is a metabolic disorder affecting the protective covering of nerve fibers. Intellectual disability, generalized hypotonia, cerebellar atrophy, strabismus, cerebellar agenesis, and abnormal facial shape are not typical symptoms."
['Phenylketonuria']," +1. Down syndrome: Abnormality of prenatal development or birth, various developmental delays and physical features, not directly related to Hypertyrosinemia or Hyperphenylalaninemia.
+2. Cystic fibrosis: Not directly related to Abnormality of prenatal development or birth, but can lead to Death in infancy or adolescence, and not related to Hypertyrosinemia or Hyperphenylalaninemia.
+3. Tay-Sachs disease: Neonatal death, not directly related to Abnormality of prenatal development or birth, Hypertyrosinemia is not a symptom, but Hyperphenylalaninemia is a symptom.
+4. Maple Syrup Urine Disease: Hyperphenylalaninemia, not directly related to Abnormality of prenatal development or birth, not related to Neonatal death or Death in adolescence.
+5. Hemochromatosis: Not directly related to Abnormality of prenatal development or birth, not related to Hypertyrosinemia or Hyperphenylalaninemia, not related to Neonatal death or Death in adolescence.
+6. Sickle cell anemia: Not directly related to Abnormality of prenatal development or birth, not related to Hypertyrosinemia, but can lead to Death in infancy or adolescence, not related to Hyperphenylalaninemia.
+7. Thalassemia: Not directly related to Abnormality of prenatal development or birth, not related to Hypertyrosinemia, not related to Neonatal death, but can lead to Death in adolescence, not related to Hyperphenylalaninemia.
+8. Phenylketonuria: Hyperphenylalaninemia, not directly related to Abnormality of prenatal development or birth, not related to Neonatal death or Death in adolescence.
+9. Tyrosinemia: Hypertyrosinemia, not directly related to Abnormality of prenatal development or birth, not related to Neonatal death or Death in adolescence.
+10. Gaucher disease: Not directly related to Abnormality of prenatal development or birth, not related to Hypertyrosinemia, not related to Hyperphenylalaninemia, not related to Neonatal death, but can lead to Death in adolescence."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Mucopolysaccharidosis Type I: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration +2. Hurler Syndrome: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration +3. Pompe Disease: Generalized hypotonia, Death in infancy +4. Ricketts: Hypercalcemia +5. Gaucher Disease: Macrocephaly, Generalized hypotonia, Abnormal circulating lysosomal enzymes +6. Krabbe Disease: Abnormal cerebral morphology, Death in infancy +7. Maple Syrup Urine Disease: Abnormal circulating amino acids (lysine, leucine, isoleucine), Abnormal circulating carnitine concentration +8. Glutaric Acidemia Type I: Abnormal circulating glutaric acid, Abnormal circulating lactate concentration +9. Carnitine Deficiency: Abnormal circulating carnitine concentration.

The patient presents with Macrocephaly, Generalized hypotonia, Abnormal cerebral morphology, Increased circulating lactate concentration, Hypercalcemia, and Abnormal circulating amino acids or carnitine. The diseases proposed are Mucopolysaccharidosis Type I, Hurler Syndrome, Pompe Disease, Ricketts, Gaucher Disease, Krabbe Disease, Maple Syrup Urine Disease, and Carnitine Deficiency. The patient does not present with Death in infancy for all proposed diseases, except for Mucopolysaccharidosis Type I, Hurler Syndrome, Pompe Disease, and Krabbe Disease. The patient does not present with Abnormal circulating glutaric acid for all proposed diseases, except for Glutaric Acidemia Type I."
['Phenylketonuria']," +1. Hemangioma NVD: A common benign vascular birth defect, not typically associated with prenatal abnormalities or death. +Symptoms in common: Abnormality of prenatal development or birth.
+2. Cystic Fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems, causing persistent lung infections and difficulty digesting food. +Symptoms in common: Death in childhood.
+3. Tay-Sachs Disease: A rare, inherited metabolic disorder causing progressive degeneration of the central nervous system, leading to blindness, deafness, and eventual death. +Symptoms in common: Neonatal death, Death in infancy.
+4. Sickle Cell Anemia: A genetic disorder causing the production of abnormal hemoglobin, leading to red blood cells that are crescent-shaped and prone to clumping, resulting in anemia and various complications. +Symptoms in common: Death in childhood.
+5. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21, leading to developmental delays, physical growth delays, and characteristic facial features. +Symptoms in common: Abnormality of prenatal development or birth.
+6. Phenylketonuria (PKU): A metabolic disorder caused by the inability to metabolize phenylalanine, leading to its accumulation in the body and causing intellectual disability, seizures, and other complications. +Symptoms in common: Hyperphenylalaninemia.
+7. Maple Syrup Urine Disease: A metabolic disorder caused by the inability to break down certain amino acids, leading to their accumulation in the body and causing neurological symptoms, including developmental delay, seizures, and coma. +Symptoms in common: Hyperammonemia, Hyperphenylalaninemia.
+8. Zellweger Syndrome: A rare, genetic disorder affecting the synthesis of certain proteins in the endoplasmic reticulum, leading to multiple organ dysfunctions and developmental delays. +Symptoms in common: Neonatal death.
+9. Krabbe Disease: A metabolic disorder caused by the inability to produce a myelin protein, leading to demyelination of nerve fibers and causing neurological symptoms, including developmental delay, seizures, and vision and hearing loss. +Symptoms in common: Neonatal death, Death in infancy.
+10. Gaucher Disease: A lysosomal storage disorder caused by the deficiency of the enzyme glucocerebrosidase, leading to the accumulation of glucocerebroside in various tissues and organs, causing hepatosplenomegaly, bone involvement, and neurological symptoms. +Symptoms in common: None of the given symptoms."
['Phenylketonuria']," +1. Mucopolysaccharidoses (MPS): Microcephaly, Abnormality of prenatal development or birth, Short stature, Neonatal death, Feeding difficulties, various skeletal and organ abnormalities. +2. Down syndrome: Microcephaly, Abnormality of prenatal development or birth, Small for gestational age, Severe short stature, Feeding difficulties, characteristic facial features. +3. Turner syndrome: Microcephaly, Short stature, Feeding difficulties, various developmental and growth abnormalities, but not: Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in childhood. +4. Trisomy 13 (Patau syndrome): Microcephaly, Abnormality of prenatal development or birth, Small for gestational age, Severe developmental abnormalities, Feeding difficulties, multiple congenital anomalies, but not: Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in childhood. +5. Congenital Adrenal Hyperplasia (CAH): Microcephaly (rare), Abnormality of prenatal development or birth, Small for gestational age (rare), Feeding difficulties (rare), Salt wasting, Hyperpigmentation, but not: Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in childhood. +6. Cystic Fibrosis: Microcephaly (rare), Abnormality of prenatal development or birth (rare), Small for gestational age (rare), Feeding difficulties (rare), Persistent lung infections, Salty sweat, but not: Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in childhood. +7. Inborn Errors of Metabolism (IEM): Microcephaly (varies), Abnormality of prenatal development or birth (varies), Small for gestational age (varies), Feeding difficulties (varies), Developmental delay, Seizures, but not: Pericardial effusion (except for some IEMs), Pleural effusion (except for some IEMs), Hypertyrosinemia (except for some IEMs), Hyperphenylalaninemia (except for some IEMs), Neonatal death (varies), Death in childhood (varies)."
['Ornithine transcarbamylase deficiency']," +1. Reye's Syndrome: This is a metabolic disorder characterized by vomiting, encephalopathy, and metabolic acidosis. Hyperammonemia, hyperglutaminemia, and death in childhood are common symptoms. Orotic aciduria is not typically associated with Reye's Syndrome.

+2. Urea Cycle Disorders: This group of metabolic disorders includes conditions such as Ornithine Transcarbamylase Deficiency and Citrullinemia. Symptoms include vomiting, developmental delay, seizures, and hyperammonemia. Hyperglutaminemia and orotic aciduria are not common symptoms.

+3. Maple Syrup Urine Disease: This is a metabolic disorder caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase complex. Symptoms include vomiting, developmental delay, seizures, and a distinctive sweet urine smell. Hyperammonemia and hyperglutaminemia are common symptoms, but orotic aciduria is not.

+4. Organic Acidemias: This group of metabolic disorders includes conditions such as Propionic Acidemia and Methylmalonic Acidemia. Symptoms include vomiting, developmental delay, metabolic acidosis, and hyperammonemia. Hyperglutaminemia and orotic aciduria are not common symptoms.

+5. Galactosemia: This is a metabolic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase. Symptoms include vomiting, jaundice, and developmental delay. Hyperammonemia, hyperglutaminemia, and orotic aciduria are not common symptoms.

+6. Tyrosinemia: This is a metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms include vomiting, developmental delay, and liver damage. Hyperammonemia, hyperglutaminemia, and orotic aciduria are not common symptoms.

+7. Homocystinuria: This is a metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms include vomiting, developmental delay, mental retardation, and ectopia lentis. Hyperammonemia, hyperglutaminemia, and orotic aciduria are not common symptoms.

+8. Glutaric Acidemia Type I: This is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms include vomiting, developmental delay, seizures, and metabolic acidosis. Hyperammonemia, hyperglutaminemia, and orotic aciduria are not common symptoms.

+9. Isovaleric Acidemia: This is a metabolic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms include vomiting, developmental delay, metabolic acidosis, and a distinctive odor of sweat, urine, and breath. Hyperammonemia, hyperglutaminemia, and orotic aciduria are not common symptoms.

+10. Glutathione"
['Phenylketonuria']," +1. Phenylketonuria (PKU): Abnormality of prenatal development or birth, Elevated urinary carboxylic acids, Neonatal death, Hyperphenylalaninemia : Obesity, Abnormal circulating tyrosine concentration, Death in early adulthood
+2. Down syndrome: Abnormality of prenatal development or birth : Obesity, Neonatal death, Hyperphenylalaninemia, Elevated urinary carboxylic acids, Death in early adulthood
+3. Cystic fibrosis: Abnormality of prenatal development or birth : Obesity, Neonatal death, Hyperphenylalaninemia, Elevated urinary carboxylic acids, Death in early adulthia (However, Cystic fibrosis is not associated with phenylketonuria or tyrosine abnormalities)
+4. Thalassemia: Abnormality of prenatal development or birth : Obesity, Neonatal death, Hyperphenylalaninemia, Death in early adulthood (Thalassemia is not associated with elevated urinary carboxylic acids)
+5. Sickle cell disease: Abnormality of prenatal development or birth : Obesity, Neonatal death, Hyperphenylalaninemia, Death in early adulthood (Sickle cell disease is not associated with elevated urinary carboxylic acids)
+6. Gaucher disease: Neonatal death, Death in early adulthood : Abnormality of prenatal development or birth, Obesity, Hyperphenylalaninemia, Elevated urinary carboxylic acids
+7. Tay-Sachs disease: Neonatal death, Death in early adulthood : Abnormality of prenatal development or birth, Obesity, Hyperphenylalaninemia, Elevated urinary carboxylic acids (Tay-Sachs disease is not associated with abnormal circulating tyrosine concentration)"
['Pearson syndrome']," +1. Nephropathies: This group of diseases includes various conditions that affect the kidneys, such as chronic kidney disease, acute kidney injury, and renal Fanconi syndrome. The patient presents with enlarged kidneys, acute kidney injury, and chronic kidney disease.

+2. Metabolic Disorders: This category includes a range of conditions that affect the body's metabolism, such as 3-Methylglutaric aciduria, exocrine pancreatic insufficiency, and hypoglycemia. The patient exhibits increased circulating lactate concentration, increased serum pyruvate, and hypoglycemia.

+3. Neurological Disorders: This group includes conditions that affect the nervous system, such as ptosis, photophobia, lethargy, coma, drowsiness, and sleep abnormality. The patient presents with ptosis, photophobia, lethargy, coma, drowsiness, and sleep abnormality.

+4. Cardiovascular Diseases: This category includes conditions that affect the heart and blood vessels, such as congestive heart failure. The patient exhibits congestive heart failure.

+5. Hematological Disorders: This group includes conditions that affect the production or function of blood cells, such as thrombocytopenia, neutropenia, and anemia. The patient presents with thrombocytopenia and neutropenia.

+6. Endocrine Disorders: This category includes conditions that affect the endocrine system, such as short stature. The patient exhibits short stature.

+7. Infectious Diseases: This group includes various infections, such as recurrent viral infections. The patient presents with recurrent viral infections.

+8. Liver Diseases: This category includes conditions that affect the liver, such as decreased plasma free carnitine and abnormal circulating monocarboxylic acid concentration. The patient exhibits decreased plasma free carnitine and abnormal circulating monocarboxylic acid concentration.

+9. Genetic Disorders: This group includes various genetic conditions, such as 3-Methylglutaric aciduria and neonatal death. The patient presents with 3-Methylglutaric aciduria and neonatal death.

+10. Gastrointestinal Disorders: This category includes conditions that affect the gastrointestinal system, such as vomiting and feeding difficulties. The patient exhibits vomiting and feeding difficulties.

+11. Renal Tubular Acidosis: This condition is characterized by impaired acid secretion in the kidneys, leading to metabolic acidosis. The patient presents with increased serum pyruvate, increased circulating lactate concentration, and decreased plasma free carnitine.

+12. Wilson's Disease: This is a genetic disorder that affects copper metabolism, leading to liver damage, neurological symptoms, and psychiatric symptoms. The patient exhibits decreased plasma free carnitine, neurological symptoms (ptosis, photophobia, lethargy, coma, drowsiness, and sleep abnormality), and liver disease (increased serum pyruvate, increased circulating lactate concentration, and abnormal circulating monocarboxylic acid concentration).

+13. Maple Syrup Urine Disease: This is a metabolic disorder caused by a def"
['Smith-Lemli-Opitz syndrome']," +1. Down syndrome: Broad philtrum, Anteverted nares, Generalized hypotonia, Neonatal death, Feeding difficulties. +2. Ehlers-Danlos syndrome: Joint hypermobility, Skin elasticity, Syndactyly. (Does not have: Long philtrum, Deep philtrum, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Death in infancy) +3. Marfan syndrome: Long philtrum, Arachnodactyly, Disproportionate limb length, Chest deformity, Feeding difficulties. (Does not have: Syndactyly, Generalized hypotonia, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Death in infancy) +4. Smith-Lemli-Opitz syndrome: Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Generalized hypotonia, Feeding difficulties. (Does not have: Broad philtrum, Long philtrum, Anteverted nares, Syndactyly, Death in infancy, Deep philtrum) +5. Cornelia de Lange syndrome: Generalized hypotonia, Feeding difficulties, Broad philtrum, Long face, Low set ears, Small stature. (Does not have: Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Death in infancy, Deep philtrum) +6. Prader-Willi syndrome: Hypotonia, Feeding difficulties, Short stature, Small hands and feet. (Does not have: Broad philtrum, Long philtrum, Anteverted nares, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Death in infancy, Deep philtrum)"
['Acute intermittent porphyria']," +1. Gastroenteritis: Abdominal pain and vomiting are common symptoms. However, this condition typically affects people of all ages and is usually caused by a viral or bacterial infection. It does not typically result in death in childhood or recurrent viral inctions.

+2. Cystic Fibrosis: Abdominal pain and recurrent viral infections are common symptoms. However, this genetic condition does not typically cause vomiting and rarely results in death in childhood if properly managed.

+3. Inflammatory Bowel Disease (IBD): Abdominal pain and vomiting are common symptoms. However, this condition does not typically result in death in childhood unless it is severe or untreated. Recurrent viral infections are not a common symptom of IBD.

+4. Celiac Disease: Abdominal pain and vomiting are common symptoms. However, this condition does not typically result in death in childhood or recurrent viral infections.

+5. Food Allergy: Vomiting and abdominal pain can be symptoms of a food allergy. However, this condition does not typically result in death in childhood or recurrent viral infections.

+6. Intestinal Obstruction: Abdominal pain and vomiting are common symptoms. However, this condition can be life-threatening in childhood if not treated promptly. Recurrent viral infections are not a common symptom of intestinal obstruction.

+7. Appendicitis: Abdominal pain and vomiting are common symptoms. However, this condition does not typically result in death in childhood unless the appendix ruptures, which can be life-threatening. Recurrent viral infections are not a common symptom of appendicitis.

+8. Measles: Vomiting and abdominal pain can be symptoms of measles. However, this condition is a viral infection that typically affects children and does not typically result in death unless the infection is severe or the child has a weakened immune system. Recurrent viral infections are a common symptom of measles.

+9. Typhoid Fever: Abdominal pain and vomiting are common symptoms. However, this condition does not typically result in death in childhood unless it is severe or the child has a weakened immune system. Recurrent viral infections are not a common symptom of typhoid fever.

+10. Tuberculosis: Abdominal pain and vomiting can be symptoms of tuberculosis. However, this condition does not typically result in death in childhood unless it is severe or the child has a weakened immune system. Recurrent viral infections are not a common symptom of tuberculosis."
['Citrullinemia type I']," +1. Urea Cycle Disorders (UCD): Metabolic acidosis, Hyperammonemia, Hyperglutaminemia, Argininuria, Elevated plasma citrulline. The patient does not have symptoms of Neonatal death and Death in infancy.

+2. Maple Syrup Urine Disease (MSUD): Hyperammonemia, Hyperglycinuria, Elevated plasma citrulline. The patient does not have symptoms of Neonatal death, Death in infancy, and Abnormal circulating arginine concentration.

+3. Citrullinemia: Metabolic acidosis, Elevated plasma citrulline. The patient does not have symptoms of Neonatal death, Death in infancy, Hyperammonemia, Hyperglycinuria, and Hyperglutaminemia.

+4. Organic Acidemias: Metabolic acidosis. The patient does not have symptoms of Neonatal death, Death in infancy, Hyperammonemia, Hyperglycinuria, Hyperglutaminemia, Argininuria, and Abnormal circulating arginine concentration.

+5. Reye Syndrome: Metabolic acidosis, Neonatal death. The patient does not have symptoms of Hyperammonemia, Hyperglycinuria, Hyperglutaminemia, Argininuria, and Abnormal circulating arginine concentration.

+6. Galactosemia: Hyperammonemia, Hyperglycinuria (in some cases). The patient does not have symptoms of Neonatal death, Death in infancy, Metabolic acidosis, Hyperglutaminemia, Argininuria, and Elevated plasma citrulline.

+7. Tyrosinemia: Hyperammonemia (in some cases). The patient does not have symptoms of Neonatal death, Death in infancy, Metabolic acidosis, Hyperglycinuria, Hyperglutaminemia, Argininuria, Elevated plasma citrulline, and Abnormal circulating arginine concentration.

+8. Propionic Acidemia: Metabolic acidosis, Hyperammonemia. The patient does not have symptoms of Neonatal death, Death in infancy, Hyperglycinuria, Hyperglutaminemia, Argininuria, Elevated plasma citrulline, and Abnormal circulating arginine concentration.

+9. Glutaric Acidemia Type I: Metabolic acidosis. The patient does not have symptoms of Neonatal death, Death in infancy, Hyperammonemia, Hyperglycinuria, Hyperglutaminemia, Argininuria, Elevated plasma citrulline, and Abnormal circulating arginine concentration.

+10. Isovaleric Acidemia: Metabolic acidosis. The patient does not have symptoms of Neonatal death, Death in infancy, Hyperammonemia, Hyperglycinuria, Hyperglutaminemia, Argininuria, Elevated plasma citrulline, and Abnormal circulating arginine concentration.

+11. Methylmalonic Acidemia: Metabolic acidosis. The patient does not have symptoms of Neonatal death, Death"
[]," +1. Intellectual Disability (Delayed speech and language development, Lethargy, Generalized hypotonia): This condition is characterized by below-average intelligence or mental ability. The patient may have normal physical development but will face challenges in learning and adapting to new environments. They may also exhibit symptoms such as delayed speech and language development and generalized hypotonia.

+2. Hypothyroidism (Lethargy, Drowsiness, Sleep abnormality): This condition is characterized by an underactive thyroid gland, leading to a decrease in the production of essential hormones. Symptoms include lethargy, drowsiness, and sleep abnormalities. However, delayed speech and language development is not typically associated with hypothyroidism.

+3. Mitochondrial Disorders (Delayed speech and language development, Lethargy, Generalized hypotonia, Dehydration): Mitochondrial disorders are a group of genetic conditions that affect the mitochondria, the energy-producing structures in cells. Symptoms can include delayed speech and language development, lethargy, generalized hypotonia, and dehydration.

+4. Metabolic Disorders (Dehydration, Hyperammonemia, Hyperhomocystinemia, Methylmalonic acidemia, Decreased plasma free carnitine, Methylmalonic aciduria): Metabolic disorders are a group of conditions that affect the body's ability to convert food into energy. Symptoms can include dehydration, hyperammonemia, hyperhomocystinemia, methylmalonic acidemia, decreased plasma free carnitine, and methylmalonic aciduria. Delayed speech and language development and lethargy are not typically associated with metabolic disorders.

+5. Down Syndrome (Delayed speech and language development, Generalized hypotonia): Down syndrome is a genetic condition caused by the presence of an extra chromosome 21. Symptoms include delayed speech and language development and generalized hypotonia. However, it is not typically associated with dehydration, lethargy, or sleep abnormalities.

+6. Muscular Dystrophies (Generalized hypotonia): Muscular dystrophies are a group of genetic conditions that cause progressive muscle weakness and wasting. Symptoms include generalized hypotonia. However, they are not typically associated with delayed speech and language development, dehydration, or sleep abnormalities.

+7. Seizure Disorders (Lethargy, Sleep abnormality): Seizure disorders are a group of conditions characterized by the presence of seizures, which are sudden, uncontrolled electrical disturbances in the brain. Symptoms can include lethargy and sleep abnormalities. However, they are not typically associated with delayed speech and language development, dehydration, or hyperammonemia.

+8. Hepatic Encephalopathy (Lethargy, Sleep abnormality, Hyperammonemia): Hepatic encephalopathy is a condition caused by liver dysfunction, leading to the buildup of toxins in the brain. Symptoms can include lethargy, sleep abnormalities, and hyperammonemia. However, it is not typically associated with delayed speech and language development or dehydration.

+9. Hypoglycemia (Dehydration): Hypoglycemia is a condition characterized by low blood"
['Very long chain acyl-CoA dehydrogenase deficiency']," +1. Reye's Syndrome: This is a rare but serious condition that affects the brain and liver. It is characterized by symptoms such as hyperactivity, vomiting, and decreased consciousness. In severe cases, it can lead to coma and death, particularly in children. Patients with Reye's Syndrome may also have hypoglycemia, hyperammonemia, and elevated liver enzymes. +2. Maple Syrup Urine Disease: This is an inherited metabolic disorder that affects the ability to break down certain amino acids, particularly branched-chain amino acids. Symptoms include hypotonia, developmental delay, and a distinctive sweet urine smell. Patients may also experience hyperammonemia, ketoacidosis, and seizures. +3. Pompe Disease: This is a lysosomal storage disorder caused by a deficiency of the enzyme acid alpha-glucosidase. Symptoms include hypotonia, muscle weakness, and respiratory distress. Patients may also experience cardiomegaly, hepatomegaly, and a characteristic enlargement of the tongue. +4. Menkes Disease: This is a rare X-linked recessive disorder caused by mutations in the ATP7A gene. Symptoms include hypotonia, developmental delay, and kinky or brittle hair. Patients may also experience neurological symptoms such as seizures, ataxia, and tremors. +5. Zellweger Syndrome: This is a peroxisomal disorder characterized by the absence or dysfunction of peroxisomes, which are organelles involved in various metabolic processes. Symptoms include hypotonia, developmental delay, and characteristic facial features such as a broad forehead, large fontanelles, and low-set ears. Patients may also experience liver dysfunction, seizures, and hearing loss. +6. Citrullinemia: This is an inherited metabolic disorder caused by a deficiency of the enzyme argininosuccinate synthetase. Symptoms include hypotonia, developmental delay, and vomiting. Patients may also experience hyperammonemia, seizures, and a characteristic odor of ammonia on the breath. +7. Propionic Acidemia: This is an inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms include hypotonia, developmental delay, and vomiting. Patients may also experience metabolic acidosis, hyperammonemia, and ketoacidosis. +8. Urea Cycle Disorders: This is a group of inherited metabolic disorders that affect the urea cycle, which is the process by which the body eliminates excess ammonia. Symptoms include hypotonia, developmental delay, and vomiting. Patients may also experience hyperammonemia, seizures, and coma. +9. Mitochondrial Disorders: This is a group of disorders caused by mutations in genes that encode proteins involved in the mitochondrial respiratory chain. Symptoms may include hypotonia, developmental delay, and metabolic acidosis. Patients may also experience neurological symptoms such as seizures, ataxia, and myopathy. +10. Organic Acidemias: This is a group of inherited metabolic disorders caused by a deficiency in the metabolism of certain organic acids. Symptoms may include hypotonia, developmental delay, and vom"
['Phenylketonuria']," +1. Cystic Fibrosis: A genetic disorder that causes persistent lung infections and difficulty in breathing due to thick and sticky mucus in the airways. +Symptoms: Upper airway obstruction, Neonatal death, Chronic pulmonary obstruction- Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia

+2. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. +Symptoms: Abnormality of prenatal development or birth, Neonatal death- Upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction

+3. Phenylketonuria (PKU): A genetic disorder that affects the metabolism of the amino acid phenylalanine. +Symptoms: Hyperphenylalaninemia, Neonatal death- Abnormality of prenatal development or birth, Upper airway obstruction, Hypertyrosinemia, Chronic pulmonary obstruction

+4. Hurler Syndrome: A lysosomal storage disorder caused by a deficiency of the enzyme iduronidase. +Symptoms: Abnormality of prenatal development or birth, Neonatal death- Upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction (can occur as a result of respiratory infections)

+5. Congenital Diaphragmatic Hernia: A birth defect where the diaphragm fails to form properly, allowing abdominal organs to move into the chest cavity. +Symptoms: Abnormality of prenatal development or birth, Neonatal death, Upper airway obstruction- Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction (due to lung compression)

+6. Trisomy 13: A genetic disorder caused by the presence of an extra chromosome 13. +Symptoms: Abnormality of prenatal development or birth, Neonatal death- Upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction (can occur due to respiratory infections)

+7. Trisomy 18: A genetic disorder caused by the presence of an extra chromosome 18. +Symptoms: Abnormality of prenatal development or birth, Neonatal death- Upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction (can occur due to respiratory infections)

+8. Zellweger Syndrome: A rare genetic disorder that affects the synthesis of certain proteins in the endoplasmic reticulum. +Symptoms: Abnormality of prenatal development or birth, Neonatal death- Upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction (can occur due to respiratory infections)

+9. Mucopolysaccharidosis: A group of lysosomal storage disorders caused by a deficiency of enzymes needed to break down complex sugars called glycosaminoglycans. +Symptoms"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic Disorder - Methylmalonic Acidemia: This is a metabolic disorder caused by a deficiency of methylmalonic acidemia, which affects the body's ability to break down certain proteins and fats. Common symptoms include metabolic acidosis, developmental delay, and neurological problems. The patient presents with spasticity, decreased plasma free carnitine, and decreased 3-hydroxyacyl-CoA dehydrogenase level.

+2. Neurological Disorder - Spinal Muscular Atrophy: This is a motor neuron disorder that causes muscle weakness and atrophy. Common symptoms include muscle weakness, spasticity, and decreased reflexes. The patient presents with spasticity.

+3. Metabolic Disorder - Sickle Cell Anemia: This is a genetic disorder that affects the production of hemoglobin in the red blood cells, leading to the formation of sickle-shaped cells. Common symptoms include anemia, pain crises, and jaundice. The patient does not present with sickle cell anemia symptoms such as anemia, jaundice, or pain crises.

+4. Metabolic Disorder - Inborn Error of Metabolism - Maple Syrup Urine Disease: This is a metabolic disorder caused by a deficiency of the enzyme needed to break down certain amino acids. Common symptoms include poor feeding, vomiting, and developmental delay. The patient does not present with symptoms such as poor feeding or vomiting.

+5. Metabolic Disorder - Galactosemia: This is a metabolic disorder caused by a deficiency of the enzyme needed to metabolize galactose. Common symptoms include jaundice, vomiting, and diarrhea. The patient does not present with jaundice or vomiting.

+6. Metabolic Disorder - Homocystinuria: This is a metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase, leading to the accumulation of homocysteine in the body. Common symptoms include mental retardation, developmental delay, and skeletal abnormalities. The patient does not present with mental retardation or developmental delay.

+7. Metabolic Disorder - Organic Acidemia - Propionic Acidemia: This is a metabolic disorder caused by a deficiency of propionyl-CoA carboxylase, leading to the accumulation of propionic acid in the body. Common symptoms include metabolic acidosis, vomiting, and lethargy. The patient does not present with vomiting or lethargy.

+8. Metabolic Disorder - Inborn Error of Metabolism - Phenylketonuria: This is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body. Common symptoms include mental retardation, seizures, and developmental delay. The patient does not present with mental retardation, seizures, or developmental delay.

+9. Metabolic Disorder - Inborn Error of Metabolism - Glutaric Acidemia Type I: This is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid in the"
['Phenylketonuria']," +1. Metabolic Disorder - Hurler Syndrome: Symptoms include Death in infancy, Heightened susceptibility to recurrent viral infections, and Developmental delays. This condition is caused by a deficiency of the enzyme iduronidase, leading to the accumulation of glycosaminoglycans in various body tissues.

+2. Metabolic Disorder - Krabbe Disease: Symptoms include Death in infancy or early childhood, and Developmental regression. This condition is caused by a deficiency of the enzyme galactocerebrosidase, leading to the accumulation of galactosylsphingosine in the central nervous system.

+3. Metabolic Disorder - Pompe Disease: Symptoms include Death in infancy or childhood, and Muscle weakness. This condition is caused by a deficiency of the enzyme acid alpha-glucosidase, leading to the accumulation of glycogen in the lysosomes.

+4. Metabolic Disorder - Maple Syrup Urine Disease: Symptoms include Hyperammonemia, Hyperphenylalaninemia, and Developmental delay. This condition is caused by a deficiency of the enzymes needed to break down certain amino acids, leading to their accumulation in the body.

+5. Immunodeficiency Disorder - Severe Combined Immunodeficiency: Symptoms include Recurrent viral infections, and Susceptibility to bacterial infections. This condition is caused by a deficiency in both B and T cells, making the individual unable to mount an effective immune response.

+6. Metabolic Disorder - Wilson Disease: Symptoms include Liver damage, Speech difficulties, and Death in adolescence or adulthood. This condition is caused by a deficiency in ceruloplasmin, leading to the accumulation of copper in the liver and other organs.

+7. Metabolic Disorder - Gaucher Disease: Symptoms include Enlarged liver and spleen, Bone pain, and Death in adolescence or adulthood. This condition is caused by a deficiency of the enzyme glucocerebrosidase, leading to the accumulation of glucocerebroside in the macrophages.

+8. Metabolic Disorder - Niemann-Pick Disease: Symptoms include Enlarged liver and spleen, Progressive neurological deterioration, and Death in childhood or adolescence. This condition is caused by a deficiency of the enzyme sphingomyelinase, leading to the accumulation of sphingomyelin in the liver, spleen, and brain.

+9. Metabolic Disorder - Tay-Sachs Disease: Symptoms include Progressive neurological deterioration, and Death in childhood. This condition is caused by a deficiency of the enzyme hexosaminidase A, leading to the accumulation of GM2 ganglioside in the brain.

+10. Metabolic Disorder - Fabry Disease: Symptoms include Chronic pain, Angiokeratoma, and Death in adulthood. This condition is caused by a deficiency of the enzyme alpha-galactosidase A, leading to the accumulation of globotriaosylceramide in various tissues.

+11. Metabolic Disorder - Galactosemia: Symptoms include Jaundice"
['3-methylcrotonyl-CoA carboxylase deficiency']," +1. Phenylketonuria (PKU): A metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, resulting in an accumulation of phenylalanine in the blood and urine. Common symptoms include mental retardation, seizures, and a musty odor to the urine. + Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid
+2. Maple Syrup Urine Disease (MSUD): A metabolic disorder caused by a deficiency of the enzymes needed to break down certain amino acids, leading to their accumulation in the body. Common symptoms include poor feeding, vomiting, lethargy, and a distinctive sweet urine smell. + Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid
+3. Propionic Acidemia: A metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to an accumulation of propionic acid in the body. Common symptoms include metabolic acidosis, vomiting, lethargy, and developmental delay. + Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid
+4. Citrullinemia: A metabolic disorder caused by a deficiency of the enzyme argininosuccinate synthetase, leading to an accumulation of citrulline in the blood and urine. Common symptoms include poor feeding, vomiting, lethargy, and developmental delay. + Aminoaciduria, Elevated urinary carboxylic acid
+5. Tyrosinemia: A metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to an accumulation of tyrosine and other toxic metabolites in the body. Common symptoms include hepatomegaly, jaundice, and a musty odor to the urine. + Aminoaciduria, Abnormal circulating glycine concentration (not typically associated with this condition)"
['Succinic semialdehyde dehydrogenase deficiency']," +1. Metabolic Disorder (e.g., Mitochondrial Disease): Delayed speech and language development, Motor delay, Generalized hypotonia, Death in infancy or childhood.
+2. Cerebral Palsy: Motor delay, Ataxia.
+3. Epilepsy: Seizure.
+4. Rett Syndrome: Delayed speech and language development, Motor delay, Generalized hypotonia, Death in childhood.
+5. Maple Syrup Urine Disease: Elevated urinary carboxylic acid, Delayed speech and language development, Motor delay, Generalized hypotonia, Death in infancy or childhood.
+6. Pompe Disease: Generalized hypotonia, Death in infancy or childhood.
+7. Prader-Willi Syndrome: Delayed speech and language development, Hyperactivity, Generalized hypotonia.
+8. Spinal Muscular Atrophy: Motor delay, Generalized hypotonia, Death in infancy or childhood.

Please note that this list is not exhaustive, and further diagnostic tests are required to confirm a definitive diagnosis. The symptoms listed here are common for the diseases mentioned but not exclusive."
['Argininosuccinic aciduria']," +1. Metabolic disorders (e.g., Inborn Errors of Metabolism): Metabolic acidosis, Vomiting, Neonatal death. These conditions can cause metabolic acidosis due to an inability to metabolize certain substances properly. Tachycardia and hepatomegaly may not be common symptoms, but they can occur in some cases.

+2. Sepsis: Tachycardia, Tachypnea, Metabolic acidosis, Vomiting. Sepsis is a life-threatening condition caused by a severe infection. It can lead to metabolic acidosis due to the body's response to the infection. Hepatomegaly and neonatal death are not typical symptoms of sepsis.

+3. Congenital Heart Disease: Tachycardia, Cyanoosis (not mentioned in the symptoms but often associated with this condition), Hepatomegaly. Congenital heart disease can lead to heart failure, which can cause tachycardia and hepatomegaly. Metabolic acidosis, vomiting, and neonatal death are not typical symptoms.

+4. Sepsis with Congenital Heart Disease: Tachycardia, Tachypnea, Metabolic acidosis, Vomiting, Hepatomegaly (can occur due to heart failure), Neonatal death. This condition combines the symptoms of sepsis and congenital heart disease.

+5. Mitochondrial Disorders: Metabolic acidosis, Vomiting, Hepatomegaly. Mitochondrial disorders can cause metabolic acidosis due to an inability to produce energy efficiently. Tachycardia and tachypnea are not typical symptoms, but they can occur in some cases. Neonatal death is a common outcome for these conditions.

+6. Sepsis with Mitochondrial Disorders: Tachycardia, Tachypnea, Metabolic acidosis, Vomiting, Hepatomegaly, Neonatal death. This condition combines the symptoms of sepsis and mitochondrial disorders.

+7. Sepsis with Congenital Heart Disease and Mitochondrial Disorders: Tachycardia, Tachypnea, Metabolic acidosis, Vomiting, Hepatomegaly, Neonatal death. This condition combines the symptoms of sepsis, congenital heart disease, and mitochondrial disorders.

+8. Dwarfism with Metabolic Acidosis: Metabolic acidosis, Hepatomegaly. Dwarfism can be associated with certain metabolic disorders that cause metabolic acidosis. Tachycardia, tachypnea, vomiting, and neonatal death are not typical symptoms.

+9. Sepsis with Dwarfism and Metabolic Acidosis: Tachycardia, Tachypnea, Metabolic acidosis, Vomiting, Hepatomegaly, Neonatal death. This condition combines the symptoms of sepsis, dwarfism, and metabolic acidosis.

+10. Sepsis with Congenital Heart Disease, Mitochondrial Disorders, and Dwarfism: Tachycardia, Tachypnea, Metabolic acidosis, Vomiting, Hepatomegaly, Neonatal death. This condition combines the symptoms of se"
['Gyrate atrophy of choroid and retina']," +1. Maple Syrup Urine Disease (MSUD): Blindness, Malabsorption, Hyperammonemia, Hyperglycinemia, Abnormal circulating serine concentration, Death in childhood. The patient does not have Anemia, Headache, Severe short stature, Hypoargininemia, Death in adolescence, Feeding difficulties, Hyperornithinemia.

+2. Phenylketonuria (PKU): Blindness (if untreated), Malabsorption, Hyperammonemia, Hyperglycinemia, Abnormal circulating serine concentration, Death in early adulthood (if untreated). The patient does not have Anemia, Headache, Severe short stature, Hypoargininemia, Death in childhood, Feeding difficulties, Hyperornithinemia.

+3. Homocystinuria: Malabsorption, Hyperammonemia, Death in childhood (if untreated). The patient does not have Blindness, Anemia, Hyperglycinemia, Headache, Severe short stature, Hypoargininemia, Death in adolescence, Feeding difficulties, Hyperornithinemia.

+4. Canavan Disease: Blindness, Severe short stature, Death in childhood. The patient does not have Anemia, Hyperammonemia, Hyperglycinemia, Headache, Hypoargininemia, Death in adolescence, Feeding difficulties, Hyperornithinemia, Hyperammonemia.

+5. Krabbe Disease: Blindness, Death in childhood. The patient does not have Anemia, Hyperammonemia, Hyperglycinemia, Headache, Severe short stature, Hypoargininemia, Death in adolescence, Feeding difficulties, Hyperornithinemia.

+6. Galactosemia: Feeding difficulties. The patient does not have Blindness, Anemia, Hyperammonemia, Hyperglycinemia, Headache, Severe short stature, Hypoargininemia, Death in childhood, Death in adolescence.

+7. Sickle Cell Anemia: Anemia. The patient does not have Blindness, Hyperammonemia, Hyperglycinemia, Headache, Severe short stature, Hypoargininemia, Death in childhood, Death in adolescence, Feeding difficulties, Hyperornithinemia.

+8. Thalassemia: Anemia. The patient does not have Blindness, Hyperammonemia, Hyperglycinemia, Headache, Severe short stature, Hypoargininemia, Death in childhood, Death in adolescence, Feeding difficulties, Hyperornithinemia.

+9. Wilson's Disease: Headache, Death in early adulthood. The patient does not have Blindness, Anemia, Hyperammonemia, Hyperglycinemia, Severe short stature, Hypoargininemia, Death in childhood, Death in adolescence, Feeding difficulties, Hyperornithinemia.

+10. Gaucher Disease: No symptoms in common with the given list.

+11. Fabry Disease: No symptoms in common with the given list.

+1"
['Phenylketonuria']," +1. Hemangioma NVD: A common benign vascular birth defect, not typically associated with prenatal abnormalities or death. +Symptoms in common: Abnormality of prenatal development or birth.
+2. Cystic Fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems, causing persistent lung infections and difficulty digesting food. +Symptoms in common: Death in childhood.
+3. Tay-Sachs Disease: A rare, inherited metabolic disorder causing progressive degeneration of the central nervous system, leading to blindness, deafness, and eventual death. +Symptoms in common: Neonatal death, Death in infancy.
+4. Sickle Cell Anemia: A genetic disorder causing the production of abnormal hemoglobin, leading to red blood cells that are crescent-shaped and prone to clumping, resulting in anemia and various complications. +Symptoms in common: Death in childhood.
+5. Down Syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21, leading to developmental delays, physical growth delays, and characteristic facial features. +Symptoms in common: Abnormality of prenatal development or birth.
+6. Phenylketonuria (PKU): A metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the blood and brain, causing intellectual disability and other health issues. +Symptoms in common: Hyperphenylalaninemia.
+7. Maple Syrup Urine Disease: A metabolic disorder caused by a deficiency of the enzymes needed to break down certain amino acids, leading to the accumulation of these substances in the blood and urine, causing neurological symptoms and metabolic acidosis. +Symptoms in common: Hyperammonemia, Hyperglycinemia.
+8. Zellweger Syndrome: A rare, genetic disorder of peroxisome biogenesis, leading to the absence or dysfunction of peroxisomes, causing various developmental and neurological problems, and often resulting in death in infancy or childhood. +Symptoms in common: Abnormality of prenatal development or birth, Neonatal death, Death in infancy.
+9. Krabbe Disease: A metabolic disorder caused by a deficiency of the enzyme galactocerebrosidase, leading to the accumulation of a fatty substance called galactosylsphingosine in the brain and causing progressive demyelination and neurological symptoms, often resulting in death in infancy or childhood. +Symptoms in common: Neonatal death, Death in infancy.
+10. Canavan Disease: A metabolic disorder caused by a deficiency of the enzyme aspartoacylase, leading to the accumulation of N-acetylaspartic acid in the brain and causing progressive neurological symptoms, often resulting in death in infancy or childhood. +Symptoms in common: Neonatal death, Death in infancy."
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. Reye's Syndrome: A metabolic disorder characterized by acute encephalopathy, liver dysfunction, and metabolic acidosis. Common symptoms include Apathy, Cerebral edema, and Neonatal death. Does not typically present with Generalized hypotonia, Feeding difficulties, or Hyperammonemia.

+2. Menkes Disease: A genetic disorder of copper metabolism causing progressive neurological deterioration. Common symptoms include Apathy, Neonatal death, and Cerebral edema. Does not typically present with Generalized hypotonia, Hyperammonemia, or Feeding difficulties.

+3. Krabbe Disease: A genetic disorder of the central nervous system characterized by demyelination. Common symptoms include Apathy, Cerebral edema, and Neonatal death. Does not typically present with Generalized hypotonia, Hyperammonemia, or Feeding difficulties.

+4. Maple Syrup Urine Disease: An inherited metabolic disorder of amino acid metabolism. Common symptoms include Apathy, Hyperammonemia, and Neonatal death. Does not typically present with Generalized hypotonia, Cerebral edema, or Feeding difficulties.

+5. Zellweger Syndrome: A rare genetic disorder of peroxisome biogenesis. Common symptoms include Apathy, Neonatal death, and Cerebral edema. Does not typically present with Generalized hypotonia, Hyperammonemia, or Feeding difficulties.

+6. Pompe Disease: A lysosomal storage disorder caused by a deficiency of acid alpha-glucosidase. Common symptoms include Apathy, Generalized hypotonia, and Neonatal death. Does not typically present with Cerebral edema, Hyperammonemia, or Feeding difficulties.

+7. Mitochondrial Disorders: A group of genetic disorders affecting the mitochondria. Common symptoms include Apathy, Generalized hypotonia, and Neonatal death. Can present with some or all of the symptoms, including Cerebral edema, Hyperammonemia, and Feeding difficulties.

+8. Lysosomal Storage Disorders: A group of genetic disorders caused by the deficiency of specific enzymes in lysosomes. Common symptoms include Apathy, Neonatal death, and Cerebral edema. Can present with some or all of the symptoms, including Generalized hypotonia, Hyperammonemia, and Feeding difficulties.

+9. Inborn Errors of Metabolism: A group of genetic disorders affecting various metabolic pathways. Common symptoms include Apathy, Neonatal death, and Cerebral edema. Can present with some or all of the symptoms, including Generalized hypotonia, Hyperammonemia, and Feeding difficulties.

+10. Septicemia: A serious blood infection. Common symptoms include Apathy, Neonatal death, and Feeding difficulties. Does not typically present with Generalized hypotonia, Cerebral edema, or Hyperammonemia."
['Canavan disease']," +1. Metachromatic Leukodystrophy: A genetic disorder causing the progressive degeneration of the myelin sheath in the central and peripheral nervous system. Common symptoms include: Seizures, Motor delay, Opisthotonus, Neonatal death, Abnormal myelination, and Death in infancy. The patient does not have symptoms of Blindness, Nystagmus, and Severe hearing impairment.

+2. Krabbe Disease: A metabolic disorder caused by the deficiency of galactocerebrosidase, leading to the accumulation of galactosylsphingosine in the central nervous system. Common symptoms include: Seizures, Motor delay, Opisthotonus, and Death in infancy. The patient does not have symptoms of Blindness, Nystagmus, and Severe hearing impairment.

+3. Canavan Disease: A metabolic disorder caused by the deficiency of the enzyme N-acetylaspartate-acyltransferase, leading to the accumulation of N-acetylaspartic acid in the brain. Common symptoms include: Seizures, Motor delay, Hypotonia, and Developmental regression. The patient has Generalized hypotonia and does not have symptoms of Blindness, Nystagmus, Seizure, Neonatal death, Opisthotonus, Abnormal circulating aspartate family amino acid concentration, and Severe hearing impairment.

+4. Pompe Disease: A lysosomal storage disorder caused by the deficiency of acid alpha-glucosidase, leading to the accumulation of glycogen in the lysosomes. Common symptoms include: Hypotonia, Muscle weakness, and Cardiomegaly. The patient has Generalized hypotonia and does not have symptoms of Blindness, Nystagmus, Seizure, Neonatal death, Opisthotonus, Abnormal circulating aspartate family amino acid concentration, Abnormal myelination, and Severe hearing impairment.

+5. Tay-Sachs Disease: A genetic disorder caused by the deficiency of hexosaminidase A, leading to the accumulation of GM2 ganglioside in the brain. Common symptoms include: Progressive loss of motor skills, Vision loss, and Mental regression. The patient does not have symptoms of Blindness, Nystagmus, Seizure, Motor delay, Neonatal death, Opisthotonus, Abnormal circulating aspartate family amino acid concentration, Abnormal myelination, and Severe hearing impairment.

+6. Pelizaeus-Merzbacher Disease: A disorder of myelination caused by mutations in the proteolipid protein gene. Common symptoms include: Nystagmus, Ataxia, and Hypotonia. The patient has Nystagmus and does not have symptoms of Blindness, Seizure, Motor delay, Neonatal death, Opisthotonus, Abnormal circulating aspartate family amino acid concentration, Abnormal myelination, Severe hearing impairment, and Death in infancy.

+7. Usher Syndrome: A genetic disorder causing both hearing impairment and vision loss. Common symptoms include: Severe hearing impairment, Vision loss, and Retinitis pigmentosa. The patient does not have symptoms of Blindness, Nystagmus, Seizure, Motor delay, Neonatal death, Opisthotonus, Abnormal circulating aspart"
"['Methylmalonic acidemia with homocystinuria, type cblC']"," +1. Hydrocephalus: Enlargement of the head due to an abnormal accumulation of cerebrospinal fluid in the ventricles. Common symptoms: Head enlargement. Does not have: Intellectual disability, Microcephaly, Strabismus, Nystagmus, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+2. Microcephaly: A condition characterized by an abnormally small head size and underdeveloped brain. Common symptoms: Small head size. Does not have: Hydrocephalus, Strabismus, Nystagmus, Intellectual disability, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+3. Strabismus: A condition where the eyes are misaligned and do not look in the same direction. Common symptoms: Eye misalignment. Does not have: Hydrocephalus, Microcephaly, Intellectual disability, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia, Nystagmus.

+4. Nystagmus: Involuntary and rapid movement of the eyes. Common symptoms: Involuntary eye movements. Does not have: Hydrocephalus, Microcephaly, Intellectual disability, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia, Strabismus.

+5. Intellectual disability: A condition characterized by below-average intelligence or mental ability. Common symptoms: Below-average intelligence or mental ability. Does not have: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+6. Premature birth: Birth before 37 weeks of gestation. Common symptoms: Birth before 37 weeks of gestation. Does not have: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Intellectual disability, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+7. Respiratory insufficiency: Difficulty breathing or inadequate exchange of gases in the lungs. Common symptoms: Difficulty breathing or shortness of breath. Does not have: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Intellectual disability, Premature birth, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+8. Hy"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Zellweger Spectrum Disorders: This is a group of disorders caused by mutations in genes involved in peroxisome biogenesis. Patients may present with prenatal developmental abnormalities, neonatal death, and decreased 3-hydroxyacyl-CoA dehydrogenase level. Vomiting and gastrointestinal inflammation are not typical symptoms. Abnormal circulating carnitine concentration is a hallmark of this condition.

+2. Carnitine Palmitoyltransferase Deficiency: This is a metabolic disorder characterized by a deficiency in carnitine palmitoyltransferase, an enzyme involved in the transport of long-chain fatty acids into the mitochondria for beta-oxidation. Patients may present with vomiting, neonatal death, and abnormal circulating carnitine concentration. Prenatal developmental abnormalities and gastrointestinal inflammation are not typical symptoms.

+3. Maple Syrup Urine Disease: This is an inherited metabolic disorder caused by a deficiency in the enzyme branched-chain ketoacid dehydrogenase complex. Patients may present with vomiting, gastrointestinal inflammation, and abnormal circulating carnitine concentration. Prenatal developmental abnormalities and neonatal death are not typical symptoms.

+4. Inborn Errors of Metabolism: This is a broad category of genetic disorders that affect various metabolic pathways. Patients may present with a combination of symptoms, including prenatal developmental abnormalities, neonatal death, vomiting, gastrointestinal inflammation, and abnormal circulating carnitine concentration. The specific symptoms and underlying metabolic disorder depend on the specific enzyme deficiency.

+5. Gastrointestinal Inflammation: This is a broad category of conditions that can cause inflammation in the gastrointestinal tract. Patients may present with vomiting and gastrointestinal inflammation. Prenatal developmental abnormalities, neonatal death, and abnormal circulating carnitine concentration are not typical symptoms.

+6. Gastrointestinal Infections: This includes various bacterial, viral, or parasitic infections that can cause gastrointestinal symptoms, including vomiting. Prenatal developmental abnormalities, neonatal death, and abnormal circulating carnitine concentration are not typical symptoms.

+7. Congenital Disorders of Glycosylation: This is a group of disorders caused by mutations in genes involved in the synthesis, modification, or transport of glycoproteins and glycolipids. Patients may present with prenatal developmental abnormalities, but vomiting, gastrointestinal inflammation, neonatal death, and abnormal circulating carnitine concentration are not typical symptoms.

+8. Organic Acidemias: This is a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to a deficiency in enzymes involved in their metabolism. Patients may present with vomiting, gastrointestinal inflammation, and abnormal circulating carnitine concentration. Prenatal developmental abnormalities and neonatal death are not typical symptoms, but some specific types of organic acidemias may present with these symptoms.

+9. Lysosomal Storage Disorders: This is a group of disorders caused by mutations in genes involved in the"
['Biotinidase deficiency']," +1. Metabolic Disorder - Methylmalonic Acidemia: Generalized hypotonia, Metabolic acidosis, Hyperammonemia, Neonatal death.
+2. Neuromuscular Disorder - Congenital Myasthenia Gravis: Generalized hypotonia, not typically associated with Leukopenia or Death in infancy.
+3. Inborn Error of Metabolism - Maple Syrup Urine Disease: Generalized hypotonia, Metabolic acidosis, not typically associated with Death in infancy or Hyperammonemia.
+4. Lysosomal Storage Disease - Pompe Disease: Generalized hypotonia, not typically associated with Leukopenia or Death in infancy, but can present with Metabolic acidosis and Hyperammonemia.
+5. Inborn Error of Metabolism - Organic Acidemia: Generalized hypotonia, Metabolic acidosis, Hyperammonemia, not typically associated with Leukopenia or Death in infancy.
+6. Neurological Disorder - Spinal Muscular Atrophy: Generalized hypotonia, not typically associated with Leukopenia, Metabolic acidosis, or Death in infancy.
+7. Inborn Error of Metabolism - Propionic Acidemia: Generalized hypotonia, Metabolic acidosis, Hyperammonemia, not typically associated with Leukopenia or Death in infancy.
+8. Neurological Disorder - Muscular Dystrophy: Generalized hypotonia, not typically associated with Leukopenia, Metabolic acidosis, or Death in infancy.
+9. Inborn Error of Metabolism - Urea Cycle Disorder: Generalized hypotonia, Hyperammonemia, not typically associated with Leukopenia, Metabolic acidosis, or Death in infancy.
+10. Genetic Disorder - Down Syndrome: Generalized hypotonia, not typically associated with Leukopenia, Metabolic acidosis, or Death in infancy.
+11. Inborn Error of Metabolism - Citrullinemia: Generalized hypotonia, not typically associated with Leukopenia, Metabolic acidosis, or Death in infancy, but can present with Hyperammonemia.
+12. Neurological Disorder - Hypoxic-Ischemic Encephalopathy: Generalized hypotonia, not typically associated with Leukopenia, Metabolic acidosis, or Death in infancy, but can present with Neonatal death."
['Tyrosinemia type 2']," +1. Keratitis: Inflammation of the cornea, causing redness, pain, and sensitivity to light (Photophobia). The patient does not have intellectual disability or seizures.
+2. Conjunctivitis: Inflammation of the conjunctiva, causing redness, itching, and discharge (Epiphora). The patient does not have Hyperkeratosis, Intellectual disability, Seizure, Hypertyrosinemia, or Death in childhood.
+3. Photophobia: Sensitivity to light. The patient has this symptom and also Keratitis.
+4. Hyperkeratosis: Thickening of the skin or mucous membranes. The patient does not have Conjunctivitis, Intellectual disability, Seizure, Hypertyrosinemia, or Death in childhood.
+5. Intellectual disability: A significant reduction in intellectual abilities. The patient does not have Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Seizure, or Hypertyrosinemia.
+6. Seizure: A sudden, uncontrollable electrical disturbance in the brain. The patient does not have Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Intellectual disability, or Hypertyrosinemia.
+7. Hypertyrosinemia: An accumulation of tyrosine in the body, leading to liver damage and other health problems. The patient does not have Keratitis, Conjunctivitis, Photophobia, Intellectual disability, or Seizure.
+8. Death in childhood: A condition that results in death before the age of 18. The patient does not have Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Intellectual disability, Seizure, or Hypertyrosinemia.
+9. Epiphora: Excessive tearing. The patient has this symptom and also Conjunctivitis."
['Phenylketonuria']," +1. Phenylketonuria (PKU): A genetic disorder caused by the lack of an enzyme needed to break down phenylalanine, leading to its accumulation in the body. Common symptoms include mental and developmental problems, seizures, and skin pigmentation. The patient exhibits the symptoms of Abnormality of prenatal development or birth, Neonatal death, and Hyperphenylalaninemia.

+2. Maple Syrup Urine Disease (MSUD): A metabolic disorder caused by the inability to break down certain amino acids, leading to their accumulation in the body. Common symptoms include poor feeding, vomiting, lethargy, and a distinctive sweet urine smell. The patient does not exhibit the symptom of Death in infancy but shares the symptoms of Abnormality of prenatal development or birth, Neonatal death, and Abnormal circulating tyrosine concentration.

+3. Cystic Fibrosis: A genetic disorder affecting the respiratory, digestive, and reproductive systems, characterized by the production of thick, sticky mucus. Common symptoms include persistent coughing, frequent lung infections, and difficulty gaining weight. The patient does not exhibit the symptoms of Hyperphenylalaninemia or Death in early adulthood.

+4. Down Syndrome: A genetic disorder caused by the presence of an extra chromosome 21, leading to developmental delays and physical abnormalities. Common symptoms include low muscle tone, short stature, and distinctive facial features. The patient exhibits the symptom of Abnormality of prenatal development or birth and does not exhibit the symptoms of Hyperphenylalaninemia, Neonatal death, or Death in early adulthood.

+5. Sickle Cell Anemia: A genetic disorder affecting the production of hemoglobin, leading to the formation of abnormal red blood cells and various complications. Common symptoms include anemia, pain crises, and frequent infections. The patient does not exhibit the symptoms of Hyperphenylalaninemia, Neonatal death, or Death in early adulthood."
[]," +1. Methemoglobinemia: Cyanosis, but no Seizure, Death in infancy, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria.
+2. Epilepsy: Seizure, but no Cyanosis, Death in infancy, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria.
+3. Urea Cycle Disorders: Hyperammonemia, Neonatal death, but no Cyanosis, Seizure, Death in infancy, 3-hydroxydicarboxylic aciduria.
+4. Mitochondrial Disorders: No specific symptoms match exactly, but they can present with Cyanosis, Seizures, and Neonatal death.
+5. Menkes Disease: Neonatal death, but no Cyanosis, Seizure, Hyperammonemia, 3-hydroxydicarboxylic aciduria.
+6. Maple Syrup Urine Disease: 3-hydroxydicarboxylic aciduria, but no Cyanosis, Seizure, Death in infancy, Hyperammonemia, Neonatal death.
+7. Sepsis: No specific symptoms match exactly, but it can present with Cyanosis, Seizures, and sometimes Neonatal death.
+8. Hypoxic-Ischemic Encephalopathy: No specific symptoms match exactly, but it can present with Cyanosis, Seizures, and sometimes Neonatal death.
+9. Meningoencephalitis: Seizures, but no Cyanosis, Death in infancy, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria.
+10. Organic Acidemias: 3-hydroxydicarboxylic aciduria, but no Cyanosis, Seizure, Death in infancy, Hyperammonemia, Neonatal death (there are various types of organic acidemias, so please specify which one if possible)."
['Alkaptonuria']," +1. Hemolytic Disease of the Newborn: This condition is caused by incompatibility between the mother's and baby's blood types. It can lead to jaundice, anemia, and, in severe cases, death in infancy. Vomiting is a common symptom, but dark urine is not typically associated with this disease.

+2. Hepatitis: This is an inflammation of the liver that can be caused by various viruses. Symptoms include jaundice, fatigue, loss of appetite, nausea, and vomiting. Dark urine is a common symptom of hepatitis.

+3. Gallstones: Gallstones are small, hard deposits that form in the gallbladder. Symptoms include abdominal pain, nausea, and vomiting. Jaundice is not a common symptom of gallstones, but dark urine can occur if there is a blockage in the bile ducts.

+4. Food Poisoning: Food poisoning is caused by consuming contaminated food or water. Symptoms include vomiting, diarrhea, abdominal cramps, and fever. Jaundice is not a common symptom of food poisoning, but dark urine can occur due to dehydration.

+5. Malaria: Malaria is a mosquito-borne disease caused by a parasite. Symptoms include fever, chills, muscle pain, headache, and vomiting. Jaundice is not a common symptom of malaria, but dark urine can occur due to kidney damage caused by the disease.

+6. Typhoid Fever: Typhoid fever is caused by the Salmonella typhoid bacterium and is spread through contaminated food or water. Symptoms include fever, headache, abdominal pain, and vomiting. Jaundice is not a common symptom of typhoid fever, but dark urine can occur due to kidney damage caused by the disease.

+7. Viral Hepatitis: Viral hepatitis is an inflammation of the liver caused by a virus. Symptoms include jaundice, fatigue, loss of appetite, nausea, and vomiting. Dark urine is a common symptom of viral hepatitis.

+8. Cirrhosis: Cirrhosis is a chronic liver disease characterized by the replacement of normal liver tissue with scar tissue. Symptoms include jaundice, fatigue, loss of appetite, and vomiting. Dark urine is a common symptom of cirrhosis due to the buildup of bilirubin in the body.

+9. Leptospirosis: Leptospirosis is a bacterial disease spread through contact with contaminated water or soil. Symptoms include fever, headache, muscle aches, and vomiting. Jaundice is not a common symptom of leptospirosis, but dark urine can occur due to kidney damage caused by the disease.

+10. Yellow Fever: Yellow fever is a viral disease spread through the bite of an infected mosquito. Symptoms include fever, chills, muscle pain, headache, and vomiting. Jaundice is a common symptom of yellow fever, and dark urine is also observed in this disease."
['Maple syrup urine disease']," +1. Reye's Syndrome: Seizures, Lethargy, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality :: Growth delay, Death in infancy, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties, Severe hearing impairment, Elevated urinary carboxylic acid
+2. Maple Syrup Urine Disease: Seizures, Lethargy, Hyperammonemia, Hyperleucinemia, Hyperisoleucinemia, Metabolic acidosis :: Growth delay, Death in infancy, Sleep abnormality, Hypervalinemia, Drowsiness, Feeding difficulties, Severe hearing impairment, Elevated urinary carboxylic acid
+3. Phenylketonuria (PKU): Seizures, Lethargy, Hyperammonemia, Metabolic acidosis :: Growth delay, Death in infancy, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties, Severe hearing impairment, Elevated urinary carboxylic acid, Phenylalanine build-up in the blood
+4. Organic Acidemia: Seizures, Lethargy, Metabolic acidosis, Hyperammonemia, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia :: Growth delay, Death in infancy, Sleep abnormality, Drowsiness, Feeding difficulties, Severe hearing impairment, Elevated urinary carboxylic acid
+5. Inborn Errors of Metabolism: Seizures, Lethargy, Metabolic acidosis, Hyperammonemia :: Growth delay, Death in infancy, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties, Severe hearing impairment, Elevated urinary carboxylic acid (varies depending on the specific type)"
['Ornithine transcarbamylase deficiency']," +1. Eczematoid dermatitis: Skin rash, +. Obsolete: not applicable to the case.
+2. Metabolic disorders:
  * +1. Maple Syrup Urine Disease: Hypoglycemia, Hyperammonemia, Hyperglutaminemia, Oroticaciduria, Aminoaciduria, Neonatal death, Death in infancy, Death in childhood.
  * +2. Urea Cycle Disorders: Hyperammonemia, Elevated plasma citrulline.
  * +3. Organic Acidemias: Abnormal circulating arginine concentration, Abnormal circulating proline concentration, Uraciluria, Myocarditis.
+4. Inborn Errors of Metabolism: Hypoglycemia, Vomiting, Recurrent viral infections.
+5. Neurological Disorders:
  * +1. Cerebral Edema: Coma, Cerebral edema.
  * +2. Athetosis: Generalized hypotonia, Athetosis.
+6. Infectious Diseases: Fever, Recurrent viral infections.
+7. Cardiac Disorders: Myocarditis.
+8. Other Disorders:
  * +1. Gastrointestinal inflammation: Vomiting.
  * +2. Seizure Disorders: Not mentioned in the symptoms.
  * +3. Coma: Coma.
  * +4. Death in adolescence: Death in adolescence.

Please note that this list is not exhaustive and further diagnostic tests are required to confirm the diagnosis. The patient's medical history, family history, and physical examination should also be taken into consideration."
